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Abstract 
 
Dihydrofolate reductase (DHFR) is the enzyme that catalyses the reduction of 7,8-dihydrofolate 
(DHF) to 5,6,7,8-tetrahydrofolate (THF) in the presence of the cofactor reduced nicotinamide 
adenine dinucleotide phosphate (NADPH). The DHFR catalysed reaction has often been used to 
study enzymatic tunnelling and the contribution of protein dynamics to catalysis. To gain a better 
understanding of such phenomena and to investigate the key elements of structural adaptation in 
DHFR, in this thesis the hydride transfer reaction of DHFR from Moritella profunda (MpDHFR), a 
cold adapted enzyme, was studied and compared to the mesophilic and extensively studied enzyme 
from Escherichia coli (EcDHFR) and the thermophilic enzyme from Thermotoga maritima 
(TmDHFR). Chapter 1 gives a brief introduction to the thesis. Description of the materials and 
methods used in evaluating this work is reported in Chapter 2. In Chapter 3, the steady state and pre-
steady state temperature dependences of the kinetic isotope effect (KIE) for the MpDHFR catalysed 
reaction was elevated, compared to data obtained for the mesophilic and the thermophilic DHFR 
homologues and the results interpreted according to the environmentally coupled tunnelling model. 
The work presented in Chapters 4 and 5 has investigated the role of dynamics during catalysis by 
DHFR using site directed mutagenesis. In Chapter 4, mutations were created in the GH loop for both 
EcDHFR and MpDHFR to elucidate the role of the occluded conformation during catalysis by 
DHFR. In Chapter 5, different MpDHFR and EcDHFR variants in the highly mobile M20 loop were 
generated and their temperature dependences of KIE were studied in addition to studying the two 
variants MpDHFR-G123V and MpDHFR-D124N in the catalytically important FG loop. The results 
obtained suggest that MpDHFR does not undergo the dynamical loop movements that have been 
recognized previously for EcDHFR in spite of following the same catalytic cycle. Further findings 
were found which contradict the current models that relate protein dynamics to catalysis efficiency, 
thus modifying these models has become essential. Chapter 6 has focused on studying the effect of 
different denaturants/salt concentrations on MpDHFR chemical step. Finally, a summary of the work 
presented in this thesis and future guidelines are provided in Chapter 7.  
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1.1 Enzyme kinetics 
Enzymes catalyze chemical reactions at rates that are astonishingly rapid relative to uncatalyzed 
reactions under the same conditions (typically from 10
5
 up to 10
22
 fold faster). Thus, the catalytic 
rate enhancement imposed by enzymes has attracted the attention of chemists for more than a 
century. In the absence of enzymes, some chemicals would require 300 to 30,000,000 years to react. 
Therefore, enzymes are essential to maintain biological activity under physiological conditions.
1-3
 
 
To elucidate the mechanism of enzymatic reactions, it is important to understand the specific 
interactions between the substrate and its enzyme environment and their effect on the reaction rate.  
Enzyme kinetics is the study of the rate at which an enzyme works. The field of enzyme kinetics has 
undergone significant growth over the past years, accompanied by the development of several 
models for enzyme catalysis, and a true understanding of the principles which motivate the resulting 
rate equations. As a result, it is possible to write equations for the velocity in the presence of all 
reactants, predict the effect of altering the concentration of any reactant and propose the kinetic 
mechanism from experimental data.
4-5
 
 
Over the years, our understanding of enzymatic catalysis has evolved in parallel with the 
development of experimental tools to investigate chemical and kinetic mechanisms. In this thesis, 
steady state and pre-steady state kinetics and kinetic isotope effects were used to study the hydride 
transfer reaction catalysed by dihydrofolate reductase (DHFR). The theoretical bases of these 
techniques are discussed below. 
 
1.1.1 Steady state and pre-steady state kinetics 
Steady state kinetic studies can be used to determine the order of addition and release of reactants 
and products and where the major rate limiting steps are in a mechanism. However, to determine the 
intrinsic rate constants and to characterize intermediates, usually pre-steady state experiments are 
used.
6
 For example, the chemical step during catalysis by DHFR can be measured at physiological 
pH only under pre-steady state conditions and not steady state conditions where product release is the 
rate limiting step.
7
 
 
The initial rate of a given reaction is described mathematically by a rate equation. An enzyme 
catalysed reaction can described by the mechanism given below 
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E S ES P+
k1
k-1
k2
(1.1)
 
 
Equation 1.1 describes the conversion of the substrate (S) into product (P), via the enzyme-bound 
substrate complex (ES). Substrate binds to enzyme with the second order rate constant k1. It can then 
dissociate with first order rate constant k-1 to give free enzyme, or it can be converted to product with 
first order rate constant k2. 
 
Enzyme catalysed reactions are typically assumed to be at steady state, where the rates of formation 
and decay of the intermediates are equal.
8
 We can consider this situation in terms of Equation 1.1. 
When k-1 is greater than k2, then the relative concentrations of free substrate [S], free enzyme [E] and 
the enzyme-substrate complex [ES] can be described by the substrate dissociation constant KS, 
expressed in Equation 1.2. 
 
  
 ES
SE
k
k
KS 

1
1                                                                                  (1.2) 
 
For an enzymatic reaction, at the beginning of the reaction the concentration of the enzyme-substrate 
complex rises from zero to its steady state value. During this time the steady state approximation is 
not applicable as the rate of formation of products is not equal to the rate of consumption of substrate 
(Equation 1.3). This brief period of time is known as “pre-steady state”. The pre-steady state kinetics 
are simply defined as the enzyme kinetics that take place during the short time before the enzymes 
and reactants are able to reach the steady state (Figure 1.1). 
 
   
t
P
t
S




                                                                                          (1.3) 
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Figure 1.1: Graphical description showing the change in product concentration over the reaction 
time. The initial burst represents the pre-steady state region that takes place before the reaction 
reaches the steady state conditions. 
 
When carrying out pre-steady state kinetic experiments, precautions are taken to work under pseudo 
first order conditions. These can be obtained when the enzyme concentration is much greater than the 
reactant concentrations. For experimental measurements of the pre-steady state rate constant, 
techniques that allow spectra of chromophoric reaction components to be collected in the millisecond 
time regime, such as stopped flow and rapid quench techniques, can be used (Figure 1.2). Quench-
flow and stop-flow are designed to mix enzyme and reactants very rapidly to start the enzymatic 
reaction, and then quench it after a certain time. The reaction time ranges from about five 
milliseconds to several seconds. When studying catalysis by DHFR, only stopped flow kinetics were 
used. The quench-flow is used when the enzymatic reaction does not involve a component that can 
be spectrally monitored in real time.
6
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PUSH
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Mixer
 
Figure 1.2: Stopped flow / quenched flow spectrophotometer 
 
On the other hand, the steady state course can be reached when the rate of formation of product is 
equal to the rate of consumption of substrate (Equation 1.4) and can be studied using the methods of 
Michaelis and Menten. 
 
 
0
t
ES


                                                                                             (1.4) 
 
Under steady state conditions, the rate of consumption of substrate or the rate of formation of product 
should change in a linear fashion (Figure 1.1). This can be obtained experimentally by making the 
concentrations of the substrates much greater than the concentration of the enzyme; such conditions 
will maintain a linear change in the substrate concentration over a longer period of time. 
 
The steady state rate constant or the turnover number (kcat) of the reaction can be calculated from the 
reaction velocity, as a function of the concentration of enzyme (Equation 1.5). 
 
 0max EkV cat                                                                                       (1.5) 
 
where Vmax is the maximal velocity of the reaction, and [E]0 is the total enzyme concentration. The 
simplest treatment of the steady state rate equation was provided by the Michaelis-Menten equation 
(Equation 1.6). 
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   
 SK
kSE
v
M
cat

 00                                                                                    (1.6) 
 
where v0 is the velocity of the reaction, [E]0 is the total enzyme concentration, kcat is the steady state 
rate constant, KM is the Michaelis constant. This can be illustrated by plotting the substrate 
concentration against the enzyme velocity (Figure 1.3). At low substrate concentration the velocity of 
the reaction increases linearly with increasing substrate concentration [S]. At high substrate 
concentration, the velocity of the reaction will reach Vmax, the maximal velocity of the reaction 
(Equation 1.5), and KM can obtained by determining the substrate concentration at half maximum 
velocity (Vmax/2) (Figure 1.3). 
 
KM [S]
Vmax
Vmax/2
v0
 
Figure 1.3: A graphical representation of the Michaelis-Menten plot showing the relation between 
the reaction velocity (v0) and substrate concentration [S]. The maximum velocity (Vmax) and 
Michaelis constant (KM) are shown on the graph. 
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1.2 The physical basis of enzyme catalysis 
Many years of research in enzymology have determined that enzymes undergo numerous 
conformational fluctuations during the catalytic cycle.
9-10
 The questions discussed in this thesis 
mainly cover physical phenomena such as how enzyme dynamics and electrostatics contribute to 
enzyme catalysis, by evaluating the temperature dependency of kinetic isotope effects in hydride 
transfer reactions using different DHFR homologues. 
 
In 1894 Emil Fischer proposed the lock-and-key enzyme model. Since that time, various explanations 
for the catalytic power of enzymes have been proposed.
11-12
 In 1935, Eyring initiated the 
development of modern theories of the activated transition-state complex,
13
 which was modified by 
Pauling ten years after.
14
 Soon thereafter, Koshland proposed the “induced fit” mechanism, which is 
a modification of the lock and key model derived by Fischer.
15
 More recently, hydrogen tunnelling 
was proposed to explain enzyme catalysis.
1-2,16-17
 In recent years, many researchers have focused on 
exploring how enzyme dynamics contribute to catalysis.
10,18-19
 
 
1.2.1 Kinetic isotope Effects (KIEs) 
Isotope effects are powerful tools for studying the physical and biological basis of enzymatic 
reactions and are used to aid the understanding of reaction kinetics, mechanisms, and solvent effects. 
Kinetic isotope effects (KIEs) are measured by comparing the ratio of the rate of the reaction 
between two isotopologues, i.e. molecules that differ only in their isotopic composition. Primary  (1˚) 
isotope effects are due to isotopic substitution at a site of bond breaking/forming in the rate 
determining step of a reaction while secondary (2˚) isotope effects occur at sites more distant from 
the reactive centre.
20
 For instance, the primary kinetic isotope effect can be measured during the 
DHFR reaction by replacing the transferred (pro-R) hydrogen at C4 on the nicotinamide ring of the 
cofactor NADPH with deuterium, and comparing the relative rate constants with the different 
isotopically labelled cofactors (kH/kD).
21
 A secondary KIE can be measured, for example, by 
isotopically substituting the pro-S hydrogen of NADPH.
22
 In this work, only primary KIEs have 
been investigated. 
 
1.2.2 Hydrogen Tunnelling in Enzymatic Reactions 
A main concept of quantum mechanics is treating a particle in terms of its location and momentum as 
a wave of energy (‘wave-particle duality’).23 Equation (1.7) is showing that the position and 
momentum of the particle depend on its mass,
24
 defined by the de Broglie wavelength. In terms of 
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this expression, the lighter the particle in mass, the greater the uncertainty of its position and the 
higher its de Broglie wavelength. 
 
mE
h
B 2
                                                                                         (1.7) 
 
where B  is the uncertainty of the position of the transferred particle, h is the Planck’s constant, m is 
the mass of the transferred particle and E is its energy. 
 
Quantum mechanical tunnelling is the physical phenomenon by which a particle transfers through a 
reaction energy barrier by means of its wave-like properties (Figure 1.4).
25
 The de Broglie 
wavelength is an important pattern to take into account when describing the tunnelling of particles 
through the energy barrier. For example, for light particles with small wavelengths such as the H-
nucleus, assuming an energy of 20 kJ mol
-1
, the de Broglie wavelength is calculated to be 0.63 Å for 
protium (H) and 0.45 A˚ for deuterium (D).26 They are transferred over a similar distance (<1 Å) 
along a reaction coordinate, and have a positional uncertainty that gives a significant tunnelling 
probability.
26
 
 
 
Figure 1.4: Illustration of the tunnelling phenomenon along the reaction coordinate. The reactant 
well (R) is on the left and the product well (P) is on the right. The probability of finding the light and 
the heavy isotopes in the reactant or the product wells are shown in blue and red, respectively. More 
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overlap between the probability functions of the reactants and products causes higher tunnelling 
probability.
27
 
 
The tunnelling probability is also affected by many factors including certain properties of the 
particle, the distance between the donor and acceptor (donor-acceptor distance, DAD) and the 
symmetry of the reactant (R) and the product (P) wells.
28
 A light isotope has a higher zero point 
energy and and its probability function is less localized in its well (more diffuse wavefunction), thus 
it has a higher tunnelling probability (Figure 1.4). Consequently, KIEs are useful tools for studying 
tunnelling.
29
 
 
Analyzing the temperature dependence of KIEs using the Arrhenius equation is powerful 
experimental approach to examine the physical nature of H transfer reactions. According to the 
Arrhenius equation, the rate constant of the reaction is exponentially proportional to the activation 
energy and the inverse absolute temperature, 
 
RT
Ea
Aek

                                                                                            (1.8) 
 
where k is the rate constant, A is the Arrhenius pre-exponential factor, and Ea is the reaction 
activation energy. Using the Arrhenius equation, the relationship between the KIE (
h
l
k
k
) and the 
absolute temperature (T) are represented in Equation 1.9. 
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h
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KIE
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

                                                    (1.9) 
 
where kx is the rate constant, Ax is the Arrhenius pre-exponential factor, and Eax is activation energy 
for the transfer of isotope x. x=h and x=l represent the heavy and light isotopes, respectively. Ea(h-l) 
represents the difference in activation energies for the reaction with heavy and light isotopes. 
 
When ln(KIE) is plotted as a function of 1/T, the plot is typically linear. The slope is the difference in 
activation energies between two isotopes divided by the general gas constant (
R
E lha )( 
), and the y-
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axis intercept represents the logarithm of the ratio of Arrhenius pre-exponential factor for the light 
and heavy isotopes (ln Al/Ah). According to Equation 1.9, the temperature dependence/independence 
of KIEs corresponds to the difference in the energy of activation for the two isotopes (Ea). Some of 
the models that have been proposed to explain the experimental results on the temperature 
dependence of KIEs are presented below. 
 
1.2.2.1 Semi-classical models 
Traditional literature treats enzyme catalyzed reactions, including hydrogen transfer, in terms of 
transition state theory (TST).
2
 Almost all of the current discussions of isotope effects in chemical 
reactions are based on TST.
27,29
 TST assumes that the reaction coordinate may be described by a 
minimum in free energy representing the reactant well and a maximum in free energy representing 
the saddle point or transition state (TS) leading to the formation of product (Figure 1.5). Semi-
classically, a KIE is defined in terms of  transition state theory by Equation 1.10.
29
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where kl and kh are the rate constants for the light and heavy isotopic substrates, respectively and are 
expressed in Equation 1.11. 
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where Go is the free energy barrier, h is Planck’s constant and υx is the particle vibrational 
frequency, Ax is a pre-exponential factor and x can be the light or the heavy isotopes. R is the general 
gas constant and T is the absolute temperature. 
 
In H transfer reactions, the transferable hydrogen is labelled with one of the three isotopes of 
hydrogen, i.e., protium (
1
H, or H), deuterium (
2
H, or D), or tritium (
3
H, or T), taking into 
consideration that lighter isotopes have a higher zero point energy (ZPE = ½ h than heavier 
isotopes (Figure 1.5). Therefore, the KIEs can be measured as kH/kT (H/T), kH/kD (H/D), or kD/kT 
(D/T). In the cases addressed here, the KIE significantly depends on the zero point energy of the 
transferred particle and neglects motions in the transition state.
29-30
 Based on the semi-classical 
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models, a primary H/D KIE for C-H cleavage at 298 K is calculated to be 6.9 based on the stretching 
frequencies of a C-H bond and a C-D bond. Similarly, kH/kT is predicted to be 18. This arises because 
the stretching frequencies of a C-H bond, C-D bond and C-T bond are ~3000 cm
–1
, 2200 cm
–1
 and 
1800 cm
–1
, respectively. Such models are not able to explain temperature independent KIE values or 
small KIEs with sharp temperature dependency.
26,31
 
 
 
Figure 1.5: Illustration of the energy barrier to an enzymatic reaction from a semi-classical point of 
view with the path of transfer for the three isotopes of hydrogen indicated. 
 
In 1958 Swain et al. proposed an equation that explains the kinetic relationships between reaction 
rate constants for the three hydrogen isotopes according to the differences in the zero-point energy. 
The Swain-Schaad exponential relationships (EXP) are the semi-classical corrections among the 
hydrogen three isotopes.
32
 They can be represented using H as a reference, 
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or using T as a reference, 
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where k is the rate constant for each hydrogen isotope, and EXP represents the Swain-Schaad 
exponent, which is calculated based on differences in the zero-point energy between two hydrogen 
isotopes. EXPHD and EXPDT are for the relationship for H/T vs. H/D, and H/T vs. D/T, respectively. 
Each EXP is calculated from the following equations:
29
 
 
Using hydrogen as a reference, 
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And using tritium as a reference, 
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where μx is the reduced mass and mx is the atomic mass for the hydrogen isotope (x). The EXPHD was 
calculated as a value of 1.44 using atomic masses
33
 whereas based on reduced mass it is a value of 
1.42. The calculated EXPDT is 3.34 from reduced mass, and 3.26 from atomic mass.
34
 
 
The Swain-Schaad ratio can be used as indicator of tunnelling if the step in the catalytic cycle giving 
rise to the isotope effect is fully rate limiting. Deviations from the values mentioned above could be 
due to kinetic complexity, when more than one step is rate limiting under the reaction conditions or 
the rate determining step is not well isolated and this will lead to a smaller KIE. 
 
1.2.2.2 Bell Model 
The Bell model is a tunnelling correction model of the semi-classical theory, in which tunnelling of 
light particles is described through the energy barrier of the reaction around the transition state 
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(Figure 1.6). According to this model, tunnelling occurs below the energy of the transition state (i.e., 
for the reaction to proceed to products, the difference in energy between the ground state and the 
transition state does not have to be realised) (Figure 1.6). The potential for this tunnelling to occur is 
dependent on certain properties of the particle, such as particle mass, and also on the width of the 
energy barrier or length of the reaction coordinate.
28
  
 
 
Figure 1.6: Representation of the energy barrier to an enzymatic reaction according to Bell’s 
tunnelling correction model with the path of transfer for the three isotopes of hydrogen indicated. 
 
The Bell Model for Tunnel Effect Correction is presented in Equations 1.16 and 1.17 
 
SCt kQk                                                                                                 (1.16) 
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                                                                   (1.17) 
 
where Qt is a tunnelling correction, and ksc is the semi-classical rate constant. G is the probability that 
the particle shall cross the barrier (often described as the permeability of the barrier), and is a 
function of the particle’s mass, width of barrier and the barrier height. W represents the energy of the 
particle, and kb is the Boltzmann constant. According to this, a greater probability of tunnelling can 
occur in the presence of small particle mass, narrow barrier width and small barrier height. This in 
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turn leads to higher 1˚ KIE than the semi-classically predicted value with pre-exponential ratio 
(Al/Ah) <1, and to a large difference in the activation energies (a), exceeding the semi-classical 
limit of 5.4 kJ mol
-1
 (the difference in ZPE at 300 K of the H and D hydrogen isotopes).
30
 
 
Following the arrhenius equation (equation 1.8) and Bell model for tunnelling correction 
29,35
, the 
temperature dependence of the rate constants (k) and the KIE can presented as in Figure 1.7, where 
lnk and lnKIE are plotted versus the inverse temperature. In the high temperature region (Figure 1.7, 
cyan region), the temperature dependence of the KIE reflects the difference in the activation energies 
(ΔEa) of the light and heavy isotopes. Under these conditions, thermal energy is available and 
contribution of tunnelling to the rate is minimal (no tunnelling region). Therefore, at infinite 
temperature, the KIE should be close to unity with (Al/Ah) ≈ 1. On the other hand, at very low 
temperatures, due to the lack of thermal energy, tunnelling contributions dominate the reaction rates 
(extensive tunnelling region) (Figure 1.7, orange region). As a result, the rates of the reaction become 
temperature independent accompanied by temperature independent and large KIE values, with Al/Ah 
larger than unity. In the middle temperature range (Figure 1.7, yellow region), the contribution of H 
tunnelling to the rate is significant, but the contribution of tunnelling is only for the light isotope, in 
contrast to the extensive tunnelling region which includes tunnelling of both isotopes. In the 
moderate tunnelling region, the KIE on Al/Ah is smaller than unity, which has been taken as one of 
the proofs for tunnelling. 
 
Figure 1.7: Arrhenius plot of a hydrogen transfer reaction for TST models with a tunnelling 
correction showing rate constants for the light (blue) and heavy (red) isotopes and the 
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corresponding KIEs versus the inverse absolute temperature. This figure is adapted from reference 
27
. 
 
In the last four decades, the temperature dependences of the KIEs have been determined for a wide 
range of enzymes. Many of those reports could not be fully described by the Bell tunnelling 
correction model. For example, KIEs for soybean lipoxygenase greatly exceeded the semi-classical 
limit with a value of ~80 and Al/Ah exceeded unity, which should suggest it fits the extensive 
tunnelling region in Figure 1.7. However, if this is the case the KIE should be at least six orders of 
magnitude higher than the semi-classical limit, which is not the case.
36
 For other systems a high 
activation energy (Ea) for the H transfer process was obtained along with a high KIE, with no 
temperature dependence of the KIE, which is incompatible with the predictions made above in 
Figure 1.7.
31
 As a one-dimensional potential surface, the Bell tunnelling correction model gives an 
explanation for systems with temperature dependent KIEs, and temperature independent KIEs with 
no energy of activation for the isotopically sensitive step. However, that model fails to explain 
temperature independent KIEs with significant energies of activation. Therefore, the development of 
an assumption that can elucidate more understanding of such a phenomenon is still an ongoing 
challenge. Recent treatments of hydrogen transfer reactions pay attention to the motion(s) of the 
heavy atom environment that modulate the potential surface of the reaction, and the 
multidimensional nature of hydrogen tunnelling.  
 
1.2.2.3 Dynamical treatment of enzyme catalysis 
In contrast to the static lock and key model proposed by Fischer in 1894, the “induced fit” 
mechanism proposed by Koshland pays attention to the important of enzyme flexibility.
15
 However, 
while the induced fit model takes into account the dynamic nature of enzymes, it omits fluctuation 
between different sub-states during the catalytic cycle.  
 
As mentioned previously, the Bell model fails to explain systems that have temperature independent 
KIEs with significant activation energies (vide supra). Marcus-like models are derived from Marcus 
theory for electron transfer and can accommodate both temperature dependent and temperature 
independent KIEs, whether the activation barrier for the reaction is significant or not (vide infra). 
Various modifications have been added to these models under different names such as ‘vibrationally 
enhanced tunnelling’,37 ‘rate-promoting vibrations’,38 and ‘environmentally coupled tunnelling’,39 to 
explain hydrogen transfer in an enzymatic system. 
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1.2.2.3.1 Marcus-like models  
Many researchers have developed models to explain hydrogen transfer reactions in enzymatic 
systems using Marcus theory.
37,40-42
 These models tried to explain the contribution of dynamics to 
hydrogen transfer reactions and proposed that environmental reorganization assists to form an 
optimal conformation of the transition state for tunnelling, known as the tunnelling ready 
conformation (TRC).
26,43
 Different terms are used in all of those models, but all of them share two 
common basic concepts that are required for well-organized tunnelling. One is a short average donor-
acceptor distance (DAD) or arrangement of hydrogen donor and acceptor into an orientation from 
which hydrogen tunnelling would be efficient, and the other is degeneracy of the reactant and 
product energy levels or modulation of hydrogen transfer along the environmental coordinate as 
represented in Figure 1.8. There are different definitions for such motions in the literature, but 
generally they are recognised to be active (“gating”) or re-organisational motions, and passive or pre-
organisational motions respectively.
23
  
 
 
Figure 1.8: Three dimensional representation of a Marcus-like model of the energy surface of 
environmentally coupled hydrogen tunneling. Two orthogonal coordinates are presented: Qenv is the 
environmental free energy surface for the reactants (R: blue) and the products (P: green) with free 
energy of reaction (Go), reorganisation energy (and‡ represents the reactive configuration, and 
q is the gating coordinate along which modulation of the donor acceptor distance (DAD) occurs. The 
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red lines represent the hydrogen’s probability wave-function. The figure is adapted from reference 
44
. 
 
The Marcus-like model is mathematically represented as 
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where ktun is the rate of tunnelling, C is a temperature and isotope independent constant, Go is the 
free energy difference between the reactants and the products (the driving force for the reaction),   
is the reorganization energy,
42
 R is the gas constant and T is the absolute temperature. 
 
In Equation 1.18, the first exponential is the Marcus term. This term is mostly isotopically insensitive 
and corresponds to reorganization along the environmental free energy coordinate to adjust the 
relative energy levels of the reactants and the products to the TRC. The F.C. or Franck-Condon term 
is the tunnelling term and is described in Equation 1.19 
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The F.C. term is an exponential function consisting of two terms. The first term is the integrated 
tunnelling probability of all of the relevant donor–acceptor distances (DAD) as a function of the 
isotopic mass (mx) and frequency (x). This term is DAD and isotope dependent. The second term is 
an exponential function of the energy involved in reaching each DAD (EX). This term is the 
expression of the DAD fluctuations, namely the conformational space and is often defined as ‘gating’ 
which is temperature as well as isotope sensitive. EX can defined as shown in Equation 1.20.  
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where h is Planck’s constant, x is the gating frequency, mx is the mass of the gating unit, rx is the 
tunnelling distance for the transferring isotope and X is the gating coordinate. The gating coordinate 
(X) is related to the gating frequency (x), the tunnelling distance for the transferring isotope (rx), 
and its mass (mx) as showing in Equation 1.21 
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where  is the Planck’s constant divided by 2  
 
Using Equation 1.18, the kinetic isotope effect can describe by the F.C. term as shown in Equation 
1.21, since all other terms cancel each other out. 
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According to the Marcus-like model, a system will have temperature independent KIEs when the 
first exponential of Equation 1.18 dominates and the activation energies for H and D are similar. This 
happens when the enzyme’s conformational distribution, controlled through ‘passive dynamics’, is 
the important feature and the tunnelling ready configuration (TRC) is optimized. Alternatively, when 
the second exponential of Equation 1.19 (the gating term) dominates, ‘active dynamics’ are the major 
contributing factor, temperature-dependent KIEs are observed and the values of AH/AD decrease and 
may approach unity.
26,29,45
 
 
Studies of the temperature dependence of the KIE cannot clearly separate the contribution of each 
term to the tunnelling reaction. Different studies have shown that dynamics does not enhance enzyme 
catalysis.
40,46-47
 However, other theoretical and experimental studies have established an important 
role for protein dynamics in enzyme catalysis.
38,48-50
 For further understanding of the relation 
between protein dynamics and the rate of enzymatic reaction, in this thesis, hydride transfer reaction 
and kinetic isotope effect of dihydrofolate reductase have been studied using DHFR homologues 
from bacteria living over a wide range of temperature environments, namely, the psychrophilic 
DHFR from Moritella profunda (MpDHFR), the mesophilic DHFR from Escherichia coli 
(EcDHFR) and the thermophilic DHFR from Thermatoga maritima (TmDHFR).  
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1.3 Dihydrofolate reductase 
1.3.1 Dihydrofolate reductase in biochemistry 
Dihydrofolate reductase (DHFR) catalyzes the stereospecific reduction of 7,8-dihydrofolate (DHF) to 
5,6,7,8-tetrahydrofolate (THF) in the presence of reduced nicotinamide adenine dinucleotide 
phosphate (NADPH). During the DHFR reaction, the pro-R hydrogen of C4 of NADPH transfers to 
the C6 atom of the pterin ring of DHF with simultaneous protonation at N5 (Figure 1.9).  
 
 
 
 
 
Figure 1.9: The reaction catalysed by DHFR and the structure of the cofactor (NADPH) and 
substrate (DHF). 
 
DHFR is important for maintaining the intracellular pool of THF, a cofactor involved in many 
biological reactions that require transfer of a one carbon unit such as biosynthesis of thymidylate, 
purines and some amino acids (Figure 1.10). As a result of the biological and pharmacological 
importance of DHFR, for many years researchers have been working towards a detailed picture of 
how this enzyme works and it has become a subject of intensive kinetic and structural investigations. 
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Figure 1.10: A selection of biological reactions that use different THF derivatives as a cofactor 
during one carbon transfer reactions. THF is converted to 5,10-methylene-THF. The 5,10-
methylene-THF is then converted to 5-methyl-THF by reduction with NADPH. The methyl group is 
in turn transferred to homocysteine generating methionine in the presence of cobalamin (Vit B12). 
The 5,10-methylene-THF is also used in the presence of thymidylate synthase (TS) to methylate the 
pyrimidine base uracil in deoxyuridine monophosphate (dUMP) to thymine to produce 
deoxythymidine monophosphate (dTMP) which is essential for DNA synthesis. 5,10-methylene-THF 
and 5-formyl-THF can be converted into 5,10-methenyl-THF which is in turn converted to 10-
formyl-THF which acts as a cofactor during purine biosynthesis.
51-52
 
 
THF, the product of the DHFR catalysed reaction, is essential for cell growth and proliferation. 
Hence DHFR is a major target for anticancer and antibacterial drugs.
7
 More than 50 years ago, 
studies of methotrexate (MTX), an anticancer drug that is used as a treatment of leukemias, 
lymphomas and also rheumatoid arthritis, led to the discovery of DHFR.
53
 Figure 1.11 shows a 
variety of drugs that target DHFR. 
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Figure 1.11: Structures of some DHFR inhibitors. Methotrexate (MTX) is a famous anticancer drug. 
Trimethoprim (TMP), which binds tightly to bacterial DHFRs, is an important antibacterial agent. 
Pyrimethamine (PYR) is an antimalarial agent that targets DHFR from Plasmodium falciparum.
54-55
 
 
1.3.2 The three dimensional structure of DHFR 
Due to the biological important of DHFR, it has been characterised from all of the three kingdoms 
and has prompted numerous structural studies. The first crystal structure of DHFR was published in 
1977 
56
 and soon after a huge variety of DHFRs in complex with various ligands were reported. To 
date, more than 200 structures for DHFR isolated from different organisms can be found in the 
Protein Data Bank (PDB) bound to a wide range of ligands.  
 
All the chromosomally encoded DHFRs are relatively small enzymes normally ranging from 18,000 
to 25,000 in molecular weight and they all adopt similar secondary and tertiary structure 
arrangements. The general structure of DHFRs (Figure 1.12) consists of four α-helices, eight β-sheets 
and three structural subdomains that surround the active site cleft. These subdomains are the cofactor 
binding domain (CBD) (residues 38-88 in EcDHFR) where the adenosine moiety of NADP(H) binds, 
the substrate binding domain (SBD) (residues 23-37 in EcDHFR) where DHF binds to the enzyme 
and the loop domain (LD). The loop domain forms approximately 40-50% of the major subdomains 
and is dominated by a set of three loops on the ligand binding face that surround the active site. 
These loops are the M20 loop (residues 9-24), FG loop (residues 116-132), and GH loop (residues 
142-150) (Figure 1.12).
57-58
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Figure 1.12: Cartoon representation of EcDHFR (PDB 1RX2)
59
 showing (A) the substrate binding 
domain (yellow), the cofactor binding domain (green) and the loop domain (red), and (B) the 
secondary structural elements; -helices (red), -strands (yellow) and connecting loops (green). 
Folate (cyan) and NADP
+
 (orange) are shown as spheres. Rotation between (A) and (B) is 180°. 
 
Prokaryotic organisms live at wide range of temperatures starting below 0 °C and extending up to at 
least 113 °C.
60
 The comparative analysis of a series of enzyme homologs across this range of 
temperature allows further understanding of their enzymatic molecular strategies, structural 
flexibility and stability. In this thesis three DHFRs have been used as a model system: DHFR 
isolated from Moritella profunda (MpDHFR), a psychrophilic and moderately piezophilic bacterium 
isolated from deep sea at high pressure and 2 °C;
60
 the mesophilic and the extensively studied DHFR 
from Escherichia coli (EcDHFR); and DHFR from Thermotoga maritima (TmDHFR), a 
hyperthermophilic and anaerobic bacterium with an optimal growth temperature of 80 °C.
61
 The 
amino acid sequences for the three enzymes are shown in Figure 1.13. 
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Figure 1.13: Sequence alignment of the psychrophilic MpDHFR, the mesophilic EcDHFR and the 
thermophilic TmDHFR. 
 
The crystal structures for all of the three enzymes have been reported previously.
59,62-63
 In general, 
the overall folded structures of the psychrophilic, mesophilic and thermophilic DFHR homologues 
are similar, and residues involved in catalysis are highly conserved (Figure 1.13 and Table 1.1). 
However, MpDHFR and EcDHFR are monomeric enzymes, as are most chromosomal DHFRs, 
whereas TmDHFR is the only characterised DHFR which forms a stable homodimer and its 
dimerization interface involves the catalytically important M20 and FG loops
63
 (Figure 1.14). 
Therefore, TmDHFR adopt a rigid structure which was thought to be the reason for the poor catalytic 
efficiency for this enzyme.
64
 However, the monomeric version of this enzyme did not show 
significant change in the hydride transfer rate constant.
65
 
 
Table 1.1: Sequence identity and similarity scores for EcDHFR, MpDHFR and 
TmDHFR 
Enzymes Identity (%) Similarity (%) Non-identity (%) 
Ec and Tm 23.67 21.89 54.44 
Ec and Mp 53.70 19.75 26.55 
Mp and Tm 26.32 20.47 53.21 
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Figure 1.14: Cartoon representation showing the alignment of the crystal structures of MpDHFR 
(blue, PDB 3IA4)
62
, EcDHFR (green, PDB 1DRE)
59
 and TmDHFR (red, PDB 1D1G)
63
 in complex 
with NADP
+
 and methotraxate.(MTX). Part of the dimeric interface of TmDHFR is shown in gray, 
NADP
+ 
and MTX are shown as sticks. 
 
1.3.3 The catalytic cycle of DHFR 
Over the years, DHFR from different sources have been a paradigm for extensive structural and 
mechanistic studies.  The full kinetic schemes have been reported for DHFR from different 
organisms,
66-70
 including EcDHFR
7
 (Figure 1.15). Under steady-state turnover conditions the 
catalytic cycle of EcDHFR was found to follow a specific pathway through five kinetically 
observable intermediates: the holoenzyme E:NADPH; the Michaelis complex E:DHF:NADPH and 
the product complexes E:THF:NADP
+
, E:THF, and E:THF:NADPH (Figure 1.15). The binding 
kinetics suggest that during the EcDHFR catalytic cycle, product dissociation after the chemical step 
follows a specific preferred pathway in which tetrahydrofolate (THF) dissociation occurs after 
NADPH replaces NADP
+
 in the product ternary complex. This is the rate-limiting step for steady-
state turnover at physiological pH. However, hydride transfer becomes the rate limiting step at higher 
pH values.
7
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Figure 1.15 The EcDHFR catalytic cycle at pH 7 and 25 °C. E, dihydrofolate reductase; DHF, 
dihydrofolate; THF, tetrahydrofolate; NADPH, reduced nicotinamide adenine dinucleotide 
phosphate and NADP
+
, oxidized nicotinamide adenine dinucleotide phosphate.
7,71
 
 
1.3.4 Loop motions in DHFR 
Extensive X-ray studies of DHFRs from different organisms have given valuable information on how 
the enzyme binds to its substrate and cofactor in various ligand complexes. The substrate and 
cofactor bind in the deep hydrophobic cleft of the active site in close proximity to one another, which 
allows van der Waals contact between the hydride donor atom (C4 of NADPH) and hydride acceptor 
atom (C6 of the pterin ring of DHF).
72
 Previous studies have shown the role of the loop domain in 
such contact and in maintaining the active site geometry.
73-76
 The M20 loop sits directly over the 
active site, protecting it from solvent and forms stabilizing hydrogen bonding with the neighbouring 
FG and GH loops (vide infra). X-ray studies of EcDHFR have shown that the M20 loop can adapt 
four characteristic conformations according to the bound ligand, occluded, closed, open, and 
disordered.
59
 The first two conformations have been observed in solution NMR experiments.
77-78
 The 
open M20 loop conformation has been seen for both EcDHFR
59
 and MpDHFR
62,79
 only in the 
absence of ligands.
59
 In the open conformation the substrate binding cleft is widened significantly, 
combined with an 8 Å opening to the nicotinamide binding site. Thus this conformation was seen in 
the apoenzyme for EcDHFR and MpDHFR.
62
 The fourth conformation or the ‘disordered state’, in 
which the loop’s motions are unclear crystallographically, is thought to be a result of fluctuations 
between the occluded and closed conformations.
59,72,75
 
 
As mentioned previously, the conformation of the active site loops depends on the ligands bound in 
the substrate and cofactor binding sites.
59
 Binding of the nicotinamide ribose moiety of the cofactor 
within its binding pocket leads to formation of the closed conformation. However, when the substrate 
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site is occupied, DHFR adopts the occluded conformation. Thus, loop movement is coordinated with 
the stages of the catalytic cycle. 
 
1.3.5 Loop movements during the DHFR catalytic cycle 
Movement of the M20 loop of EcDHFR has been proposed to be important for the catalytic cycle. 
Sawaya and Kraut
59 
showed that, during the EcDHFR catalytic cycle, the M20 loop adopts either the 
closed or the occluded conformation according to the binding ligand. The crystal structures provided 
for the five key intermediates of EcDHFR suggest that the enzyme switches between the two 
conformations during the catalytic cycle (Figure 1.16). 
 
 
Figure 1.16: Schematic representation of the catalytic pathway of EcDHFR. In the holoenzyme 
E:NADPH, the Michaelis complex E:NADPH:DHF and the transition state complex 
E.NADPH.THF
‡
, the Met20 loop adopts the closed conformation. In the three product complexes, 
E:NADP
+
, E:THF and E:NADPH:THF, the Met20 loop is in the occluded conformation.
59
 In the 
steady state, product release from E:NADPH:THF ternary complex (Step 5) is the rate limiting step, 
but hydride transfer becomes the rate limiting step at pH higher than 8.4.
7
 
 
The M20 loop is in the closed conformation in the holoenzyme (E.NADPH), the Michaelis complex 
(E.NADPH.DHF), and the transition state (E.NADPH.THF)
‡
, packing against NADPH and 
preventing solvent access to the active site. On the other hand, this loop occludes the nicotinamide 
binding pocket in the three product complexes: E:THF:NADP
+
, E.THF and E:THF:NADPH (Figure 
1.16). In the Michaelis complex and transition state, the nicotinamide-ribose moiety occupies its 
binding pocket within the active site, in close proximity to the pterin ring of the substrate. However, 
in the occluded product complexes, this moiety projects into the solvent.
59
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The occluded and closed conformations differ in structure in the middle part of the Met20 loop.  In 
the closed conformation (Figure 1.17), the M20 loop (residues 16 to 19 in EcDHFR) extends across 
the active site forming a short antiparallel -sheet and a hairpin turn, which effectively seals the 
active site by forming a hydrogen bond between Asn18 in the hairpin and His45. In this 
conformation Met16 and Glu17 in the active side are flipped out allowing nicotinamide binding, 
while the side chains of Asn18 and Met20 sit behind the bound substrate and cofactor. In the 
occluded state, the central region of the Met20 loop forms a 310-helix, with Met16 and Glu17 sitting 
into the active site and occluding the cofactor binding site. In this conformation, the M20 loop 
prevents the nicotinamide group from entering the active site and it instead sticks out into solution.
59
 
It was found that only in the closed conformation are the cofactor and substrate reactive centres in 
close proximity within the active site pocket. This was seen in the structures of the E.NADP
+
.folate 
and E.NADPH.MTX complexes, which are good models of the Michaelis complex and transition 
state, respectively.
59
 Movement between the closed and occluded conformations is thought to be 
important for ligand affinity and progression through the catalytic cycle.
59
 
 
 
Figure 1.17: Cartoon representation of EcDHFR highlighting the positioning of the M20 loop in the 
closed conformation (red, PDB 1RX2), and occluded conformation (blue, PDB 1RX6). DDF is 
shown in magenta and NADPH in orange.
59
 
 
The closed conformation is stabilized by pairs of hydrogen bonds between residues in the M20 loop 
and the FG loop (residues 116 to 132 in EcDHFR), namely Gly15(O) to Asp122(HN) and 
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Glu17(HN) to Asp122(O2) (Figure 1.18).7,59 In the product binary and ternary complexes, on the 
other hand, the loop switches to the occluded conformation, therefore the two hydrogen bonds 
between the M20 loop and FG loop that stabilize the closed conformation are not formed and instead 
the occluded conformation is stabilized by two hydrogen bonds between Asn23 (O and HN) in the 
M20 loop and Ser148 (HN and O2) in the GH loop (residues 142 to 149 in EcDHFR) (Figure 
1.18).
7,59 
 
 
Figure 1.18: Cartoon representation of EcDHFR showing details of the M20 loop, FG loop and GH 
loop and the residues participating in the hydrogen bonds which stabilizes the closed (left, green, 
PDB 1RX2) and the occluded conformation (right, yellow, PDB 1RX6).
59
 
 
1.4 General Research Aims 
Several kinetic, NMR and stimulation studies have been applied to DHFR in order to understand the 
relation between enzyme dynamic and catalysis. Studying catalysis by DHFR should in general 
enhance our understanding of enzyme catalysis and help answering the questions such as how 
enzyme dynamics couple to the reaction coordinate? Are enzyme dynamics important for improving 
enzyme efficiency? These questions, in turn, may lead to advances in enzymology and other aspects 
of chemical catalysis in the broadest sense. 
 
The general aims of this thesis are to study the hydride transfer reaction catalysed by the cold 
adaptive enzyme MpDHFR. And compare it to the mesophilic and the thermophilic homologues, 
EcDHFR and TmDHFR. The rate constants and KIE will be determined as a function of temperature, 
pH and salt concentration, and denaturant concentration to examine their effect on the chemical step 
in catalysis by DHFR. Comparing DHFR homologues across a wide temperature range, and study 
their ability to function at different temperatures should develop our understanding of the role of 
protein motions and tunnelling of the transferred hydride in the chemical step of the different 
homologues, and give deeper insight into the structural elements that present the specific adaptations 
Chapter 1: Introduction 
 29 
of each homologue. 
 
A 
15
N labelled cofactor, NADP
+
 will be synthesised and used to record 
1
H-
15
N HSQC NMR spectra 
with various DHFRs to provide information on how the cofactor binds to the enzyme in different 
complexes. In addition, different MpDHFR and EcDHFR variants in the catalytically important 
loops, viz the M20, FG and GH loop, will be created and studied to investigate the role of loop 
dynamics on catalysis by DHFR and how it can affect the chemical step. 
  30 
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Materials and Methods
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2.1 Materials 
NAD
+
, NADP
+
 and NADPH were purchased from Melford. All other chemicals used in this work 
were purchased from Sigma Aldrich or Fisher Scientific unless otherwise stated. Restriction enzymes 
were purchased either from Promega or New England Biolabs. Oligonucleotides were purchased 
from Eurofins. 
 
2.2 Media and buffers 
2.2.1 Luria-Bertani (LB) medium 
For 1 L LB medium, 10 g Tryptone, 5 g yeast extract and 10 g NaCl were dissolved in 950 mL of 
deionized water and the pH taken to 7.4 with 5 M NaOH. The volume was taken to 1 L and 
sterilized by autoclave for 20 minutes at 121 ºC. The medium was used immediately after cooling 
down or stored at 4 ºC. 
 
2.2.2 LB-Agar medium 
1.5 g agar was added to 100 mL LB medium (Section 2.2.1) and sterilized by autoclave for 20 
minutes at 121 ºC. The solution was allowed to cool to approximately 50 ºC and ampicillin was 
added if required. The sterilized LB-agar medium was poured into sterile petri dishes, left to set 
then stored at 4 ºC. 
 
2.2.3 Ampicillin 
100 mg L
-1
 ampicillin was added to culture media before use. Ampicillin (300 mg) was dissolved in 
1.5 mL sterile water, and then 250 L of this solution was added to 500 mL LB medium. For 
overnight cultures 10 mg ampicillin was added directly to 100 mL of LB medium. 
 
2.2.4 Isopropyl--D-1-thiogalactopyranoside (IPTG) (240 mg mL-1) 
IPTG (360 mg) was dissolved in 1.5 mL sterile water and used at a working concentration of 120 
mg mL
-1
 by adding 250 L of this solution to 500 mL culture medium.  
 
2.2.5 Dithiothreitol (DTT) (10 mM) 
DTT (154 mg) was dissolved in 100 mL deionised water. The solution was sterilised using a 0.2 μm 
syringe filter and stored at 4 °C. DTT was used at a working concentration of 1 mM for enzyme 
storage (Section 2.2.14). 
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2.2.6 Ethylenediaminetetraacetic acid (EDTA) (10 mM, pH 8) 
EDTA (1.46 g) was added to 450 mL deionised water. The pH was adjusted with 5 M NaOH to 
dissolve the solid, the total volume was taken to 500 mL with deionised water and the solution was 
sterilised using a 0.2 μm syringe filter. The stock solution was stored at room temperature and used 
at a working concentration of 0.1 mM for enzyme storage (Section 2.2.14). 
 
2.2.7 dNTP solution 
dNTPs were purchased from Promega at a concentration of 100 mM each. 10 mM stock solution of 
each dNTP was prepared using sterile deionised water, aliquoted and stored at -20 °C.  dNTPs were 
used at a working concentration of 200 Μ. 
 
2.2.8 Buffers used for preparation of ultra-competent cells 
The following solutions were prepared, sterilised using a 0.2 μm syringe filter and stored at 4 ºC. 
 
2.2.8.1 Rubidium chloride solution 1 (Rb1) (30 mM KOAc, 100 mM RbCl, 10 mM CaCl2, 50 
mM MnCl2, 15% (v/v) glycerol, pH 5.8) 
Potassium acetate (294 mg), rubidium chloride (1.21 g), calcium chloride (111 mg), manganese 
chloride (692 mg) and glycerol (15 mL) were dissolved in 80 mL deionised water and the pH was 
adjusted with dilute acetic acid (0.1 M). The total volume was taken to 100 mL with deionised 
water. 
 
2.2.8.2 Rubidium chloride solution 2 (Rb2) (10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15% 
(v/v) glycerol, pH 6.5) 
3-(N-morpholino)propanesulfonic acid (MOPS) (209 mg), calcium chloride (832 mg), rubidium 
chloride (121 mg) and glycerol (15 mL) were dissolved in 80 mL deionised water and the pH was 
adjusted with dilute  NaOH (0.1 M). The total volume was taken to 100 mL with deionised water. 
 
2.2.9 Buffers used for protein purification method 1 
2.2.9.1 Buffer A (50 mM Tris-HCl, pH 8) 
Tris base (6.1 g) was dissolved in 950 mL of deionised water and the pH was adjusted with 6 M 
HCl. The volume was then taken to 1 L with deionised water and the buffer was filtered and 
degassed via vacuum pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany). The 
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buffer was stored at room temperature and 10 mM 2-mercaptoethanol (1.4 mL) was added 
immediately before use. 
 
2.2.9.2 Buffer B (50 mM Tris-HCl, 1 M NaCl, pH 8) 
Tris base (6.1 g) and sodium chloride (58.44 g) were dissolved in 950 mL deionised water and the 
pH was adjusted with 6 M HCl. The volume was then taken to 1 L with deionised water and the 
buffer was filtered and degassed via vacuum pump (Vacuubrand GmbH + CO KG, MD4C, 
Werthein, Germany). The buffer was stored at room temperature. 10 mM 2-mercaptoethanol (1.4 
mL) was added immediately before use.  
 
2.2.9.3 Buffer C (50 mM Tris-HCl, 1 M NaCl, 5 mM sodium folate, pH 8) 
0.11 g folic acid was dissolved in the smallest amount of 0.1 M sodium hydroxide. The volume was 
taken to 50 mL with Buffer B (Section 2.2.9.2) and the pH adjusted using 6 M HCl. The buffer was 
prepared immediately before use. 
 
2.2.10 Buffers used for protein purification method 2 
2.2.10.1 Buffer A (50 mM potassium phosphate, pH 7) 
HK2PO4 (5.4 g) and H2KPO4 (2.6 g) were dissolved in 950 mL deionised water and the pH was 
adjusted using 6 M HCl. The volume was taken to 1 L, the buffer was filtered and degassed by 
vacuum pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, Germany) and stored at room 
temperature. 10 mM of 2-mercaptoethanol (1.4 mL) was added immediately before use. 
 
2.2.10.2 Buffer B (50 mM potassium phosphate, 1 M NaCl, pH 7) 
HK2PO4, (5.4 g), H2KPO4 (2.6 g) and sodium chloride (58.44 g) were dissolved in 950 mL 
deionised water and the pH was adjusted using 6 M HCl.  The volume was taken to 1 L, the buffer 
was filtered and degassed by vacuum pump (Vacuubrand GmbH + CO KG, MD4C, Werthein, 
Germany) and stored at room temperature. 10 mM mercaptoethanol (1.4 mL) was added 
immediately before use. 
 
2.2.11 Buffers used for cofactor purification 
2.2.11.1 Buffer A (20 mM Tris-HCl, pH 9) 
Tris base (1.21 g) was dissolved in 950 mL deionised water, the pH was adjusted with 6 M HCl and 
the volume was taken to 1 L with deionised water. The buffer was filtered, degassed and stored at 
room temperature. 
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2.2.11.2 Buffer B (20 mM Tris-HCl, 1 M NaCl, pH 9) 
Tris base (1.21 g) and sodium chloride (58.44 g) were dissolved in 950 mL of deionised water, the 
pH was adjusted with 6 M HCl and the volume was taken to 1 L with deionised water. The buffer 
was filtered, degassed and stored at room temperature. 
 
2.2.12 Buffers used for tetrahydrofolate (THF) purification 
2.2.12.1 Buffer A (200 mM Tris-HCl, pH 8) 
Tris base (12.1 g) was dissolved in 450 mL deionized water, the pH was adjusted with 6 M HCl and 
the volume was taken to 0.5 L with deionized water. The buffer was filtered, degassed, saturated 
with argon and used immediately. 
 
2.2.12.2 Buffer B (5 mM Tris-HCl, pH 8) 
12.5 mL of Buffer A (Section 2.2.12.1) was taken to 0.5 L with deionized water and the pH was 
adjusted using 6 M HCl before the buffer was filtered and degassed. The buffer was saturated with 
argon before use. 
 
2.2.13 SDS-PAGE 
The following solutions were prepared, stored at room temperature and used for SDS-PAGE 
analysis: 
 
2.2.13.1 Sodium Dodecyl Sulfate (SDS) (10% w/v) 
10 g SDS was dissolved in 100 mL deionized water and stored at room temperature. 
 
2.2.13.2 Bromophenol blue (0.5% w/v) 
50 mg bromophenol blue dye was dissolved in 10 mL deionized water and stored at room 
temperature. 
 
2.2.13.3 Gel buffer (3 M Tris-HCl, 10 mM SDS, pH 8.45)  
Tris base (36.42 g) was dissolved in 95 mL deionised water and 3 mL of 10% SDS stock solution 
(Section 2.2.13.1) was added. The pH was adjusted using 6 M HCl and the volume taken to 100 mL 
with deionised water. 
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2.2.13.4 Loading buffer (780 mM Tris-HCl, 34.7 mM SDS, 10% (v/v) glycerol, 1% (v/v) 2-
mercaptoethanol, 0.01% (w/v) bromophenol blue, pH 6.8) 
Tris base (0.95 g) was added to 7 mL deionised water and 1 mL 10% SDS stock solution (Section 
2.2.13.1), 1 mL glycerol, 100 L 2-mercaptoethanol and 200 L 0.5% bromophenol blue stock 
solution (Section 2.2.13.2) were added. The pH was adjusted using 6 M HCl and the volume taken 
to 10 mL with deionized water.  
 
2.2.13.5 Anode buffer (200 mM Tris-HCl, pH 8.9) 
Tris base (24.28 g) was dissolved in 950 mL deionised water. The pH was adjusted using 6 M HCl 
and the volume taken to 1 L with deionised water.  
 
2.2.13.6 Cathode buffer (100 mM Tris-HCl, 100 mM tricine, 3.5 mM SDS, pH 8.4) 
Tris base (12.14 g) and tricine (17.92 g) were dissolved in 950 mL deionised water and 10 mL 10% 
SDS stock solution (Section 2.2.13.1) was added. The pH was adjusted using 6 M HCl and the 
volume was taken to 1 L with deionised water.  
 
2.2.13.7 Staining solution 
0.25% (w/v) Coomassie blue dye was added to 45% (v/v) methanol and 10% (v/v) glacial acetic 
acid in deionised water and filtered. 
 
2.2.13.8 Destaining solution 
45% (v/v) methanol and 10% (v/v) glacial acetic acid in deionised water. 
 
2.2.14 Protein storage buffer  
MpDHFR was stored in a solution containing 1 mM DTT, 0.1 mM EDTA and 20% sterile glycerol 
using the stock solutions prepared in Sections 2.2.5 and 2.2.6. 
 
2.2.15 TAE buffer 
TAE buffer stock solution (50x) was prepared by dissolving Tris base (242 g) in 800 mL deionised 
water containing 57.1 mL glacial acetic acid and 100 mL of EDTA solution (0.5 M, pH 8). EDTA 
solution (0.5 M, pH 8) was prepared immediately prior to use by dissolving EDTA (14.61 g) in 50 
mL deionised water, adjusting the pH with 5 M NaOH, and taking the volume to 100 mL with 
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deionised water. The working solution of TAE buffer (1x) was made by diluting the stock solution 
50-fold with deionised water. Final solute concentrations are 40 mM Tris acetate and 1 mM EDTA.  
2.2.16 Agarose gel 
Agarose (1-2 g) was added to 100 mL 1x TAE buffer (Section 2.2.15) and the mixture heated in the 
microwave until fully dissolved. The gel was poured into a casting block and allowed to set. Gels 
were run at constant amplitude of 80 V for 45 minutes then stained with 200 mL of dilute ethidium 
bromide solution (Section 2.2.21) and visualized using a Syngene GeneFlash UV light box (Syngene, 
Cambridge, UK). 
 
2.2.17 Phosphate Buffers 
1 M stock solutions of monobasic and dibasic potassium phosphate were prepared by separately 
dissolving 68.1 g and 87.1 g of monobasic and dibasic potassium phosphate respectively in 450 mL 
deionised water. The total volume of each was taken to 0.5 L with deionised water. The stock 
solutions were used in the ratios shown below (Table 2.1) to prepare potassium phosphate buffers of 
varying pH, and diluted accordingly for required buffer concentrations. pD of the deuterated 
phosphate buffers used for SKIE measurements was calculated from the relation: pD = pH meter 
reading + 0.41.
80
 
 
Table 2.1: Phosphate buffer stock solutions. 
pH % 1 M K2HPO4 % 1 M KH2PO4 
5.8 8.5 91.5 
6 13.2 86.8 
6.2 19.2 80.8 
6.4 27.8 72.2 
6.6 38.1 61.9 
6.8 49.1 50.3 
7.0 61.5 38.5 
7.2 71.7 28.3 
7.4 80.2 19.8 
7.6 86.6 13.4 
7.8 90.8 9.2 
8.0 94.0 6.0 
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2.2.18 Urea stock solution (8 M) 
Urea (210.21 g) was dissolved in 200 mL deionised water. After the crystals dissolved completely, 
ion exchange resin was added to deionise the solution. The stock solution was stirred overnight at 
room temperature, filtered and stored at 4 °C. 
 
2.2.19 Kinetic buffers 
2.2.19.1 100 mM phosphate buffer, 100 mM NaCl, 10 mM βME 
For kinetic experiments at physiological pH, 100 mM phosphate buffer was used. 12.3 mL of 
monobasic potassium phosphate 1 M stock solution was added to 7.7 mL of dibasic potassium 
phosphate 1 M stock solution (Section 2.2.17) and the volume was taken to 190 mL with deionised 
water, and NaCl (1.16 g) and mercaptoethanol (140 L) were added. The pH was adjusted to 7 
and the volume was taken to 200 mL with deionised water. 
 
2.2.19.2 MTEN buffer (25 mM MES, 50 mM Tris, 25 mM ethanolamine, 100 mM NaCl, 10 mM 2-
mercaptoethanol) 
For pH values between 9 and 5, MTEN buffer was used. 2-(N-morpholino)ethanesulfonic acid (0.49 
g), Tris base (0.61 g) and NaCl (0.58 g) were dissolved in 90 mL deionised water containing 
ethanolamine (150.9 μL) and 2-mercaptoethanol (140 μL). The volume was taken to 100 mL and 
the pH was adjusted at the experimental temperature prior to use.  
 
2.2.19.3 Urea/phosphate buffers  
Kinetic experiments were performed in urea/phosphate buffers to explore the effect of different 
concentrations of urea on DHFR catalysis. 7 M urea was prepared by adding 12.3 mL of 1 M 
monobasic potassium phosphate stock solution, 7.7 mL of 1 M of dibasic potassium phosphate 
stock solution (Section 2.2.17), NaCl (1.16 g) and mercaptoethanol (140 L) to 175 mL of the 
deionised urea stock solution (Section 2.2.18), The pH was adjusted to 7 and the volume was taken 
to 200 mL with deionised water. To prepare phosphate buffers containing different dilutions of 
urea, the solution was diluted using 100 mM potassium phosphate containing 100 mM NaCl and 10 
mM βME (Section 2.2.19.1) and the pH of each serial dilution was adjusted to 7 before running 
kinetics. 
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2.2.19.4 Guanidinium hydrochloride (Gdn-HCl)/phosphate buffers 
2 M stock solution of Gdn-HCl was prepared by dissolving 19.1 g of guanidinium hydrochloride in 
90 mL of 100 mM phosphate buffer containing 100 mM NaCl and 10 mM βME (Section 2.2.19.1). 
The pH was adjusted to 7 and the volume was taken to 100 mL with 100 mM phosphate buffer and 
the pH was adjusted to 7. To make phosphate buffers containing serial dilutions of Gdn-HCl, the 
stock solution was diluted using 100 mM potassium phosphate (pH 7) containing 100 mM NaCl 
and 10 mM βME (Section 2.2.19.1) and the pH of each serial dilution was adjusted to 7 before 
running kinetics. 
 
2.2.19.5 Various salt/phosphate buffers 
2 M stock solutions of NaCl, KCl and KI were made by dissolving 5.844 g, 7.46 g and 16.6 g of 
NaCl, KCl and KF, respectively, in 45 mL of 100 mM potassium phosphate containing 10 mM 
βME (Section 2.2.19.1). The pH of each stock solution was adjusted to 7 and the volume was taken 
to 50 mL with 100 mM phosphate buffer (Section 2.2.19.1). To prepare phosphate buffers 
containing different concentrations of each salt, the stock solutions were diluted using 100 mM 
potassium phosphate (pH 7) containing 10 mM βME (Section 2.2.19.1) and the pH of each serial 
dilution was adjusted to 7 before running kinetics. 
 
2.2.20 Protein dialysis buffer (5 mM potassium phosphate, 10 mM 2-mercaptoethanol, pH 7) 
1 M monobasic potassium phosphate (12.3 mL), 1 M dibasic potassium phosphate (7.7 mL) 
(Section 2.2.17) and 2-mercaptoethanol (2.8 mL) were added to 3.95 L deionised water. The pH 
was adjusted to 7.0 and the total volume was taken to 4 L with deionised water. The buffer was 
used immediately and dialysis was performed at 4 °C. 
 
2.2.21 Plasmid DNA purification buffers 
The following buffers were prepared and stored at room temperature except buffer P1: 
 
2.2.21.1 Buffer P1 (suspension buffer) (50 mM Tris-HCl, 10 mM EDTA, 50 μg/mL RNase A pH 8) 
Tris-HCl (157.6 mg), EDTA (58.5 mg) and RNase A (50 μg/mL final concentration) were dissolved 
in 15 mL deionised water. The pH was adjusted to 8.0 and the total volume taken to 20 mL with 
deionised water. The solution was stored at 4 °C. 
 
Chapter 2: Materials and Methods 
 39 
2.2.21.2 Buffer P2 (lysis buffer) (0.2 M NaOH, 1% (w/v) SDS) 
NaOH (4 g) and SDS (5 g) were dissolved separately in 200 mL deionised water, the total volumes 
were taken to 250 mL and the solutions stored at room temperature. Immediately prior to use the 
two solutions were mixed 1:1. 
 
2.2.21.3 Buffer N3 (neutralization and binding buffer) (4 M guanidine hydrochloride, 0.5 M 
potassium acetate, pH 4.2) 
Guanidine hydrochloride (7.6 g) and potassium acetate (0.98 g) were dissolved in 15 mL deionised 
water. The pH was adjusted with 6 M HCl and the total volume taken to 20 mL with deionised 
water. 
 
2.2.21.4 Buffer PB (wash buffer) (5 M Guanidine hydrochloride, 20 mM Tris-HCl, 38% (v/v) 
ethanol, pH 6.6) 
Guanidine hydrochloride (9.5 g) and Tris-HCl (63.0 mg) were dissolved in 7.4 mL deionised water. 
Ethanol (7.6 mL) was added, the pH adjusted to 6.6 and the total volume taken to 20 mL with 
deionised water. 
 
2.2.21.5 Buffer PE (wash buffer) (2 mM Tris-HCl , 20 mM NaCl, 80% (v/v) ethanol, pH 7.5) 
NaCl (23.4 mg) and Tris-HCl (6.3 mg) were dissolved in 2 mL deionised water. Ethanol (16 mL) 
was added, the pH adjusted to 7.5 and the total volume taken to 20 mL with deionised water. 
 
2.2.21.6 Buffer EB (elution buffer) (10 mM Tris-HCl, pH 8.5) 
Tris-HCl (32 mg) was dissolved in 15 mL deionised water. The pH was adjusted to 8.5 and total 
volume taken to 20 mL. 
 
2.2.22 Ethidium bromide solution (25 mM) 
Ethidium bromide (8.1 g) was dissolved in 100 mL deionised water. The solution was wrapped in 
foil and stored in the dark at 4 °C. The solution was used at a working concentration of 6 μM, by 
adding 48 μL to 200 mL deionised water immediately prior to gel staining. 
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2.3 Methods 
2.3.1 SDS-PAGE protocol 
10 mL 4% stacking gel and 5 mL 10% running gel were prepared by mixing the following 
components (Table 2.2) 
 
Table 2.2: SDS-PAGE gel compositions 
Ingredient  Stacking gel (4%) Running gel (10%) 
30% Acrylamide/Bis-acrylamide, 29:1 0.67 mL 3.33 mL 
Gel Buffer 1.25 mL 3.33 mL 
Glycerol (50% (v/v)) - 2.60 mL 
Sterile H2O 3.00 mL 0.62 mL 
APS and TEMED were added immediately prior to pouring the gel 
10% APS 50 L 100 L 
TEMED 20 L 20 L 
 
APS and TEMED were added to the running gel, mixed gently, and the gel was poured carefully 
between the two gel casting plates. A layer of isopropanol was added at the top of the gel to remove 
air bubbles and the gel was left for 20 minutes to polymerize. After complete polymerization, the 
isopropanol was removed and absorbed from the top of the gel with tissue and the stacking gel was 
poured carefully. A comb was added and the gel was left for an additional 20 minutes for complete 
polymerization. The gel was either used immediately or wrapped in wet tissue then wrapped with 
foil and stored at 4 C. 
 
2.3.2 Plasmid purification 
After transforming cells (Section 2.3.9.2) with the desired plasmid, one colony was picked from an 
ampicillin selective plate, inoculated in 10 mL of ampicillin selective LB medium and incubated 
overnight at 37 °C and 150 rpm in an Innova® 43 shaker (New Brunswick Scientific, Hertfordshire, 
UK). Cells were harvested by centrifugation for 5 minutes at 4000 RCF (Eppendorf centrifuge 
5415R). Then pure plasmid was isolated using a QIAprep spin miniprep kit (QIAGEN, Crawley, 
UK) via alkaline lysis of the bacterial cells. After that DNA was adsorbed onto a silica membrane in 
the presence of a high salt concentration, washed and eluted following the manufacturer’s 
instructions (see Section 2.2.20 for purification buffers used). 
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2.3.3 DNA sequencing 
 
The concentration of pure plasmid DNA isolated from the appropriate cloning strain of competent 
cells was measured by Nanodrop spectrophotometer and sent for sequencing in a concentration of 
50-100 ng/L by the DNA sequencing core, School of Biosciences, Cardiff University. 
 
2.3.4 Synthesis of dihydrofolate (DHF)
81-82
 
Ascorbic acid (8 g) was dissolved in 80 mL H2O and the pH adjusted to 6.0. Folic acid (400 mg) 
was dissolved in a minimal volume of 0.1 M NaOH, added, and any fluctuation in pH adjusted back 
to pH 6.0. The mixture was stirred whilst purging with N2 and sodium dithionite (4.4 g) was added. 
The reaction was cooled on ice for 5 min and the pH slowly taken to 2.8 via drop-wise addition of 1 
M HCl. The precipitate was decanted and centrifuged at 4 °C, 27000g for 5 minutes. The solid 
pellet was added to another 80 mL of 10% ascorbic acid solution (pH 6.0), cooled on ice and the pH 
decreased to 2.8 by dropwise addition of 1 M HCl. The centrifugation step was repeated and the 
solid pellet re-suspended in ~20 mL acetone and centrifuged again. This washing step was carried 
out twice with acetone and once with diethyl ether. The sample tube containing the product was 
purged with N2, wrapped in foil and stored at -20 °C. The product was dissolved in NaOD and D2O 
for analysis of purity by proton NMR.  
 
2.3.5 Synthesis of tetrahydrofolate (THF)
82-83
 
Tetrahydrofolate was synthesized enzymatically from dihydrofolate using excess EcDHFR in the 
presence of alcohol dehydrogenase from Thermoanaerobacter brockii (TbADH), isopropanol and 
NADP
+
. The reaction was incubated at 37 °C for 1-2 hours, then the product was purified using 
Dionex ICS3000 FPLC and eluted using a linear gradient of 0.2 M Tris buffer (Section 2.2.12.1). 
The peak of interest was collected, freeze dried, aliquoted and stored at -20 °C under argon. The 
concentration of THF was determined using the UV spectrometer at 297 nm using the extinction 
coefficient of 28000 M
-1
 cm
-1
. 
 
2.3.6 Enzymatic preparation of 4R-
2
H-nicotinamide adenine dinucleotide phosphate reduced 
form (NADPD).
84-85
  
Synthesis of NADPD relies on the 4R stereospecific reduction of NADP
+
 TbADH, with d8-
isopropanol as the substrate.  
NADP
+
 (10 mg) was dissolved in ~1 mL 25 mM Tris buffer (pH 9.0) and 0.2 mL d8-isopropanol 
was added. The volume was taken to 2 mL with the same buffer, and the reaction started by adding 
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6 units of TbADH. The reaction was incubated at 40 °C with stirring for 30 minutes. The reaction 
solution was purified by Dionex ICS3000 FPLC on a SAX10 anion exchange column eluting with a 
0 to 0.75 M NaCl gradient over 14 min, then the eluted NADPD was flash frozen, wrapped in foil 
and stored at -20 °C. 
  
2.3.7 Synthesis of 
15
N-labelled NADP
+ 
2.3.7.1 Synthesis of 
15
N-nicotinamide: 
15
N-labelled nicotinamide was synthesized according to a literature protocol.
86
 First the reaction 
was performed with unlabelled ammonium chloride to adjust the reaction conditions.  
1 equivalent of nicotinic acid (123.1 mg, 1.0 mmol) was mixed with 1.5 equivalent of 
dicyclohexylcarbodiimide (DCC), (309.5 mg, 1.5 mmol) in dimethylformamide (DMF; 4 mL) and 
stirred at room temperature for 5 minutes. 1.5 equivalent of hydroxybenzotriazole (HOBt), 202.7 
mg, 1.5 mmol), 4 equivalent of 
15
N-NH4Cl (215.6 mg, 4 mmol) and diisopropylethylamine (2 mL) 
were added. The reaction was stirred overnight at room temperature, then the solvent was 
evaporated under vacuum and an excess of water was added to the crude product to precipitate the 
co-product dicyclohexylurea, excess DCC and HOBt. The last step was repeated until no further 
precipitate formed, then the water was evaporated under vacuum and the crude product was 
dissolved in 2 mL deionised water and separated by preparative HPLC using a flow rate of 10 
mL/min and monitoring the eluent at 254 nm, with a mixture of (99/1 v/v) aqueous formic acid 
(0.1%) and methanol. 
 
2.3.7.2 Incorporation of 
15
N-nicotinamide into NADP
+
: 
The 
15
N-labelled nicotinamide was exchanged into NADP
+
 using porcine brain NADase as 
described below.
87-88
 
 
The labeled nicotinamide (250 mg) was incorporated into NADP
+
 (80 mg) using porcine brain 
NADase (120 mg of 0.1 unit/mg) in 12 ml of 20 mM phosphate buffer pH 7.5 at 37 ºC. The exchange 
reaction was monitored by UV spectrometer by following the change in the absorbance at 340 nm 
after adding excess alcohol dehydrogenase from Thermoanaerobacter brockii (TbADH) and 
isopropanol. 5% trichloroacetic acid was added to the reaction mixture after 2 days to denature the 
NADase and the reaction mixture was centrifuged. 
15
N-labeled NADP
+
 was precipitated from the 
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supernatant with 5 volumes of cold acetone and used for NMR experiments without further 
purification.  
All the NMR experiments were performed on Varian INOVA 800 MHz spectrometer at 20 °C in 50 
mM phosphate buffer containing 1 mM of NaCl and 10 mM BME. 10% D2O was added to all the 
NMR samples before being acquired. 
15
N(AM)-NADP
+
 was added to 2 fold excess of either 
DHFR/folate or DHFR/THF. The pH of the samples was adjusted carefully using 1M HCl and 1M 
KOH. Spectra were processed using the MATLAB based software package NMRLab/MetaboLab.
89
  
 
2.3.8 Site directed mutagenesis 
The following primers were used for site directed mutagenesis of EcDHFR and MpDHFR. The 
MpDHFR-G123V variant was created by Dr Rhiannon Evans.
90
 The bases that have been replaced 
are underlined. 
 
Ec-N23PP -Fwd- 5'-GAAAACGCCATGCCGTGGCCGCCGCTGCCTGCCGATCTCGCC-3'  
                   Bwd- 5’-GGCGAGATCGGCAGGCAGCGGCGGCCACGGCATGGCGTTTTC-3’ 
 
Ec-M16L- Fwd- 5’-GATCGCGTTATCGGCCTGGAAAACGCCATGCCG-3’ 
                  Bwd- 5’-CGGCATGGCGTTTTCCAGGCCGATAACGCGATC-3’ 
 
Ec A19K-Fwd- 5’-GGCATGGAAAACAAAATGCCGTGGAACCTG-3’ 
                Bwd- 5’-CAGGTTCCACGGCATTTTGTTTTCCATGCC-3’ 
 
Ec-M16L/A19K-Fwd- 5’-GATCGCGTTATCGGCCTGGAAAACAAAATGCCGTGGAAC-3’ 
                            Bwd- 5’-GTTCCACGGCATTTTGTTTTCCAGGCCGATAACGCGATC-3’ 
 
Ec-S148A -Fwd- 5'-GCGCAGAACGCTCACAGCTATTGC-3' 
                   Bwd- 5’-GCAATAGCTGTGAGCGTTCTGCGC -3’ 
 
Ec-S148P -Fwd- 5’-GCTGATGCGCAGAACCCTCACAGCTATTGC-3’ 
                   Bwd- 5’-GCAATAGCTGTGAGGGTTCTGCGCATCAGC-3’ 
 
Mp-H24N -Fwd- 5’-GATAATAAGATGCCGTGGAATTTACCTGCTG-3’ 
                   Bwd- 5’-CAGCAGGTAAATTCCACGGCATCTTATTATC -3’ 
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Mp-L16M- Fwd- 5’-CCGCGTGATTGGTATGGATAATAAGATGCCG-3’ 
                   Bwd- 5’-CGGCATCTTATTATCCATACCAATCACGCGG-3’ 
 
Mp-K19A- Fwd- 5'-GATTGGTTTAGATAATGCGATGCCGTGGCAT-3' 
                   Bwd- 5’-ATGCCACGGCATCGCATTATCTAAACCAATC-3' 
 
Mp-L16M/K19A-Fwd- 5'-AACCGCGTGATTGGTATGGATAATGCGATGCCGTGGCAT-3' 
                             Bwd- 5’-ATGCCACGGCATCGCATTATCCATACCAATCACGCGGTT-3' 
 
Mp-D124N- Fwd- 5’-GAATTAACCACCGAAGGGAATACTTGGTTC -3’ 
                     Bwd- 5’-GAACCAAGTATTCCCTTCGGTGGTTAATTC -3’ 
 
Mp-G123V- Fwd 5’-GAATTAACCACCGAAGTGGATACTTGGTTC-3’ 
                     Bwd 5’-GAACCAAGTATCCACTTCGGTGGTTAATTC-3’ 
 
Mp-P150S-Fwd- 5’-GCGGCAGATGATAAAAACTCGCATAATTACCGC-3’ 
                   Bwd- 5’-GCGGTAAT TATGCGAGTTTTTATCATCTGCCGC -3’ 
 
For EcDHFR-S148P, MpDHFR-H24N and MpDHFR-P150S, the Finnzymes Phusion® site 
directed mutagenesis kit was used. Several dilutions of template DNA were made and the required 
components were added (Table 2.3). The PCR cycle was set up as outlined in Table 2.4. 
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Table 2.3: Components required for the site directed mutagenesis reactions. 
Component 50 L reaction Final conc. 
H2O To 50 L  
5x Phusion® HF Buffer 10 L 1x 
20 mM dNTPs 0.5 L 200 M each 
Fwd primer 1 L 0.5 M 
Bwd primer 1 L 0.5 M 
Template DNA 1 L - 
DMSO 1.5 L 3 % 
MgCl2 1 L 1 mM 
Phusion® DNA Polymerase 0.5 L 0.02 U/L 
 
 
Table 2.4: Temperatures and durations of the PCR cycle used in 
site directed mutagenesis. 
Cycle step Temperature Time Cycles 
Initial denaturation 98 C 1 m 1 
Denaturation 98 C 30 s  
35 Annealing 70 C 30 s 
Extension 72 C 1m 40 s 
Final extension 72 C 
4 C 
5 m 
Hold 
1 
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For all other variants, the Pfu site directed mutagenesis kit was used. The components of the PCR 
reaction and the reaction cycles used are outlined in Tables 2.5 and 2.6. 
 
Table 2.5: Components required for the site directed mutagenesis reactions. 
Component 50 L reaction Final conc. 
H2O To 50 L  
10 x Pfu polymerase Buffer 5 L 1x 
20 mM dNTPs 0.5 L 200 M each 
Fwd primer 2 L 0.5 M 
Bwd primer 2 L 0.5 M 
Template DNA 1 L - 
Pfu DNA Polymerase 1 L 0.02 U/L 
 
 
Table 2.6: Temperatures and durations of the PCR cycle used in 
site directed mutagenesis. 
Cycle step Temperature Time Cycles 
Initial denaturation 95 C 3 min 1 
Denaturation 95 C 1 min  
16 Annealing 55-60 C 2 min 
Extension 72 C 12 min  
Final extension 72 C 
4 C 
12 min 
Hold 
1 
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2.3.9 Protein preparation 
The bacterium M. profunda was purchased from the Belgian Co-ordinated Collections of 
Microorganisms – Laboratory of Microbiology Ghent University (BCCM-LMG).Moritella profunda 
chromosomal DNA was isolated, amplified and cloned in a PET expression vector by Dr Rhiannon 
Evans.
90
 Primers were designed using the gene sequence for M. profunda (EMBL ID-AJ487535, 
UniProtKB/TrEMBL entry Q70YQ6), which was submitted in 2002 to the EMBL/GenBank/DDBJ 
databases by Xu and coworkers.
60
 
 
2.3.9.1 Preparation of ultra-competent cells 
Competent cells were prepared by streaking a glycerol stock of the cells on non-selective agar 
plates and ampicillin plates (as a negative control) and incubating at 37 °C overnight. A single 
colony from the agar plate was inoculated in non-selective LB medium (10 mL) and incubated at 37 
°C until an optical density at 600 nm of 0.6 was reached after which the cells remained on ice. Cells 
were harvested by centrifugation at 5000 RPM, 4 °C for 5 minutes and the supernatant solution 
discarded. Cells were resuspended in 5 mL Rb1 solution (Section 2.2.8.1) and incubated on ice for 
20 minutes, centrifugation step repeated. Then cells were resuspended in 6 mL of Rb2 solution 
(Section 2.2.8.2) then aliquoted (100 μL) into sterile Eppendorff tubes and flash frozen in liquid 
nitrogen for storage at -80 °C. 
 
2.3.9.2 Transformation 
Ultra-competent E. coli BL21 CodonPlus®(DE3) and E. coli BL21 CodonPlus®(DE3)RIL cells 
were used for plasmids harbouring EcDHFR and MpDHFR respectively. 
A solution of the required plasmid (1-2 µL) was added to 100 µL ultra-competent cell suspension 
previously defrosted on ice. The cells were held on ice for 30 min and heat shocked in a water bath 
at 42 °C for 40 seconds. Preheated LB medium (250 µL) was then added to the cell suspension and 
the solution was incubated at 37 °C and 150 rpm for 30 min. The cells were plated on preheated 
agar plates containing ampicillin (100 mg/L). Inverted plates were incubated overnight at 37 °C and 
stored at 4 °C. 
 
2.3.9.3 Expression 
A single colony from a plate of freshly transformed cells was picked and inoculated in 100 mL LB 
medium (containing 100 mg/L ampicillin) overnight at 37 °C and 180 rpm. This overnight culture 
(60 mL) was used to inoculate 3000 mL of LB medium (containing 100 mg/L ampicillin) and the 
cells were then grown at 37 °C and 150 rpm until the OD600 was 0.6. Then temperature was taken to 
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16 °C, IPTG (120 mg/L) was added and protein was expressed at 16 °C overnight. The cells were 
then harvested via centrifugation in a Sorvall RC 6 Plus centrifuge (Thermo Fisher Scientific, Inc, 
MA, USA) using an SLA-3000 rotor at 6090 RCF for 20 minutes and the pellet either used 
immediately for purification or stored at -80 °C.  
 
2.3.10 Protein purification 
The harvested cells were re-suspended in a minimal volume of Buffer A (either 50 mM Tris buffer, 
pH 8.0 (Section 2.2.9.1) or 50 mM potassium phosphate buffer, pH 7 (Section 2.2.5.1), according to 
the purification method used). The suspension was sonicated three times for 5 min on ice and re-
centrifuged at 17065 RCF for 30 minutes in a Sorvall RC 6 Plus centrifuge (Thermo Fisher 
Scientific, Inc, MA, USA) using an F21S-8x50 rotor to pellet cell debris. The supernatant solution 
was used for subsequent purification. 
 
2.3.10.1 Protein purification method 1 
2.3.10.1.1 Affinity chromatography (MTX) 
The supernatant solution was applied to a methotrexate/agarose column equilibrated with Buffer A 
(Section 2.2.9.1). The column was washed with three coloum volumes of Buffer A then with one 
column volume of Buffer B (Section 2.2.9.2). Methotrexate is a specific reversible inhibitor of 
DHFR; therefore any DHFR present in the supernatant will bind the ligand and remain on the 
column. DHFR was eluted from the methotrexate column with 50 mL of 5 mM sodium folate 
(Buffer C, Section 2.2.9.3). Folic acid is the enzyme’s substrate, which therefore competes with the 
methotrexate for the active site, releasing the enzyme from the column matrix. The eluent was 
dialysed overnight against 4 L of 5 mM potassium phosphate buffer at pH 7 (Section 2.2.18). 
 
2.3.10.1.2 Anion exchange chromatography (DEAE)  
The protein solution was applied to DEAE-Sepharose equilibrated with Buffer A. Bound proteins 
were eluted with a gradient from 0 to 1 M NaCl and used immediately for pre-steady state kinetics. 
For steady state kinetics the protein was either used fresh or exchanged into 2.5 mM potassium 
phosphate buffer (pH 7), 20 % glycerol, 0.1 mM EDTA, 1 mM DTT (Section 2.2.14), flash frozen 
and stored at -20°C. 
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2.3.10.2 Protein purification method 2 
2.3.10.2.1 Anion exchange chromatography (Q-sepharose)  
The supernatant solution (~30 mL) was applied to Q-sepharose column with column volume of 70 
mL equilibrated with Buffer A (Section 2.2.5.1). The column was washed with 3-4 column volumes 
of Buffer A (Section 2.2.5.1) before eluting the protein with gradient from 0 to 1 M NaCl (using 
Buffer B (Section 2.2.5.2)) over 3 column volumes.  
 
2.3.10.2.2 Size exclusion chromatography (Superdex 75)  
The volume of the eluted protein was taken to 10 mL with Amicon and injected into Superdex 75 
sixe exclusion column with column volume of 320 mL, equiliberated with Buffer A (Section 
2.2.5.1). The enzyme was eluted with 1.5 column volume of Buffer A (Section 2.2.5.1). 
 
2.3.11 Enzyme concentration determination 
The concentration of the pure enzyme was determined by measuring the absorption at wavelengths 
of 210, 215 and 220 nm using equation (2.1) 
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where df is the dilution factor, A210,  A215, A220  and 210, 215, 220 are the absorptions and the 
excitation coefficients at 210, 215 and 220 nm respectively. 210 = 20 ml.mg
-1
.cm
-1
, 215 =15 
ml.mg
-1
.cm 
-1 
and 220 = 11 ml.mg
-1
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To express the concentration into M, the concentration in mg/mL was divided by the enzyme 
molecular weight (18000 for EcDHFR and 18291 for MpDHFR) and multiplied by 10
6
 (equation 
2.2). 
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2.3.12 Kinetic assay  
2.3.12.1 Steady state kinetics 
Steady state turnover numbers (kcat) were measured under saturating conditions by monitoring the 
linear decrease in the absorbance of the reduced cofactor NADPH at 340 nm with time via UV 
spectroscopy. For all the steady state kinetics reported in this work, 8-50 nM DHFR was incubated 
with NADPH/NADPD (100 M) in the appropriate assay buffer for 60 seconds at the experimental 
temperature, to avoid hysteresis,
7
 prior to the addition of DHF (100 M) to initiate the reaction. 
Each data point was measured at least three times then the total rate of formation the product in 
µM.s
-1
 was calculated using the expression: 
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Where ε is the molar absorbance change at 340 nm during the DHFR catalysed reaction, 11800 M-1 
cm
-1
.
80
 
 
2.3.12.2 Measuring the Michaelis constant (KM) 
Michaelis constants were measured following the same method as kcat (Section 2.3.12.1), except 
that an enzyme concentration of 10-20 nM was used. The concentration of NADPH was varied 
from 0.1 to 200 µM, and of the concentration of DHF was varied from 0.1 to 100 µM. When the 
concentration of one substrate was varied, that of the other was maintained at 100 µM. Each data 
point is the result of three independent measurements. The Michaelis-Menten equation was fit to the 
change in initial rate with concentration using SigmaPlot 10. 
 
2.3.12.3 Pre-steady state (stopped-flow) kinetics 
Pre-steady state kinetic experiments were performed on an Applied Photophysics stopped-flow 
spectrophotometer. Hydride transfer rate constants were measured following the fluorescence 
resonance energy transfer from the protein to the reduced cofactor NADPH. The reaction mixture 
was excited at 292 nm and the emission was measured using an output filter with a cut-off at 400 
nm. DHFR (20-40 μM syringe concentration) was incubated with NADPH or NADPD (10-20 μM) 
at the experimental temperature for at least 3 minutes to avoid hysteresis. Then the reaction was 
started by rapidly mixing with an equal volume of dihydrofolate (200-400 μM).  
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2.3.12.4 Measurements of THF dissociation rates 
The dissociation rates of THF were measured using stop flow apparatus by monitoring the decrease 
in the fluorescence signals at 340 nm following excitation at 292 nm. Different binary and ternary 
complexes were rapidly mixed with an excess of methotrexate. 
 
2.3.12.5 pH dependence kinetics 
Steady state and pre-steady state pH dependences were examined in MTEN buffer (Section 2.2.19) 
in the range between 5 and 9 for steady state catalysis either at room temperature or at 5 C. The pH 
of the buffer was adjusted carefully at the experimental temperature before use. For all the 
experiments performed in deuterated buffers, pD was calculated from the relation: pD = pH meter 
reading + 0.41.
80
 
 
2.3.13 Circular Dichroism spectroscopy 
All circular dichroism spectroscopy was carried out using a Chirascan
TM
 spectrometer (Applied 
Photophysics Limited, UK). 
 
2.3.13.1 Buffers for thermal denaturation experiments 
5 mM potassium phosphate buffer (pH 7) was used to record the thermal melting temperature of the 
various enzymes used. The buffer was sterilised with a 0.2 μm syringe filter and degassed via 
vacuum pump. A blank run was always taken of the buffer alone before starting the experiment. 
 
2.3.13.2 Calculation of Mean Residue Ellipticity (MRE) 
The signal obtained from CD experiments was converted into mean residue ellipticity (MRE) using 
Equation 2.4. 
MRE =  / 10.n.c.l                                        (2.4) 
 
where:  = CD signal in millideg, n = number of backbone peptide bonds (i.e. number of amino 
acid residues - 1), c = molar concentration of sample, and l = pathlength of cuvette used in cm. 
Typically a 1 mm pathlength cuvette was used to monitor the CD spectrum of DHFR from 190-400 
nm using ~10 μM enzyme. 
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2.3.14 Errors and propagations 
2.3.14.1 Standard deviation and standard error of the mean 
The errors in this work are reported as the standard error of the mean (M) as in Equation 2.5 which 
is defined as the standard deviation (Equation 2.6) of the values in the sample divided by the square 
root of the sample size. 
                                                          
n
M

                                                           (2.5) 
where X is each value measured in the sample, M is the mean of the sample and n is the sample 
size. 
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2.3.14.2 Propagation of errors 
In this thesis the effect of the uncertainty of values directly measured experimentally (X or Y) on 
the uncertainty of a function based up on them (Z) was calculated using Equations 2.7-10. The 
equation used is dependent on the treatment of X and Y in order to obtain the value of Z. 
 
If Z = X + Y or Z = X – Y          then                 
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If Z = X * Y or Z = X / Y          then 
                                                                   
22





 





 

Y
Y
X
X
ZZ                                          (2.8) 
 
If        Y = ln X      then 
                                                                     

Y 
X
X                                                              (2.9) 
 
Y = e
X 
       then  
                                                                    

Y X eX                                                        (2.10) 
where X and Y are independently measured values, X and Y are their errors or uncertainty, and 
Z is the calculated value and Z is its propagated error. 
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Hydride transfer catalysed by a cold adapted 
dihydrofolate reductase 
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3.1 Preface 
DHFRs from the mesophilic bacterium Escherichia coli (EcDHFR) and the thermophilic bacterium 
Thermotoga maritima (TmDHFR) have been extensively studied. Studying a psychrophilic DHFR is 
important to expand the temperature range over which they have been analysed. The main target is to 
compare DHFR homologues across a wide temperature range, and to study their ability to function at 
different temperatures. This should give more information about the role of protein motions and 
tunnelling of the transferred hydride in the chemical step of the different homologues, and give 
deeper insight into the structural elements that present the specific adaptations of each homologue.  
 
DHFR from the psychrophilic bacterium Moritella profunda (MpDHFR) has a very similar crystal 
structure to EcDHFR
91
 and the two enzymes are monomers and exhibit 55% sequence identity.
92 
On 
the other hand, DHFR from the hyperthermophilic bacterium Thermotoga maritima (TmDHFR) is 
the only DHFR shown to be dimeric so far, although it is likely that other DHFRs from the genus 
Thermotoga are also dimeric.
93-94
 In spite of the dimeric structure of TmDHFR, this enzyme 
maintains a very similar tertiary structure to that of monomeric DHFRs
63
 with 23% sequence identity 
with EcDHFR and 26% with MpDHFR. 
 
In this chapter, hydride transfer catalysed by the cold adapted dihydrofolate reductase from Moritella 
profunda (MpDHFR) and kinetic isotope effect (KIE) in the steady and pre-steady state are reported. 
The data obtained is compared with hydride transfer data for the mesophilic EcDHFR and the 
hyperthermophelic TmDHFR. 
 
3.2 Measurements of hydride transfer catalysed by MpDHFR 
Hydride transfer rate constants for MpDHFR were measured under single-turnover conditions using 
an Applied Photophysics stopped-flow spectrophotometer. Reduction of the fluorescence resonance 
energy transfer (FRET) from the enzyme to NADPH during the reaction was observed by exciting 
the sample at 292 nm and measuring the emission at 450 nm (Figure 3.1).  
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Figure 3.1: Cartoon representation of MpDHFR (PDB 3IA4)
62
 illustrating fluorescence resonance 
energy transfer (FRET) from W23 in the active site to the cofactor (NADPH). The position of C105 is 
shown as a red sphere. 
 
Unlike in EcDHFR, hydride transfer could not be measured in MpDHFR purified using buffers 
containing only 5 mM β-mercaptoethanol. MpDHFR has only one cysteine residue in position 105, 
(phenylalanine in EcDHFR), close to the cofactor-binding site (Figure 3.1), which might become 
oxidised, causing the poor stopped flow signals. Therefore, either 10 mM β-mercaptoethanol or 5 
mM DTT were added to all of the purification and kinetic buffers in order to measure hydride 
transfer by MpDHFR to prevent the enzyme oxidation during the purification and the measurements. 
 
A recent NMR study in our group for MpDHFR in the ternary complex E.NADP
+
.Folate showed a 
doubling of resonance for the residues around C105 related to the reduced and the oxidized enzyme. 
Such doubling of resonances was not observed for the cysteine residues in EcDHFR in the same 
complex under the same conditions.
95
 Hydrogen-deuterium exchange experiments gave evidence that 
MpDHFR is more flexible than EcDHFR, which might in turn make MpDHFR more exposed to 
oxidation than its mesophilic counterpart.
96
 The two variants MpDHFR-C105A and C105S have 
been created and studied before, but both mutants showed remarkably different kinetics to the wild-
type enzyme and no additional studies were performed.
90,95
 To avoid enzyme oxidation, argon 
saturated buffers were used for preparing all the NMR samples.
95
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Figure 3.2: Stopped flow traces of hydride (black) and deuteride (red) transfer catalysed by 
MpDHFR at 20 °C. 
 
The stopped flow trace was different when deuteride was transferred in comparison to hydride 
(Figure 3.2). An initial burst phase was observed for both NADPH and NADPD, but with NADPD 
the change in signal amplitude was to some extent lower than that of NADPH across the whole time 
of the measurement. 
 
3.2.1 Temperature dependences of hydride transfer from MpDHFR 
The temperature dependences for hydride and deuteride transfer were measured for MpDHFR at 
temperatures between 5 and 30 
o
C, at pH 7 in H2O (Figure 3.3 and Table 3.1) and D2O (Table 3.1). A 
wider temperature range could not be used due to the low melting temperature for MpDHFR as 
measured by CD spectroscopy (~37 °C).
79
 
 
At pH 7 and under the temperature range used, kH was significantly higher than kcat (kcat = 14.78 ± 
0.79 s
-1
 at 20 ˚C)79, which is in good accordance with the reported value of the steady state primary 
hydrogen kinetic isotope effect (KIE) (KIE = 1.05 ± 0.04 at 20 ˚C)79 and indicates that kcat is 
reflecting a physical step of the catalytic cycle. Similar observations were reported for EcDHFR as 
kcat is representing THF release from the ternary product complex E.NADPH.THF.
7
 In contrast the 
thermophilic enzyme, TmDHFR, has a contribution from the chemical step to the steady state rate at 
physiological pH with a KIE of 3.5.
64
 Comparing the rate constants obtained for MpDHFR in both 
H2O and D2O with those obtained for EcDHFR and TmDHFR, shows an increase in the efficiency of 
hydride transfer with decreasing thermophilicity (Tables 3.1, 3.2 and 3.3). The psychrophilic 
enzyme, MpDHFR, and mesophilic enzyme, EcDHFR, have hydride transfer rate constants of 
similar magnitude (100-1000 s
-1
), whilst that for the thermophilic TmDHFR is reduced in 
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comparison, at around 1-10 s
-1
.
96-98
 The hydride transfer rate constants were predicted for the three 
DHFRs, by linear extrapolation from the Arrhenius plots, at the typical operating temperatures and 
were found to be 255.0 ± 6.4, 317.3 ± 1.6 and 8.2 ± 0.1 s
-1
 for MpDHFR at 2 ºC, EcDHFR at 37 ºC 
and TmDHFR at 90 ºC, respectively.
96
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Figure 3.3: Temperature dependence (left) and Arrhenius plots (right) of the pre-steady state rate 
constants for hydride (kH, circles) and deuteride (kD, triangles) transfer during catalysis by 
TmDHFR
98
 (red), EcDHFR
98
 (green) and MpDHFR (blue) at pH 7. 
 
In D2O, similar to the mesophilic and the thermophilic enzyme (Tables 3.2 and 3.3),
98
 a significant 
increase in the rate constants for both hydride and deuteride transfer was seen with MpDHFR (Table 
3.1). An apparent inverse solvent KIE of 0.63 ± 0.04 for hydride transfer and 0.63 ± 0.06 for 
deuteride transfer was determined for the MpDHFR catalysed reaction at 20 ºC compared to 0.41 ± 
0.05 and 0.42 ± 0.02 for hydride transfer and 0.25 ± 0.12 and 0.45 ± 0.05 for deuteride transfer for 
the mesosphilic and the thermophilic homologs at the same temperature,
98
 respectively. 
Measurement of hydride transfer rates at varying pH in D2O for MpDHFR catalysed reaction (Figure 
3.4 and Table 3.4) is showing that the increase in kH is a result of a D2O-induced pKa shift (to 7.13 ± 
0.13, a shift of 0.60 ± 0.03 pH units) rather than affecting the chemistry of the reaction.
99
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Figure 3.4: The pH/D dependence for the MpDHFR catalyzed reaction in MTEN buffer at 5 ºC. 
 
Table 3.1: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by MpDHFR at pH 7 in H2O and D2O.  
T (
o
C) 
H2O
 
D2O 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 267.6 ± 14.4 118.9 ± 14.5 400.0 ± 57.8 231.6 ± 35.5  
10 327.2 ± 14.4 157.2 ± 25.6 545 ± 54.6  307.4 ± 52.7 
15 420.3 ± 21.3 213.9 ± 25.1 698.0 ± 66.9 381.7 ± 36.9 
20 484.4 ± 28.0 253.0 ± 30.4 773.2 ± 79.6 403.5 ± 43.2 
25 526.8 ± 23.2 288.0 ± 24.8 815.5 ± 138.1 420.7 ± 76.5 
30 570.5 ± 44.1 323.5 ± 26.9 871.6 ± 142.3 421.7 ± 80.8 
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Table 3.2: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR in H2O and D2O at pH 7.
a
 
T (
o
C) 
H2O
 
D2O 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 81.9 ± 1.7 26.9 ± 1.9 141.4 ± 10.8  68.9 ± 13.1 
10 106.3 ± 3.1  34.1± 3.4 198.5 ± 12.2  121.3 ± 13.6 
15 135.3 ± 5.6 44.6± 3.7 246.3 ± 22.4  153.3 ± 22.0 
20 159.8 ± 7.9  60.2 ± 4.1 386.3 ± 5.8  239.1 ± 51.9 
25 203.7 ± 7.4 75.1 ± 5.4 506.3 ± 22.6  234.1 ± 3.0 
30 235.4 ± 13.8 98.5 ± 2.8 597.8 ± 12.0  408.8 ± 9.6 
35 287.9 ± 12.0 125.9 ± 3.5 767.0 ± 39.4  535.5 ± 17.6 
a
 Data measured by Dr Joel Loveridge and Dr Richard Swanwick
98
 
 
Table 3.3: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by TmDHFR in H2O and D2O at pH 7.
a
 
T (
o
C) 
H2O
 
D2O 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
6 0.044 ± 0.001 0.0066 ± 0.0002 0.090 ± 0.006 0.015 ± 0.001 
11 0.060 ± 0.003 0.010 ± 0.001 0.126 ± 0.013 0.022 ± 0.001 
16 0.087 ± 0.002 0.016 ± 0.001 0.191 ± 0.011 0.037 ± 0.003 
20 0.122 ± 0.003 0.027 ± 0.001 0.266 ± 0.020 0.063 ± 0.003 
25 0.169 ± 0.002 0.042 ± 0.003 0.379 ± 0.017 0.093 ± 0.011 
30 0.242 ± 0.005 0.060 ± 0.002 0.581 ± 0.049 0.147 ± 0.010 
35 0.341 ± 0.006 0.082 ± 0.005 0.812 ± 0.035 0.181 ± 0.015 
40 0.488 ± 0.010 0.116 ± 0.007 1.126 ± 0.033 0.270 ± 0.026 
45 0.668 ± 0.015 0.161 ± 0.003 1.518 ± 0.081 0.389 ± 0.028 
50 0.932 ± 0.036 0.245 ± 0.011 2.058 ± 0.095 0.510 ± 0.030 
55 1.253 ± 0.057 0.336 ± 0.015 2.868 ± 0.198 0.775 ± 0.043 
60 1.654 ± 0.093 0.444 ± 0.019 3.634 ± 0.219 1.034 ± 0.034 
65 2.120 ± 0.159 0.575 ± 0.013 4.467 ± 0.272 1.290 ± 0.113 
a
 Data measured by Dr Joel Loveridge
98
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Table 3.4: Rate constants for hydride transfer (kH) for the 
MpDHFR catalyzed reaction in MTEN buffered H2O and D2O at 
5 ºC. 
pH kH in H2O / s
-1
 kH in D2O / s
-1
 
5 690.9 ± 59.1 678.8 ± 54.9 
5.5 752.2 ± 63.1 698.2 ± 122.8 
6 545.7 ± 40.6 705.6 ± 60.4 
6.5 401.6 ± 54.8 669.2 ± 56.1 
7 195.4 ± 47.1 353.7 ± 35.3 
7.5 115.3 ± 23.4 184.0 ± 29.6 
8 75.3 ± 5.5 153.0 ± 16.1 
8.5 25.2 ± 5.2 75.7 ± 10.1 
9 14.0 ± 3.2 48.7 ± 8.9 
 
3.2.2 Temperature dependence of the kinetic isotope effect (KIE) for the reaction catalyzed by 
MpDHFR 
The pre-steady state rate constants with both NADPH and NADPD for the MpDHFR catalysed 
reaction were measured in both H2O and D2O. The primary KIE of the hydride transfer event was 
determined by dividing the rate constant with NADPH by that of NADPD at the same temperature 
(Table 3.5). The data was compared with the KIE for the mesophilic and the thermophilic enzyme 
(Figure 3.5). 
 
In H2O, MpDHFR has a similar temperature dependence of the KIE to that observed for EcDHFR
98
 
(Figure 3.5). The activation energy for MpDHFR-catalyzed hydride transfer was found to be 21.6 ± 
2.2 kJ.mol
-1
, compared to 28.1 ± 2.5 kJ.mol
-1
 for deuteride transfer, The KIE is temperature 
dependent with a ∆Ea of 6.6 ± 3.4 kJ.mol
-1
 (Figure 3.4 and Table 3.6). The activation energy (and 
activation enthalpy) for the hydride transfer reaction was most favorable for MpDHFR and least 
favorable for TmDHFR (Table 3.11).  
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Figure 3.5:  The temperature dependence of the KIEs, plotted on a logarithmic scale against the 
inverse temperature, during catalysis by MpDHFR (blue), EcDHFR
98
 (green) and TmDHFR
98
 (red), 
measured in H2O (circles) and D2O (triangles) under single turnover conditions at pH 7. 
 
In D2O, MpDHFR has a different temperature dependence of the KIE to that reported for EcDHFR 
(Figure 3.5). However, the isotope effects in EcDHFR at pH 7 were interdependent with KIE values 
lower than those of H2O; KIEs in D2O for MpDHFR (Table 3.6) were very similar within 
experimental error to those in H2O (Table 3.5), as seen previously for TmDHFR.
98
  
 
Unlike MpDHFR and EcDHFR, the temperature dependence of the KIE for TmDHFR, in both H2O 
and D2O, was shown to have a breakpoint at 25 ˚C with the KIE being temperature dependence 
below the breakpoint and temperature independent above.
100
 However, the breakpoint disappeared 
when the salt bridges in the dimer interface were removed
93
 and in high concentration of sucrose,
100
 
which was proposed to apply specific effects at the dimer interface, suggesting that the breakpoint in 
the temperature dependence of the KIE for TmDHFR is most probably related to the dimer 
interface.
93,100
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Table 3.5: Temperature dependence of the pre-steady state KIE during catalysis by MpDHFR, 
EcDHFR and TmDHFR in H2O at pH 7 
T (
o
C) MpDHFR EcDHFR
 a
 TmDHFR
a
 
5 2.25 ± 0.13 3.04 ± 0.22 nd 
6 nd nd 6.67 ± 0.25 
10 2.08 ± 0.17 3.12 ± 0.32 nd 
11 nd nd 6.19 ± 0.71 
15 1.96 ± 0.13 3.03 ± 0.28 nd 
16 nd nd 5.44 ± 0.36 
20 1.91 ± 0.13 2.65 ± 0.22 4.52 ± 0.20 
25 1.83 ± 0.10 2.71 ± 0.22 4.02 ± 0.29 
30 1.76 ± 0.11 2.39 ± 0.16 4.03 ± 0.16 
35 nd 2.29 ± 0.11 4.16 ± 0.26 
40 nd nd 4.21 ± 0.27 
45 nd nd 4.15 ± 0.12 
50 nd nd 3.80 ± 0.23 
55 nd nd 3.73 ± 0.24 
60 nd nd 3.73 ± 0.26 
65 nd nd 3.69 ± 0.29 
a
 Data measured by Dr Joel Loveridge
98
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Table 3.6: Temperature dependence of the pre-steady state KIE during catalysis by MpDHFR, 
EcDHFR and TmDHFR in D2O at pH 7 
T (
o
C) MpDHFR EcDHFR
 a
 TmDHFR
 a
 
5 1.7 ± 0.2 2.05 ± 0.42 nd 
6 nd nd 5.96 ± 0.53 
10 1.8 ± 0.2 1.64 ± 0.21 nd 
11 nd nd 5.77 ± 0.60 
15 1.8 ± 0.1 1.61 ± 0.27 nd 
16 nd nd 5.11 ± 0.50 
20 1.9 ± 0.2 1.62 ± 0.35 4.24 ± 0.36 
25 1.9 ± 0.3 1.56 ± 0.07 4.07 ± 0.53 
30 2.1 ± 0.3 1.46 ± 0.05 3.95 ± 0.42 
35 nd 1.43 ± 0.09 4.48 ± 0.42 
40 nd nd 4.16 ± 0.42 
45 nd nd 3.90 ± 0.35 
50 nd nd 4.03 ± 0.30 
55 nd nd 3.70 ± 0.33 
60 nd nd 3.52 ± 0.24 
65 nd nd 3.46 ± 0.37 
a
 Data measured by Dr Joel Loveridge
98
 
 
Table 3.7: Pre steady state activation energies during catalysis by MpDHFR and EcDHFR at pH 7 
in H2O. 
 
Enzyme 
Ea
H
 
(kJ.mol
−1
) 
Ea
D
 
(kJ.mol
−1
) 
ΔEa 
(kJ.mol
−1
) 
MpDHFR 21.55 ± 2.18 28.11 ± 2.55 6.56 ± 3.35 
EcDHFR
a
 29.42 ± 0.71 37.02 ± 0.58 7.60 ± 0.92 
TmDHFR
a
 
(< 25 ºC) 49.95 ± 1.68 69.28 ± 3.69 19.32 ± 4.05 
(> 25 ºC) 53.55 ± 0.44 56.03 ± 0.84 2.49 ± 0.95 
a
 rate constants measured by Dr Joel Loveridge
98
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Table 3.8: Pre-steady state activation energies during catalysis by MpDHFR and EcDHFR at pH 
7 in D2O. 
 
Enzyme 
Ea
H
 
(kJ.mol
−1
) 
Ea
D
 
(kJ.mol
−1
) 
ΔEa 
(kJ.mol
−1
) 
MpDHFR 21.0 ± 3.5 16.17 ± 3.74 -4.85 ± 5.13 
EcDHFR
a 
40.79 ± 1.77 47.62 ± 2.28 6.83 ± 2.89 
TmDHFR
a
 
(< 25 ºC) 53.29 ± 1.34 68.90 ± 3.77 15.61 ± 4.00 
(> 25 ºC) 51.79 ± 0.93 55.66 ± 1.16 3.87 ± 1.49 
a
 rate constants measured by Dr Joel Loveridge
98
 
 
Table 3.9: Pre-steady state Arrhenius prefactors (A) during catalysis by MpDHFR and EcDHFR 
at pH 7 in H2O. 
 
Enzyme 
AH (s
−1
) AD (s
−1
) AH/AD 
MpDHFR (3.17 ± 0.19) x 10
6
 (2.44 ± 0.15) x 10
7
 0.13 ± 0.09 
EcDHFR
a
 (2.82 ± 0.05) x 10
7
 (2.34 ± 0.03) x 10
8
 0.12 ± 0.002 
TmDHFR
a
 
(< 25 ºC) (9.47 ± 0.36) x 10
7
 (5.65 ± 0.35) x 10
10
 0.002 ± 0.001 
(> 25 ºC) (4.11 ± 0.03) x 10
7 
(2.67 ± 0.04) x 10
8
 1.54 ± 0.36 
a
 rate constants measured by Dr Joel Loveridge
98
 
 
Table 3.10: Pre steady state Arrhenius prefactors (A) during catalysis by MpDHFR and 
EcDHFR at pH 7 in D2O. 
 
Enzyme 
AH (s
−1
) AD (s
−1
) AH/AD 
MpDHFR (4.01 ± 0.38) x 10
6
 (2.88 ± 0.36) x 10
5
 13.94 ± 0.2 
EcDHFR
a
 (6.58 ± 0.21) x 10
9
 (6.75 ± 0.25) x 10
10
 0.098 ± 0.005 
TmDHFR
a
 
(< 25 ºC) (8.20 ± 0.22) x 10
8
 (1.11 ± 0.07) x 10
11
 0.007 ± 0.006 
(> 25 ºC) (4.79 ± 8.42) x 10
8 
(5.31 ± 0.12) x 10
8
 0.90 ± 0.56 
a
 rate constants measured by Dr Joel Loveridge
98
 
 
Chapter 3: Results and discussion 
 
 66 
Table 3.11: Activation parameters for hydride transfer catalyzed by MpDHFR, 
EcDHFR and TmDHFR at pH 7. 
Parameter MpDHFR EcDHFR
99
 TmDHFR
101
 
∆H‡H / kJ mol
-1 
19.2 ± 2.2 27.4 ± 0.6 50.9 ± 0.5 
b
 
∆H‡D / kJ mol
-1
 25.7 ± 2.6 35.3 ± 0.6 53.4 ± 0.8 
b 
∆S‡H / J mol
-1 
-128.6 ± 1.4 -109.0 ± 2.5 -88.9 ± 1.2 
b
 
∆S‡D / J mol
-1 
-111.6 ± 1.2 -90.3 ± 1.8 -92.4 ± 2.3 
b 
∆G‡H /
 
kJ mol
-1
 
a
 57.5 ± 2.2 59.9 ± 0.6 77.4 ± 0.5 
∆G‡D /
 
kJ mol
-1
 
a
 59.0 ± 2.6 62.2 ± 0.6 80.9 ± 0.8 
a
 At 25 °C; 
b
 Above 25 ºC. 
 
3.3 Measuring hydride transfer using steady state kinetics 
The complete kinetic cycle for EcDHFR has been reported in 1987 by Benkovic and co-workers.
7
 
They give evidence that product release is the rate determining step for EcDHFR in the steady state 
at physiological pH. However, hydride transfer becomes the rate-determining step above pH 8.4.
7,102
 
Hence, hydride transfer rates were measured under steady-state conditions at pH 9.5 for EcDHFR 
where the steady-state rate reflects the rate of the chemical step only.
103
 The steady state rate for the 
MpDHFR catalysed reaction was determined at pH 9, not pH 9.5 as for EcDHFR, due to high errors 
on the catalytic rate at pH 9.5. For TmDHFR the steady state measurements were determined at pH 
7, where hydride transfer is partially rate limiting.
64
 
 
The temperature dependences of the steady state turnover rates during EcDHFR catalysis (Table 
3.13) was reported previously.
103
 In this part, the temperature dependences of the steady state 
turnover rates for the reduction of DHF with NADPH and NADPD during MpDHFR (Table 3.12) 
and TmDHFR (Table 3.14) catalysis (Figure 3.6) were determined in H2O and D2O from the 
decrease in the absorbance at 340 nm due to the oxidation of the cofactor using UV/vis spectroscopy.  
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Figure 3.6: Temperature dependence (left) and Arrhenius plots (right) of the steady state rate 
constants for hydride (kcat
H
, circles) and deuteride (kcat
D
, triangles) transfer during catalysis by 
TmDHFR (red), EcDHFR
103
 (green) and MpDHFR (blue) in H2O at pH 7, 9.5 and 9 respectively. 
 
Similar to the pre-steady state kinetics, the rate constants obtained in D2O were higher than those in 
H2O (Tables 3.12, and 3.14). The KIE for hydride/deuteride transfer in H2O and D2O was determined 
by dividing the rate of H transfer by the rate of D transfer (Figure 3.7). 
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Figure 3.7: KIEs measured under saturating conditions in H2O (circle) and D2O (triangle) plotted 
on a logarithmic scale against the inverse temperature for MpDHFR (blue) at pH 9, EcDHFR at pH 
9.5
103
 (green) and TmDHFR (red) at pH 7. 
 
As seen with EcDHFR, during catalysis by MpDHFR at elevated pH the chemical step is partially 
rate limiting and the KIE was temperature independent (on average 2.55 ± 0.11 in H2O and 2.20 ± 
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0.11 in D2O) within experimental errors (Figure 3.7 and Table 3.15). Under steady state conditions at 
pH 9.5, a breakpoint was noted for EcDHFR in the temperature dependence of the KIE in H2O at 
temperatures below 15 ˚C. However, within the temperature range of 15 and 35 ˚C the KIEs 
remained constant within the experimental errors (Figure 3.7). This breakpoint was not seen for the 
MpDHFR catalysed reaction at elevated pH in H2O, but seen when the reaction was carried out in 
D2O. The difference in the temperature dependences of KIE for MpDHFR in H2O and D2O is most 
probably due to the D2O buffer induced pKa shift of the (vide supra). Recent data have shown no 
breakpoint either for in the temperature dependence of KIE for EcDHFR when performing the 
reaction at pH 9 under single turnover conditions.
47
 The breakpoint for the DHFR catalysed reaction 
for both the mesophilic and the psychrophilic enzymes suggests contribution from kinetic complexity 
at the conditions used that caused a partial change in the rate limiting step at temperatures lower than 
15 ˚C. 
 
The activation energy for MpDHFR-catalyzed hydride transfer at pH 9 was found to be 15.6 ± 0.2 kJ 
mol
-1
, compared to 17.1 ± 1.1 kJ mol
-1
 for deuteride transfer, leading to an activation energy 
difference (∆Ea) of 1.5 ± 1.1 kJ mol
-1
 (Figure 3.7) and Arrhenius pre-exponential factor ratio (AH/AD) 
of 1.4 ± 0.5. This is similar to the activation energy difference and Arrhenius pre-exponential factor 
ratio observed for EcDHFR (Table 3.16).
103
 The activation energy (and the activation enthalpy) for 
the hydride transfer reaction was most favorable for MpDHFR and least favorable for TmDHFR 
(Table 3.17) as seen previously under pre-steady state conditions. 
 
Similar to the pre-steady state, all the three DHFRs show an inverse SKIE on the chemical step under 
steady state conditions. Proton inventories were linear (Figure 3.8) showing that the SKIE arises 
from a single protonation event,
104
 consistent with the DHFR-catalyzed reaction. At 20 ˚C, while 
TmDHFR shows a higher SKIE (0.63 ± 0.18) than the value observed in the pre-steady state (0.42 ± 
0.02), MpDHFR shows a slightly lower SKIE (0.48 ± 0.09) than that obtained under single turnover 
conditions (0.63 ± 0.04), but comparable to that obtained for EcDHFR under steady state (0.41 ± 
0.05) and pre-steady state conditions (0.43 ± 0.18). For all the DHFRs, in the steady state the primary 
(1°) KIEs were independent of the isotopic composition of the solvent and the SKIEs were 
independent of the cofactor isotopic composition. 
 
Chapter 3: Results and discussion 
 
 69 
0
2
4
6
8
10
0 20 40 60 80 100
% D2 O
k
c
a
t 
/ 
s
-1
-0.1
0
0.1
0.2
0.3
0 20 40 60 80 100
% D2 O
k
c
a
t 
/ 
s
-1
 
Figure 3.8: Proton inventories for hydride transfer catalysed by MpDHFR ( blue), EcDHFR (green) 
and TmDHFR (red) at pH 9, 9.5 and 7 respectively and 20 ˚C.98 
 
Table 3.12: Temperature dependence of the steady state rate constants for hydride (kcat
H
) 
and deuteride (kcat
D
) transfer during catalysis by MpDHFR at pH 9. 
T (
o
C) 
H2O D2O 
kcat
H
 (s
-1
) kcat
D
 (s
-1
) kcat
H
 (s
-1
) kcat
D
 (s
-1
) 
5 1.75 ± 0.14 0.67 ± 0.04 2.86 ± 0.27 1.35 ± 0.12 
10 1.93 ± 0.08 0.75 ± 0.08 3.89 ± 0.52 1.88 ± 0.27 
15 2.20 ± 0.16 0.81 ± 0.13 4.47 ± 0.74 2.00 ± 0.30 
20 2.46 ± 0.19 1.00 ± 0.10 5.14 ± 0.65 2.17 ± 0.25 
25 2.72 ± 0.21 1.09 ± 0.20 6.01 ± 0.82 2.65 ± 0.38 
30 3.03 ± 0.15 1.25 ± 0.09 6.28 ± 0.93 2.97 ± 0.41 
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Table 3.13: Temperature dependence and KIE of the steady state rate constants 
for hydride (kcat
H
) and deuteride (kcat
D
) transfer during catalysis by EcDHFR
103
 
at pH 9.5. 
T (
o
C) kcat
H
 (s
-1
) kcat
D
 (s
-1
) KIEa 
5 0.349 ± 0.005 0.175 ± 0.003 2.99 ± 0.04 
10 0.484 ± 0.004 0.197 ± 0.002 2.45 ± 0.03 
15 0.600 ± 0.008 0.208 ± 0.001 2.88 ± 0.04 
20 0.722 ± 0.009 0.252 ± 0.004 2.8 ± 0.06 
25 0.927 ± 0.012 0.341 ± 0.008 2.72 ± 0.07 
30 0.994 ± 0.005 0.359 ± 0.006 2.77 ± 0.05 
35 1.090 ± 0.007 0.385 ± 0.006 2.83 ± 0.05 
Data taken from reference
103
 
 
Table 3.14: Temperature dependence of the steady state rate constants for hydride (kcat
H
) 
and deuteride (kcat
D
) transfer during catalysis by TmDHFR at pH 7. 
T (
o
C) 
H2O D2O 
kcat
H
 (s
-1
) kcat
D
 (s
-1
) kcat
H
 (s
-1
) kcat
D
 (s
-1
) 
20 0.080 ± 0.013 0.019 ± 0.005 0.125 ± 0.033 0.033 ± 0.005 
25 0.106 ± 0.023 0.032 ± 0.014 0.180 ± 0.044 0.062 ± 0.014 
30 0.159 ± 0.043 0.043 ± 0.010 0.211 ± 0.030 0.075 ± 0.011 
35 0.220 ± 0.025 0.071 ± 0.017 0.326 ± 0.049 0.104 ± 0.018 
40 0.287 ± 0.043 0.089 ± 0.016 0.476 ± 0.100 0.162 ± 0.024 
45 0.402 ± 0.056 0.136 ± 0.023 0.597 ± 0.106 0.253 ± 0.037 
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Table 3.15: Temperature dependence of the steady-state KIE during catalysis by MpDHFR 
at pH 9. 
T (
o
C) H2O D2O 
5 2.61 ± 0.10 2.12 ± 0.13 
10 2.58 ± 0.12 2.07 ± 0.20 
15 2.71 ± 0.18 2.23 ± 0.23 
20 2.46 ± 0.13 2.37 ± 0.17 
25 2.51 ± 0.20 2.27 ± 0.20 
30 2.42 ± 0.09 2.11 ± 0.20 
 
Table 3.16: Temperature dependence of the steady-state KIE during catalysis by TmDHFR 
at pH 7. 
T (
o
C) H2O D2O 
20 4.21 ± 0.32 3.80 ± 0.30 
25 3.29 ± 0.47 2.91 ± 0.34 
30 3.70 ± 0.35 2.81 ± 0.20 
35 3.09 ± 0.27 3.13 ± 0.23 
40 3.23 ± 0.23 2.93 ± 0.26 
45 2.95 ± 0.22 2.35 ± 0.23 
 
Table 3.17: Steady state activation energies during catalysis by MpDHFR, EcDHFR and 
TmDHFR at pH 9, 9.5 and 7 respectively. 
Enzyme 
Ea
H
 
(kJ.mol
−1
) 
Ea
D
 
(kJ.mol
−1
) 
ΔEa 
(kJ.mol
−1
) 
MpDHFR 15.6 ± 0.2 17.1 ± 1.1 1.5 ± 1.1 
EcDHFR
a
 22.4 ± 2.8 23.5 ± 4.0 1.1 ± 4.9 
TmDHFR 50.5 ± 1.2 59.4 ± 2.6 8.9 ± 0.9 
a
 taken from reference 
103
, above 15 ˚C 
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Table 3.18: Steady state Arrhenius prefactors (A) during catalysis by MpDHFR, EcDHFR 
and TmDHFR at pH 9, 9.5 and 7 respectively. 
Enzyme AH (s
−1
) AD (s
−1
) AH/AD 
MpDHFR (1.5 ± 0.7) x 10
3
 (1.1 ± 0.1) x 10
3
 1.4 ± 0.5 
EcDHFR
a
 (7.3 ± 0.9) x 10
3
 (4.0 ± 0.8) x 10
3
 1.8 ± 0.42 
TmDHFR (8.0  ± 0.2) x 10
7
 (8.0 ± 0.4) x 10
8
 0.1 ± 0.006 
a
 taken from reference 
103
, above 15 ˚C 
 
 
 
3.4 Discussion 
The role of protein motions in the chemical step during enzymatically catalysed reactions is one of 
the hot topics in modern enzymology. Several theories of enzyme catalysis have proposed that 
protein dynamics are coupled to tunnelling, leading to a variety of models for active promotion of 
tunnelling.
65,105-108
 These models include rate-promoting vibrations,
38,48-49,109-110
 vibrationally 
enhanced ground-state tunnelling
37,111
 and environmentally coupled tunnelling.
26,30,34
 Within these 
models, a discrimination was made between passive motions that help bring the substrates into 
reactive configurations (environmentally reorganization) and motions that actively modulate the 
tunnelling barrier (gating, or vibrational enhancement)
112-113
 (Chapter 1). To study the contribution of 
Table 3.19: Activation parameters for the MpDHFR, EcDHFR and TmDHFR 
catalyzed reaction at pH 9, 9.5 and 7 respectively. 
Parameter MpDHFR EcDHFR TmDHFR 
∆H‡H / kJ mol
-1 
13.2 ± 0.2 20.0 ± 2.8 
b
 47.99 ± 1.23 
∆H‡D / kJ mol
-1
 14.7 ± 1.1 18.2 ± 2.0 56.93 ± 1.23 
∆S‡H / J mol
-1 
-192.2 ± 0.1 -179.3 ± 0.5 
b
 -102.10 ± 1.89 
∆S‡D / J mol
-1 
-194.8 ± 1.4 -193.7 ± 1.8 -82.97 ± 2.27
 
∆G‡H /
 
kJ mol
-1
 
a
 70.5 ± 0.2 73.4 ± 2.8 
b
 78.43 ± 0.66 
∆G‡D /
 
kJ mol
-1
 
a
 72.8 ± 1.1 75.9 ± 2.0 81.67 ± 0.55 
a
 At 25 °C; 
b
 Above 25 ºC. 
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enzyme motion to catalysis, a determination of the temperature dependence of the primary kinetic 
isotope effects (KIEs) is often used.
43,107,114-115
 Hydride transfer reactions in which contributions 
from quantum-mechanical tunnelling play a role and especially the hydride transfer reaction 
catalysed by dihydrofolate reductase (DHFR) was used for a long time as a model system to study 
such phenomena. 
 
Studying enzyme homologues from different temperature environments allows a further 
understanding of DHFR catalysis. In this chapter, hydride transfer and kinetic isotope effects in the 
steady state and pre-steady state for the cold adapted enzyme MpDHFR were reported and compared 
to the data obtained with the mesophilic EcDHFR and the thermophilic TmDHFR. When measuring 
the chemical step, either in the pre-steady state or steady state, MpDHFR had the most favorable 
activation energy (and activation enthalpy) while TmDHFR had the least favorable variables. This is 
matched by MpDHFR having the least favourable Arrhenius prefactor (and activation entropy). 
 
MpDHFR has higher rate constants for hydride transfer than the other two DHFRs. However, at the 
enzymes’ typical operating temperatures the hydride transfer rate constant for MpDHFR is slightly 
lower than that of EcDHFR (255.0 ± 6.4, 317.3 ± 1.6 and 8.2 ± 0.1 s
-1
 for MpDHFR 2 ºC, EcDHFR 
at 37 ºC and TmDHFR at 90 ºC respectively). Similar to EcDHFR, MpDHFR shows inverse pre-
exponential factor ratios (AH/AD) below the lower limit for the semi-classically calculated value of 
0.71,
35,102
 0.13 and 0.12 for MpDHFR and EcDHFR
 
respectively. 
 
Within the environmentally coupled tunnelling model, when the KIEs are temperature dependent and 
the ratio of the pre-exponential factors is inverse, it was predicted that active dynamic motions are 
dominant and generate a temperature-dependent tunnelling distance. The experimentally observed 
inverse AH/AD and the temperature dependence of the KIEs reported here, suggest that DHFR 
actively modulates the tunnelling distance and hence the reaction rates under single turnover 
conditions at pH 7.0.
116
 However, the KIE values seen for MpDHFR under pre-steady state 
conditions, which are smaller than those seen for EcDHFR and TmDHFR, suggest contributions 
from other different steps during the catalytic cycle causing kinetic complexity. Kinetic complexity 
has been shown previously to lead to the wrong estimated temperature dependence of the KIE.
99
 
 
On the other hand, a temperature independent KIE is seen, according to the environmentally coupled 
tunnelling model, when the gating vibration does not modulate the tunnelling distance appreciably. 
Thus, the dominant environmental contribution becomes the environmental reorganization (passive 
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dynamics).
30
 Such a case can be seen in TmDHFR at temperatures above 25 ˚C64,97,101 and also when 
the chemical step was analysed for the two monomeric DHFRs in the steady state at elevated pH 
(vide infra). 
 
When the chemical step for the MpDHFR catalysed reaction was determined at elevated pH under 
steady state conditions, the KIEs were in the same range as those obtained under pre-steady state 
conditions at pH 7, suggesting that the chemical step for MpDHFR is at least partially rate limiting in 
the steady state at pH 9, as seen previously with EcDHFR at pH 9.5.
103
 MpDHFR has a temperature 
independent KIE at elevated pH similar to EcDHFR at temperatures higher than 15 ˚C and TmDHFR 
under pre-steady state conditions at pH 7.0. So, generally speaking, a temperature independent KIE 
was obtained for all of the three homologues, MpDHFR between 5 and 30 ˚C, EcDHFR between 15 
and 35˚C, and TmDHFR between 25 and 65 ˚C. 
 
A temperature dependent KIE was seen for TmDHFR at temperatures below 25 ˚C, increasing in 
value as the temperature fell, but at pH 7.0. The opposite is seen with EcDHFR at pH 9.5, with the 
KIE of EcDHFR falling as the temperature decreases below 15 ˚C suggesting kinetic complexity. 
Such behaviour was not observed for MpDHFR at the temperature range used, suggesting, perhaps 
that there is no re-organisation required for the MpDHFR active site at that temperature range. 
However, a previous study has shown a break point for the temperature dependence of the steady 
state KIE on the MpDHFR catalysed reaction at temperatures lower than 7.5 ˚C.90 
 
As mentioned previously, at elevated pH the monomeric DHFRs homologues (MpDHFR and 
EcDHFR) display a temperature dependence of the KIE similar to that of the structurally more rigid 
and dimeric homologue TmDHFR at physiological pH.
101
 This may suggest that all of the three 
enzymes rely on passive motions only to generate active site configurations conducive to hydrogen 
transfer. These observations were thought previously to suggest an evolutionary model in which 
catalysis progresses from a relatively rigid active site in the dimeric TmDHFR to a more flexible and 
kinetically more efficient structure in the monomeric homologues,
103
 MpDHFR and EcDHFR, that 
actively promotes hydrogen transfer at physiological pH. However taking into consideration the rate 
constants of hydride transfer for the three homologues at their physiological temperatures (2 ºC for 
MpDHFR, at 37 ºC for EcDHFR and 90 ºC for TmDHFR) shows that MpDHFR is a slightly poorer 
catalyst than EcDHFR and is similar to TmDHFR in the steady state under the same conditions. 
Also, a recent study in our group has shown that the KIE on hydride transfer in EcDHFR is 
temperature dependent below pH 8 and temperature independent at or above this pH, indicating that 
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the temperature dependent KIEs observed at pH 7 must be physiologically relevant, in contrast to the 
temperature independent KIEs observed at elevated pH.
99
 Thus it is inappropriate to compare the 
behaviour of the temperature dependence of KIE for the monomeric homologues at elevated pH with 
that of the dimeric enzyme at physiological pH. 
 
Further findings during studies of the hydride transfer reaction catalysed by DHFR, in our group and 
different research groups as well, derived from investigating solvent effect on DHFR chemical 
step,
96,117
 studying various DHFR variants
47
 (as will be shown in later chapters of this thesis), in 
addition to computational studies,
46
 have shown that the environmentally coupled tunnelling model is 
inadequate to explain catalysis by DHFR. Experimental data has indicated that protein dynamics are 
only important for the generation of the reaction ready conformation (RRC) on the free energy 
landscape and suggest no contribution for such motion to the chemical step during catalysis by 
DHFR.
47,96
 Such annotations, in addition to accumulating evidence against current models that relate 
protein motions to chemical step, suggest that modulation of these models is essential to propose 
better understanding of the temperature dependence of the KIE for the hydride transfer reactions.  
 
3.5 Conclusions 
From the data presented here, it is clear that the rates of hydride transfer by MpDHFR, measured 
either in the steady state or the pre-steady state, are higher than those of EcDHFR and TmDHFR at 
all temperatures. However, at the typical operating temperatures of the three DHFRs (2 ˚C for 
MpDHFR,
92
 37 ˚C for EcDHFR and 90 ˚C for TmDHFR61) at pH 7, the hydride transfer rate 
constants were estimated to be 255.0 ± 6.4, 317.3 ± 1.6, and 8.2 ± 0.1 s
-1
, respectively. Furthermore, 
it has been shown that the kcat value for MpDHFR is very similar to TmDHFR (5.0 ± 1.5 and 4.5 ± 
2.3 s
-1 
for MpDHFR and TmDHFR respectively) and very low compared to the mesophilic 
homologue EcDHFR (kcat = 35.8 ± 2.6 s
-1
) under the same conditions.
79,96
 These observations suggest 
that MpDHFR is actually a slightly poorer catalyst than EcDHFR at their respective physiological 
temperatures under single turnover conditions and is equivalent to TmDHFR in the steady state. The 
activation energy (and enthalpy) for the hydride transfer reaction is most favourable for MpDHFR 
and least favourable for TmDHFR. This behaviour is comparable to that observed for the activation 
parameters for the steady-state reactions of MpDHFR and EcDHFR.
79
 The temperature dependence 
of the KIE on hydride transfer is similar to that observed for EcDHFR,
103
 and quite different to that 
of TmDHFR.
101
 The lower value observed for the primary KIEs on hydride transfer in MpDHFR and 
the lower ΔEa than EcDHFR suggest increased kinetic complexity on the measurements for 
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MpDHFR. Similar to EcDHFR, MpDHFR has shown a temperature independent KIE when the 
chemical step is isolated under steady state conditions, at elevated pH. Such behaviour was observed 
for the thermophilic and the dimeric homologue in the steady state at pH 7 where the chemical step is 
partially rate limiting, thus it is difficult to compare the behaviour of the steady state temperature 
dependence of the KIEs of the monomeric enzymes with that of the dimeric enzyme due to the 
different pH used. From the data obtained here, it seems reasonable to conclude that monomeric 
DHFRs (MpDHFR and EcDHFR) have similar kinetic behaviour for the hydride transfer step, 
exemplified by temperature dependent KIEs under physiological conditions, whereas dimeric DHFR 
(TmDHFR) has different kinetic behavior. 
  77 
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Role of the occluded conformation during 
catalysis by DHFR 
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4.1 Preface 
During catalysis, DHFR from Escherichia coli (EcDHFR) cycles through five intermediates: 
E.NADPH, E.NADPH.DHF, E.NADP
+
.THF, E.THF and E.NADPH.THF, with product (THF) 
release from the E.NADPH.THF mixed ternary complex being the rate limiting step at pH 7 under 
steady state conditions (Figure 4.1).
7
  
 
 
 
Figure 4.1: Schematic representation of the catalytic pathway of EcDHFR. In E:NADPH and the 
Michaelis complex E:NADPH:DHF, the Met20 loop adopts the closed conformation. In the three 
product complexes, E:NADP
+
, E:THF and E:NADPH:THF, the Met20 loop is in the occluded 
conformation.
59
 In the steady state, product release from the E:NADPH:THF ternary complex (Step 
5) is the rate limiting step, but hydride transfer becomes the rate limiting step at pH higher than 8.4.
7
 
 
The M20 loop (residues 9-24) of EcDHFR switches between two conformations during the catalytic 
cycle (Figure 4.2A). In the two reactant complexes (E.NADPH and E.NADPH.DHF), this loop 
adopts the ‘closed’ conformation, packing against NADPH and preventing solvent access to the 
active site. This conformation is stabilized by pairs of hydrogen bonds between residues in the M20 
loop and the FG loop (residues 116 to 132 in EcDHFR), namely Gly15(O) to Asp122(HN) and 
Glu17(HN) to Asp122(O2) (Figure 4.2B).7,59 In the product binary and ternary complexes, on the 
other hand, this loop switches to the occluded conformation (Figure 4.2C). The two hydrogen bonds 
between the M20 loop and FG loop that stabilize the closed conformation are not formed and instead 
the occluded conformation is stabilized by two hydrogen bonds between Asn23 (O and HN) in the 
M20 loop and Ser148 (HN and O2) in the GH loop (residues 142 to 149 in EcDHFR) (Figure 4.2C). 
The M20 loop prevents the nicotinamide group from entering the active site and it instead sticks out 
into solution. It has been proposed that movement between the closed and occluded conformations is 
important for both modifying ligand affinity and aiding progression through the catalytic cycle.
7,59 
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Figure 4.2: (A) Cartoon representation of 
EcDHFR (gray, PDB 1RX2)
1
 in the closed 
conformation, with the M20, FG and GH 
loops shown in green. The position of these 
loops in the occluded conformation in 
EcDHFR (yellow, PDB 1RX6)
1
 and in the 
closed conformation for MpDHFR (wheat, 
PDB 3IA4)
4
 are also shown. Ligands are 
shown as sticks, folate in cyan and NADP
+
 in 
pink. (B) Alignment of the active site loops of 
EcDHFR (green, PDB 1DRE)
1
 and MpDHFR 
(wheat, PDB 3IA4)
4
 in complex with 
methotrexate (MTX) and NADPH (green for 
EcDHFR and wheat for MpDHFR) showing  
the residues participating in hydrogen bonds 
which stabilize the closed and occluded 
conformations in EcDHFR and corresponding 
residues in MpDHFR. Hydrogen bonds 
stabilizing the closed conformations are 
shown as dashed lines. (C) Alignment of the 
active site loops of EcDHFR in the closed 
conformation (green, PDB 1RX2)
1
 with 
ligands as described in A, and in the occluded 
conformation (yellow, PDB 1RX6)
1
 with 5,10-
dideazatetrahydrofolate (DDF) in pale pink 
and NADPH in yellow, showing the residues 
participating in hydrogen bonds which 
stabilize the closed and occluded 
conformations. Hydrogen bonds stabilizing the 
occluded conformation are shown as dashed 
yellow lines. 
 
Although MpDHFR exhibits a very similar crystal structure to EcDHFR
91
 and the two enzymes have 
55% sequence identity,
92
 Ser148 of EcDHFR is replaced with proline in MpDHFR, which cannot 
form either of the hydrogen bonds that stabilize the occluded conformation. In DHFR from 
Lactobacillus casei (LcDHFR)
112,118-119
 Ser148 is replaced by alanine, which in principle can form 
the backbone hydrogen bond with Asn23 but not the side chain hydrogen bond (Figure 4.3). The 
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occluded conformation has not been observed in other DHFRs including LcDHFR,
119-120
 which is 
known to have a very similar catalytic cycle to EcDHFR,
121
 and the EcDHFR-S148A mutant is 
known to adopt the closed conformation in the product complex rather than an occluded 
conformation.
50
 In addition to MpDHFR and LcDHFR, DHFRs from a number of other organisms 
have an alternative residue in place of Ser148 (Figure 4.4). It is therefore extremely unlikely that 
MpDHFR or other DHFRs with a proline residue replacing Ser148 are able to form the occluded 
conformation. 
 
 
Figure 4.3: Residues which stabilise the occluded conformation in EcDHFR (left), and the 
equivalent residues in the EcDHFR-S148A variant (middle) and in MpDHFR (right). In EcDHFR, 
two hydrogen bonds can form between Asn23 and. In EcDHFR-S148A, however, while Ala148 can 
theoretically form the backbone hydrogen bond with Asn23, the second hydrogen bond is eliminated 
and this variant was shown to adopt the closed conformation in the product complex
50
 not the 
occluded conformation as the wild type EcDHFR.
59
 In MpDHFR both hydrogen bonds which 
stabilize the occluded conformation in EcDHFR are lost (right) due to replacement of Ser148 by 
proline and it is therefore highly unlikely that the occluded conformation can form. 
 
To investigate the importance of the occluded conformation on catalysis by DHFR, two variants 
EcDHFR-S148P and MpDHFR-P150S were generated. The results presented in this chapter show 
that while MpDHFR-P150S follows a similar catalytic cycle to EcDHFR, with product release being 
the rate limiting step in the steady state at pH 7, kinetics and NMR studies support the idea that 
destabilizing the occluded conformation in EcDHFR-S148P prevents the fast release of NADP
+ 
from 
the active site after the chemical step, causing a change in the steady state rate limiting step without 
affecting the chemistry of the reaction (vide infra). However, despite lacking the key residue that 
stabilises the occluded conformation, MpDHFR follows the same catalytic cycle as EcDHFR at 
physiological pH, suggesting that different methodology is used in MpDHFR to facilitate product 
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release. Hence, this methodology seems to be inefficient at low pH, causing a different rate limiting 
step for MpDHFR.  
 
 
Figure 4.4: Alignment of the amino acid sequences of various DHFRs showing residues that 
participate in stabilizing the closed (blue) and the occluded (red) conformations in EcDHFR and the 
corresponding residues in DHFR from Moritella profunda (MpDHFR), Lactobacillus casei 
(LcDHFR), Moritella yayanosii (MyDHFR), Shewanella violacea (SvDHFR), Geobacillus 
stearothermophilus (BsDHFR), Streptococcus pneumoniae (SpDHFR), Bacillus anthracis 
(BaDHFR), Mycobacterium tuberculosis (MtDHFR), Mycobacterium avium (MaDHFR), Human 
(HsDHFR) and Mus musculus (mouse, MmDHFR).  
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4.2 Structure and thermal stability for the EcDHFR-S148P and MpDHFR-P150S variants 
Circular dichroism spectroscopy was used to demonstrate that EcDHFR-S148P and MpDHFR-P150S 
have similar secondary structure to their wild type counterparts (Figure 4.5). MpDHFR-P150S was 
found to melt at 55.4 ± 0.2 °C, similar to the melting temperature of wild type EcDHFR (51.6 ± 0.7 
°C)
122
 or wild type MpDHFR in the presence of methotrexate (53.7 ± 0.6 °C) and considerably 
higher than that of apo-MpDHFR (37.5 ± 0.8 °C).
79
 The melting point of EcDHFR-S148P was 59.6 ± 
0.2 °C. This suggests that while the S148P mutation did not decrease the thermal stability for 
EcDHFR, MpDHFR is more tolerant of high temperature after replacing Pro150 with serine. 
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Figure 4.5: CD spectra for MpDHFR (blue), MpDHFR-P150S (cyan) and EcDHFR-S148P (red) at 
20 C.  
 
4.3 Temperature dependence of kH and KIE for the two variants (EcDHFR-S148P and 
MpDHFR-P150S) 
The pH dependence of the hydride transfer rate constant was measured under single turnover 
conditions in MTEN buffer (Figure 4.6) at 5 C for MpDHFR96 and MpDHFR-P150S (Table 4.1) 
and at 25 C for EcDHFR99 and EcDHFR-S148P (Table 4.1). The two mutants were found to have 
similar pH dependences with pKa values around 6.5 with comparable hydride transfer rates to their 
wild type counterparts (Table 4.2). 
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Figure 4.6: pH dependence of the rate constant for hydride transfer (kH) for MpDHFR (cyan) and 
MpDHFR-P150S (orange) at 5 C and EcDHFR99 (black) and EcDHFR-S148P (red) at 25 C.  
 
Table 4.1: pH dependence of the rate constants for hydride transfer (kH) for the MpDHFR, 
MpDHFR-P150S EcDHFR and EcDHFR-S148P catalyzed reaction in MTEN buffer at 5 ºC. 
pH MpDHFR MpDHFR-P150S EcDHFR
a
 EcDHFR-S148P 
5 690.9 ± 59.1 598.2 ± 175.4 878.68 ± 83.00 693 ± 136.5 
5.5 752.2 ± 61.6 595.6 ± 189.2 832.36 ± 20.87 584.2 ± 72.3 
6 545.3 ± 10.2 375.9 ± 76.8 645.17 ± 13.68 587.5 ± 100.7 
6.5 391.8 ± 55.2 255.8 ± 61.4 392.56 ± 8.78 nd 
7 195.4 ± 61.6 219.5 ± 27.1 203.70 ± 7.40 170.1 ± 7.9 
7.5 115.3 ± 10.2 152.2 ± 19.9 97.26 ± 5.47 nd 
8 75.5 ± 55.2 93.4 ± 13.1 44.68 ± 1.83 43.0 ± 1.7 
8.5 25.4 ± 5.86 83.5 ± 10.0 16.89 ± 0.37 nd 
9 14.2 ± 6.0 nd 2.52 ± 0.02 7.7 ± 1.2 
9.5 10.2 ± 3.5 nd nd nd 
nd: not determined, 
a
 taken from ref 
99
 
 
Table 4.2: pKa for the MpDHFR and MpDHFR-P150S catalyzed reaction 
at 5 ºC and for EcDHFR and EcDHFR-S148P at 25 ºC. 
Enzyme pKa 
MpDHFR 6.50 ± 0.10 
MpDHFR-P150S 6.04 ± 0.31 
EcDHFR 6.61 ± 0.20 
EcDHFR-S148P 6.40 ± 0.03 
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The kinetic isotope effect (KIE) on hydride transfer for MpDHFR-P150S, EcDHFR-S148A and 
EcDHFR-S148P was found to depend on temperature in a fashion similar to their wild type 
counterparts (Figure 4.7 and Tables 4.3-4.7), indicating that destabilizing the occluded conformation 
in MpDHFR and EcDHFR-S148P does not affect hydride transfer. Since both EcDHFR-S148A and 
wild type MpDHFR are known to be able to form the closed conformation,
50,62
 this suggests that all 
DHFRs stu55 
died here are able to form the closed conformation in which hydride transfer occurs, and therefore 
shows that conformational changes between the closed and the occluded conformation do not affect 
the actual chemistry of the reaction. This is in agreement with recent studies, which also showed that 
conformational dynamics between the closed and occluded states do not affect the chemical step.
46-47
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Figure 4.7: Kinetic isotope effect on hydride transfer at pH 7 by EcDHFR
47
 (black), EcDHFR-
N23PP (green), EcDHFR-S148A (pink), EcDHFR-N23PP/S148A
47
 (blue), EcDHFR-S148P (red), 
MpDHFR
96
 (cyan) and MpDHFR-P150S (orange), plotted on a logarithmic abscissa as a function of 
the inverse temperature. 
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Table 4.3: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR and MpDHFR at pH 7.  
T (
o
C) 
EcDHFR
a 
MpDHFR 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 81.9 ± 1.7 26.9 ± 1.9 267.6 ± 14.4 118.9 ± 14.5 
10 106.3 ± 3.1 34.1± 3.4 327.2 ± 14.4 157.2 ± 25.6 
15 135.3 ± 5.6 44.6± 3.7 420.3 ± 21.3 213.9 ± 25.1 
20 159.8 ± 7.9 60.2 ± 4.1 484.4 ± 28.0 253.0 ± 30.4 
25 203.7 ± 7.4 75.1 ± 5.4 526.8 ± 23.2 288.0 ± 24.8 
30 235.4 ± 13.8 98.5 ± 2.8 570.5 ± 44.1 323.5 ± 26.9 
35 287.9 ± 12.0 125.9 ± 3.5 nd nd 
nd: not determined, 
a
 data measured by Dr Joel Loveridge
47
 
 
Table 4.4: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR-S148P and MpDHFR-P150S at pH 7.  
T (
o
C) 
EcDHFR-S148P MpDHFR-P150S 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 87.2 ± 8.2 29.4 ± 20.1 268.0 ± 2.2 138.3 ± 10.9 
10 111.9 ± 10.4 39.5 ± 24.3 285.4 ± 33.5 160.5 ± 53.3 
15 134.6 ± 21.0 46.1 ± 18.6 351.9 ± 0.3 207.5 ± 50.5 
20 158.7 ± 23.0 54.6 ± 13.6 420.4 ± 87.7 241.3 ± 19.8 
25 180.8 ± 0.8 77.3 ± 6.2 337.1 ± 8.4 210.0 ± 7.3 
30 235.9 ± 10.7 96.4 ± 2.8 348.7 ± 9.1 229.4 ± 56.7 
35 265.4 ± 42.8 126.3 ± 3.9 nd nd 
nd: not determined 
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Table 4.5: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR-N23PP and EcDHFR-S148A at pH 7.  
T (
o
C) 
EcDHFR-N23PP
 
EcDHFR-S148A
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 11.85 ± 0.21 4.15 ± 0.07 89.00 ± 1.41 30.00 ± 0.71 
10 15.70 ± 0.42 5.95 ± 0.07 122.00 ± 5.66 40.35 ± 4.74 
15 19.10 ±  0.14 7.25 ± 0.07 121.70 ± 0.99 47.00 ± 2.83 
20 27.10 ± 0.14 9.40 ± 0.14 157.50 ± 0.71 60.50 ± 0.71 
25 36.50 ± 0.71 14.75 ± 1.06 213.00 ± 2.83 81.50 ± 0.71 
30 46.00 ± 1.41 23.05 ± 0.07 252.00 ± 1.41 103.50 ± 0.71 
 
Table 4.6: Temperature dependence of the pre-steady-
state rate constants for hydride (kH) and deuteride (kD) 
transfer during catalysis by N23PP/S148A
 
at pH 7.
a
 
T (
o
C) kH (s
-1
) kD (s
-1
) 
5 12.9 ± 0.2 4.1 ± 0.2 
10 15.2 ± 0.1 5.2 ± 0.3 
15 18.2 ± 0.4 6.6 ± 0.1 
20 21 ± 0.4 8.0 ± 0.5 
25 25.9 ± 0.3 10.0 ± 0.3 
30 32.6 ± 0.4 13.8 ± 0.6 
35 37.1 ± 1.3 16.8 ± 0.4 
a
 Data measured by Dr Joel Loveridge
47
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Table 4.7: Temperature dependence of the pre-steady-state KIE during catalysis by EcDHFR, 
MpDHFR, EcDHFR-S148P and MpDHFR-P150S at pH 7. 
T (
o
C) EcDHFR
a 
MpDHFR EcDHFR-S148P MpDHFR-P150S 
5 3.04 ± 0.22 2.25 ± 0.13 2.97 ± 0.35 1.94 ± 0.10 
10 3.12 ± 0.32 2.08 ± 0.17 2.83 ± 0.31 1.78 ± 0.25 
15 3.03 ± 0.28 1.96 ± 0.13 2.92 ± 0.22 1.70 ± 0.17 
20 2.65 ± 0.22 1.91 ± 0.13 2.91 ± 0.15 1.74 ± 0.16 
25 2.71 ± 0.22 1.83 ± 0.10 2.34 ± 0.10 1.61 ± 0.03 
30 2.39 ± 0.16 1.76 ± 0.11 2.45 ± 0.33 1.52 ± 0.18 
35 2.29 ± 0.11 nd 2.10 ± 0.16 nd 
nd: not determined, 
a
 data measured by Dr Joel Loveridge
47
 
 
Table 4.8: Temperature dependence of the pre-steady-state kinetic isotope effect during 
catalysis by EcDHFR-N23PP, -S148A and N23PP/S148A at pH 7. 
T (
o
C) EcDHFR-N23PP
 
EcDHFR-S148A
 
EcDHFR-
N23PP/S148A
a 
5 2.86 ± 0.01 2.74 ± 0.01 3.15 ± 0.03 
10 2.64 ± 0.02 3.02 ± 0.06 2.92 ± 0.03 
15 2.63 ± 0.01 2.59 ± 0.03 2.76 ± 0.01 
20 2.88 ± 0.01 2.60 ± 0.01 2.63 ± 0.03 
25 2.47 ± 0.04 2.61 ± 0.01 2.59 ± 0.02 
30 2.00 ± 0.02 2.43 ± 0.01 2.36 ± 0.02 
35 nd nd 2.21 ± 0.04 
a
Rate constants measured by Dr Joel Loveridge 
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Table 4.9: Pre steady state activation energies during catalysis by MpDHFR, MpDHFR-
P150S, EcDHFR and EcDHFR-S148P, -N23PP, -S148A and -N23PP/S148A at pH 7. 
 
Enzyme 
Ea
H
 
(kJ.mol
−1
) 
Ea
D
 
(kJ.mol
−1
) 
ΔEa 
(kJ.mol
−1
) 
MpDHFR 21.6 ± 2.2 28.1 ± 2.6 6.6 ± 3.4 
MpDHFR-P150S 21.1 ± 3.2 26.1 ± 2.1 5.0 ± 3.8 
EcDHFR
a
 29.9 ± 0.6 37.8 ± 0.6 7.9 ± 0.9 
EcDHFR-S148P 26.1 ± 1.5 33.6 ± 2.4 7.5 ± 2.9 
EcDHFR-N23PP 38.7 ± 1.5 46.1 ± 3.8 7.5 ± 4.1 
EcDHFR-S148A 28.5 ± 2.9 34.2 ± 1.5 5.7 ± 3.2 
EcDHFR-N23PP/S148A
a 
25.7 ± 0.9 33.4 ± 1.2 7.7 ± 1.5 
a
 Rate constants measured by Dr Joel Loveridge
47
 
 
Table 4.10: Pre steady state Arrhenius prefactors (A) during catalysis by MpDHFR, 
MpDHFR-P150S, EcDHFR and EcDHFR-S148P, -N23PP, -S148A and -N23PP/S148A at pH 
7. 
Enzyme AH (s
−1
) AD (s
−1
) AH/AD 
MpDHFR (3.2 ± 0.2) x 10
6
 (2.4 ± 0.2) x 10
7
 0.13 ± 0.09 
MpDHFR-P150S (2.4 ± 0.2) x 10
6
 (1.1 ± 0.1) x 10
7
 0.22 ± 0.1 
EcDHFR
a
 (2.82 ± 0.1) x 10
7
 (2.34 ± 0.03) x 10
8
 0.12 ± 0.002 
EcDHFR-S148P (7.2 ± 0.2) x 10
6
 (5.9 ± 0.2) x 10
7
 0.12 ± 0.04 
EcDHFR-N23PP (2.1 ± 0.1) x 10
8 
(1.8 ± 0.1) x 10
9
 0.12 ± 0.08 
EcDHFR-S148A (2.0 ± 0.1) x 10
7
 (8.0 ± 0.3) x 10
7
 0.25 ± 0.08 
EcDHFR-N23PP/S148A
a 
(8.2 ± 0.2) x 10
5
 (7.4 ± 0.2) x 10
6
 0.11 ± 0.04 
a 
Rate constants measured by Dr Joel Loveridge
47
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4.4 Steady-state kinetics  
4.4.1 Steady state pH dependences 
The pH dependences of the steady state rate constants (kcat) were measured for MpDHFR, EcDHFR 
and their variants. For the MpDHFR catalyzed reaction, the pH dependance is bell shaped with a 
maximal rate at pH ~7 and apparent pKa values of 8.1 and 5.7 at 20 ºC (Figure 4.8).
79
 On the other 
hand, the reaction catalyzed by EcDHFR is characterized by a sigmoidal pH dependence,
123
  with a 
pH independent kcat of 9.0  1.7 s
-1
 at low pH and 20 ºC (Figure 4.8). The decrease in kcat for 
MpDHFR at low pH has been shown previously not to be due to protonation of His24 (the only ionic 
residue close to the active site) (Table 4.13). It was shown as well that the reduction in kcat at low pH 
is not due to enzyme inactivation, as the half life of MpDHFR is around 40 min at pH 5.
79
 
 
 
Figure 4.8: pH dependence of kcat (left) for MpDHFR (cyan), MpDHFR-H24N (blue), MpDHFR-
P150S (orange), EcDHFR (black) and EcDHFR-S148P (red) and CD spectra (right) of wild-type 
MpDHFR (cyan) and MpDHFR-H24N (blue) at 20 °C. The inset is a cartoon representation of the 
MpDHFR structure showing the position of H24.  
 
Interestingly, the pH dependence of kcat for MpDHFR-P150S was found to be sigmoidal like that of 
EcDHFR, with a pH independent kcat of 14.5  0.3 s
-1
, very similar to kcat for wild type MpDHFR at 
pH 7 and 20 ºC (15.6  0.2 s-1)6 (Table 4.11). On the other hand, a five-fold decrease in the value of 
kcat was observed for EcDHFR-S148P (2.1  0.2 s
-1
) compared to wild type EcDHFR (10.6  1.5 s-1) 
at pH 6 and 20 ºC (Table 4.11). Similar to their wild type counterparts,
79,122
 the two variants have a 
KIE of unity at pH 7 under steady state conditions (Table 4.12). 
 
 
Chapter 4: Results and discussion 
 90 
Table 4.11: pH dependence of the steady state rate constant (kcat) for the MpDHFR, MpDHFR-
P150S, MpDHFR-H24N, EcDHFR and EcDHFR-S148P catalyzed reaction in MTEN buffer at 20 
ºC. 
pH 
kcat / s
-1
 
MpDHFR 
MpDHFR-
P150S 
MpDHFR-
H24N 
EcDHFR 
EcDHFR-
S148P 
4 7.4 ± 0.7 nd 7.55 ± 1.51 nd nd 
4.5 6.9 ± 1.4 nd 8.05 ± 0.53 nd nd 
5 8.3 ± 0.7 14.1± 1.1 9.18 ± 0.80 10.7 ± 0.6 2.4 ± 0.2 
5.5 9.1± 2.1 14.2 ± 0.9 11.01 ± 1.50 8.8 ± 1.0 2.5 ± 0.1 
6 12.4 ± 0.9 14.5 ± 0.2 13.32 ± 2.42 10.6 ± 1.5 2.1 ± 0.2 
6.5 15.2 ± 1.9 14.5 ± 1.4 15.11 ± 0.90 8.0 ± 1.3 2.0 ± 0.3 
7 15.6 ± 1.7 15.0 ± 0.6 15.24 ± 1.65 6.9 ± 0.1 2.8 ± 0.4 
7.5 12.4 ± 0.9 13.59 ± 0.9 12.05 ± 3.52 5.0 ± 0.4 2.7 ± 0.5 
8 7.5 ± 0.7 11.69 ± 1.0 7.70 ± 0.86 3.7 ± 0.8 2.6 ± 0.2 
8.5 4.3 ± 0.5 6.9 ± 0.6 3.88 ± 0.55 2.5 ± 0.2 1.6 ± 0.2 
9 2.0 ± 0.2 3.6 ± 0.3 1.61 ± 0.41 1.3 ± 0.2 1.0 ± 0.2 
9.5 0.3 ± 0.6 nd 0.20 ± 0.05 0.5 ± 0.1 0.5 ± 0.1 
nd: not determined, 
a
 taken from ref 
99
 
 
Table 4.12: pH dependence of the KIE during catalysis by MpDHFR, 
MpDHFR-P150S and S148P-EcDHFR in MTEN buffer at 20 ºC. 
pH MpDHFR
a
 MpDHFR-P150S EcDHFR-S148P 
5 1.0 ± 0.1 1.0 ± 0.2 1.2 ± 0.1 
5.5 nd 0.9 ± 0.1 1.1 ± 0.1 
6 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.2 
6.5 nd 1.2 ± 0.2 1.1 ± 0.2 
7 1.0 ± 0.1 1.3 ± 0.1 1.1 ± 0.1 
7.5 1.3 ± .01 1.7 ± 0.2 1.2 ± 0.1 
8 1.7 ± 0.1 1.7 ± 0.1 1.2 ± 0.1 
8.5 1.8 ± 0.1 1.9 ± 0.1 2.0 ± 0.2 
9 2.7 ± 0.1 2.0 ± 0.2 2.7 ± 0.2 
a 
taken from ref 
79
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4.4.2 Effect of pH on KM for EcDHFR-S148P and MpDHFR-P150S  
KM for NADPH and DHF were measured for EcDHFR-S148P and MpDHFR-P150S at pH 7 and pH 
5 at 20 ºC (Table 4.13). Both have similar KM values as their wild type counterparts for both DHF 
and NADPH at pH 7, although KM for DHF with EcDHFR-S148P at pH 5 is 10 times higher than 
that of the wild type. 
 
Table 4.13: KM for NADPH and DHF with EcDHFR, EcDHFR-S148P, MpDHFR and 
MpDHFR-P150S at 20 C. 
Enzyme pH KM
DHF
 (µM) KM
NADPH
 (µM) 
EcDHFR
a
 
7 0.7 ± 0.2 4.8 ± 1.0 
5 0.7 ± 0.5 Nd 
EcDHFR-S148P 
7 0.7 ± 0.1 4.7 ± 0.7 
5 6.8 ± 0.5 5.5 ± 0.4 
MpDHFR
b
 
7.5 2.4 ± 0.2 5.7 ± 0.2 
5 0.4 ± 0.1
c 
10.8 ± 3.1 
MpDHFR- P150S 
7 2.2 ± 0.2 10.7 ± 0.6 
5 3.2 ± 0.5 15.2 ± 0.9 
nd: not determined, 
a
: taken from reference 
79
, 
b
: taken from reference 
7
, c: at pH 5.5. 
 
This type of bell-shaped steady-state pH dependence has been seen previously when residues in helix 
αC (Figure 4.2A) in EcDHFR were replaced by those of helix αC of LcDHFR, which lacks Ser148 
(EcDHFR numbers) and most likely cannot form the occluded conformation.
124
 A similar pH 
dependence was also obtained when the three residues Glu-Lys-Asn were inserted in the αC helix of 
EcDHFR.
125
 While these two EcDHFR αC mutants have about the same kH and kcat as the wild type 
EcDHFR at pH 7, kcat is reduced by 50% at lower pH,
124-125
 similar to MpDHFR.
79
 In the case of the 
EKN insertion,
125
 the decrease in kcat at low pH was demonstrated to be due to impaired dissociation 
of THF from the E.NADPH.THF mixed ternary complex,
125
 which is the rate limiting step in 
EcDHFR under steady state conditions.
7
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4.5 Steady state rate limiting step for MpDHFR, EcDHFR-S148P and MpDHFR-P150S 
Dissociation rate constants 
The dissociation rate constants (koff) of THF from different complexes were measured at pH 6 and 25 
ºC for MpDHFR and the two variants to explore the rate limiting step (Table 4.17). The results show 
that kcat for MpDHFR-P150S at low pH is limited by the dissociation of THF from the mixed 
E.NADPH.THF ternary complex, as seen for wild type EcDHFR.
7
 For MpDHFR, the rate constant 
for THF release from the mixed ternary complex E.NADPH.THF at pH 6 (koff = 19.1 s
-1
) is in the 
same order of magnitude as kcat at pH 7 (15.6 s
-1
) (Table 4.14).  In turn, at pH 5, the koff value is 15.7 
± 1.0 s
-1
, while kcat drops significantly to 8.3 ± 0.8 s
-1
. This implies that in the MpDHFR reaction the 
magnitude of koff is essentially unaffected by the decrease of pH while the rate-determining step has 
shifted from the dissociation of E.NADPH.THF to an alternative chemical step. For EcDHFR-S148P, 
kcat is limited by the dissociation of THF from the product ternary complex E.NADP
+
.THF, not from 
the mixed ternary complex E.NADPH.THF as in the wild type EcDHFR and the MpDHFR-P150S 
reaction. The koff values for EcDHFR-S148P and MpDHFR-P150S are similar to that of the wild type 
MpDHFR, suggesting that the mutation did not affect dissociation of THF. 
 
Table 4.14: Dissociation rate constants koff for THF from the various DHFRs, measured 
using the competition method with methotrexate as the trapping ligand, at 25 C in MTEN 
buffer, pH 6. 
 
Complex 
koff  (s
-1
) 
EcDHFR
a
 MpDHFR 
EcDHFR-
S148P 
MpDHFR-
P150S 
LcDHFR
b
 
E.THF 
E.NADPH.THF 
E.NADP
+
.THF 
0.97 ± 0.1 
12.0 ± 1.0 
2.4 ± 0.3 
0.55  ± 0.1 
19.1 ± 2.0 
3.8 ± 1.0 
0.5 ± 0.1 
18.4 ± 0.8 
2.6 ± 0.1 
0.9 ± 0.2 
17.3 ± 2.0 
2.5 ± 1.0 
0.5 ± 0.1 
40.0 ± 8.0 
1.7 ± 0.2 
kcat (s
-1
)
c
 9.5 ± 1.4 15.4 ± 0.3 2.4 ± 0.3 14.5 ± 0.4 31.0 ± 2.0 
a
: taken from reference 
7
, 
b
: taken from reference 
68
 (pH 6.5), 
c
: pH independent value 
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4.6 NMR investigation 
HSQC spectroscopy was employed to investigate how the occluded conformation modifies the 
enzyme’s affinity to NADP+. When NADP+ is bound by DHFR, the amide functionality of the ligand 
experiences a substantial change in chemical environment due to an ordered network of hydrogen 
bonds inside the active site.
59
 When the nicotinamide ring is inside the active site, the nicotinamide 
amide protons should have very different chemical shifts to those in solution, partly due to the 
hydrophobic environment of the active site and partly due to the hydrogen bonds, which form 
between this group and the backbone carbonyls of Ala7 and Ile14 in the protein. When the 
nicotinamide group is not held within the active site, the amide chemical shifts should resemble those 
in free solution. When the amide group of NADP
+
 is labeled with a 
15
N isotope, the change in 
chemical environment can be seen by 
1
H-
15
N HSQC measurement. Data obtained from this 
experiment should then reveal insights into how NADP
+
 binds to different DHFRs, including 
EcDHFR, EcDHFR-S148P, MpDHFR and MpDHFR-P150S. 
 
The measurements were obtained for DHFRs in two complexes: the Michaelis complex 
(DHFR.NADP
+
.folate) and the product complex (DHFR.NADPH.THF). In the latter complex, no 
difference was observed for the four DHFRs used in this study and the spectra obtained were very 
similar to that of the free ligand in absence of the enzyme, indicating that the NADP
+
 protons are free 
in solution (Figure 4.9). However, in the Michaelis complex (DHFR.NADP
+
.folate), a very 
remarkable difference was observed (Figure 4.10).  
 
The 
1
H-
15
N HSQC spectrum of the free ligand mixture, 
15
N-labeled NADP
+
 and folate, at pH 7 and 
20 C shows a pair of signals at N 109.9 ppm and H 7.7 and 8.5 ppm, which correspond to the 
labelled nitrogen atom and its attached protons, respectively (Figure 4.10). When EcDHFR was 
added to the mixture, the resulting 
1
H-
15
N HSQC NMR spectrum displays a pair of signals with 
chemical shifts that are similar to the ones of the free ligand (Figure 4.10), thus indicating the 
nicotinamide moieiety of NADP
+
 is outside the active site. In contrast, when the wild type enzyme 
was replaced by the S148P variant, an extra pair of 
15
N/
1
H signals at N 107.2 ppm and H 8.4 and 
10.2 ppm was observed (Figure 4.10). This, therefore, suggests that a noticeable population of 
NADP
+
 is bound to the active site of EcDHFR-S148P. Since substitution of Ser148 with a proline 
residue would destabilize the occluded conformation, the NMR data might suggest that the mutant 
has a stronger binding affinity to the oxidized cofactor NADP
+
 because of its inability to adapt to the 
occluded conformer. This can be confirmed by performing further binding studies for DHFR with 
various ligands. 
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Figure 4.9: Left: 
1
H-
15
N HSQC spectra for 
15
N-labeled NADP
+
 in free solution with THF (blue), and 
in complex with THF and MpDHFR (green) or MpDHFR-P150S (red). Right: 
1
H-
15
N HSQC spectra 
for 
15
N-labeled NADP
+
 in free solution with THF (blue) and in complex with THF plus EcDHFR-
S148P (green) or wild type EcDHFR (red), right, at pH 7 and 20 C. 
 
    
Figure 4.10: Left: 
1
H-
15
N HSQC spectra for 
15
N-labeled NADP
+
 in free solution with folate (blue) 
and in complex with folate plus EcDHFR (red) or EcDHFR-S148P (green) at pH 7 and 20 C, Right: 
1
H-
15
N HSQC spectra for 
15
N-labeled NADP
+
 in free solution with folate (blue) and in complex with 
folate plus MpDHFR (green) or MpDHFR-P150S (red) at pH 7 and 20 C. 
 
Interestingly, replacement of Pro150 with a serine residue in MpDHFR generated an opposite effect 
on the binding with NADP
+
. A significant amount of 
15
N-labeled NADP
+
 binds to the wild type 
MpDFHR, as the 
15
N/
1
H signals of the bound ligand can be seen in the 
1
H-
15
N HSQC spectrum (free 
ligand at N 109.9 ppm and H 7.7 and 8.5 ppm vs. bound ligand at N 106.3 ppm and H 8.3 and 10.2 
ppm, Figure 4.10). On the other hand, MpDHFR-P150S, similar to EcDHFR, as its corresponding 
NMR spectrum only shows the 
15
N/
1
H signals of the free ligand (N 109.9 ppm and H 7.7 and 8.5 
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ppm, Figure 4.10). Eventually, this leads us to propose that the serine replacement in MpDHFR 
likely introduces hydrogen bond(s) that can promote the occluded conformation, which in turn 
decreases the enzyme affinity for NADP
+
. 
 
In an attempt to study the effect of pH on the binding of NADP
+
, the same set of NMR experiments 
were carried out in buffer at pH 5.5 in the Michaelis complex (DHFR.NADP
+
.folate) (Figures 4.11 to 
4-13). While the change in the pH does not affect the binding of NADP
+ 
to the EcDHFR-S148P 
variant (Figure 4.11), two additional peaks representing bound NADP
+
 were observed for EcDHFR 
at the same pH (Figure 4.11). Unfortunately, both wild type MpDHFR and the P150S variant 
precipitated at high concentration at this pH, thus prohibiting proper NMR data collection. For 
MpDHFR at pH 6.6, while some precipitation can be observed, the two peaks of the bound NADP
+
 
can be seen clearly (Figures 4.13).  
 
 
Figure 4.11: (
1
H-
15
N) HSQCs for 
15
N(AM)-NADP
+
 with EcDHFR-S148P (left) and EcDHFR (right) 
at 20 C in the ternary complex E.NADP+.folate at pH 5.5. 
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Figure 4.12: (
1
H-
15
N) HSQCs for 
15
N(AM)-NADP
+
 with MpDHFR-P150S at pH 5.5 and 20 C in 
the ternary complex E.NADP
+
.folate. Enzyme precipitation at high concentration and low pH 
prevented proper NMR measurements. 
 
 
Figure 4.13: (
1
H-
15
N) HSQCs for 
15
N(AM)-NADP
+
 with MpDHFR at 20 C in the ternary complex 
E.NADP
+
.folate at pH 6.6 (left) and 5.5 (right). The enzyme precipitated at low pH due to the high 
protein concentration used for the measurements. 
 
Taking all the data together is suggesting that EcDHFR-S148P binds tighter to NADP
+
 than its wild 
type counterpart, which most probably causes the change in the rate limiting step to the release of 
THF from the ternary complex E.NADP
+
.THF instead of the mixed ternary complex 
E.NADPH.THF. Therefore the amount of NADP
+
 binding to MpDHFR is expected to increase at low 
pH to cause the change in the rate limiting step. The NMR data for MpDHFR could not support this 
due to enzyme precipitation at low pH, but EcDHFR shows a very weak binding to NADP
+
 at pH 
Chapter 4: Results and discussion 
 97 
5.5, suggesting that at low pH the affinity of EcDHFR to NADP
+
 has increased. This in turn can lead 
us to thinking that probably the same happens with MpDHFR at low pH causing the change in the 
rate limiting step. 
 
4.7 Role of the occluded conformation 
EcDHFR is often used as a model to study the relationship between protein dynamics and the 
chemical step of enzyme catalysis. This enzyme has been demonstrated to proceed through a cycle of 
ordered physical steps with THF release from the mixed ternary complex, E.NADPH.THF, being 
rate-determining at physiological pH.
7
 Moreover, the enzyme was shown to oscillate between the 
closed and the occluded conformations, which have been proposed to help progression through the 
catalytic cycle.
73,126-128
 On the other hand, DHFR from another bacterial species, Moritella profunda, 
is unlikely to adopt the occluded conformation, because it lacks the key residue (Ser148 in EcDHFR) 
to stabilize this conformer. Hence, it is of great interest to investigate the importance of the occluded 
conformation in DHFR catalysis. 
 
In this part of the thesis, we show that the role of the occluded conformation in EcDHFR catalysis is 
to modify the enzyme’s affinity to NADPH/NADP+. The first line of evidence is provided by our 
kinetic characterization of the EcDHFR-S148P reaction, which shows a sharp decrease of kcat while 
the rate constants for hydride transfer (kH) and THF dissociation (koff), and the Michaelis constants 
(KM), remain essentially unaffected. Also, this mutant has a stronger affinity for the oxidized cofactor 
NADP
+
, as shown in the (
1
H-
15
N) HSQC studies. Taking all these data together, we conclude that the 
occluded conformation does not affect the step of hydride transfer but assists NADP
+
 release from 
active site instead (Figure 4.14). 
 
It is well established that NADP
+ 
is first released from the product complex, followed by NADPH 
entry and THF release in the EcDHFR catalytic cycle.
7
 Previously, it was proposed that THF release 
from the mixed ternary complex, E.NADPH.THF, is promoted by the repulsive interactions between 
the pyrophosphate moiety of NADPH and the p-aminobenzoyl-L-glutamate (pABG) moiety of 
THF.
59
 Yet, it remains unclear how the enzyme manages to differentiate between NADPH and 
NADP
+
, as both compounds are structurally similar. The decrease of NADP
+
 binding affinity in the 
occluded conformer could help to guide EcDHFR through the physical steps in a sequential manner. 
Also, it has been suggested that fidelity to the order of the physical steps is of great importance to the 
function of EcDHFR, to prevent product inhibition as bacterial cells contain equal amounts of 
NADPH and NADP
+
, in contrast to eukaryotic cells in which NADP
+
 represents only 1% of the 
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NADPH concentration.
59
 This idea is further supported by the remarkably different koff and kcat 
values that were measured with EcDHFR-S148 (Table 2). Because the rate constant for THF release 
from the mixed ternary complex is significantly higher than the steady-state reaction rate constant, it 
implies that the EcDHFR-S148P reaction is not exclusively limited by THF release.  
 
 
Figure 4.14: Schematic representation of the catalytic pathway of DHFR in the presence of the 
occluded conformation (steps from 1 to 5). The red arraws is showing the divertion of the catalytic 
cycle pathway that can happen in the absence of the occluded confomation. 
 
Our investigations provide a better understanding of the MpDHFR catalytic cycle as well. As 
suggested by the results of our binding studies, the product THF does not release from MpDHFR 
until NADP
+
 is replaced by NADPH in the ternary complex. Thus, MpDHFR likely follows a well-
ordered catalytic cycle, which is similar to that of EcDHFR. Nevertheless, certain aspects of 
MpDHFR catalysis are dramatically different. This enzyme could not adopt the occluded 
conformation as the key serine residue in the GH loop is replaced by a rigid proline residue, which 
lacks both groups (OH and NH) responsible for formation of the hydrogen bonds important to the 
occluded conformation. The 
1
H-
15
N HSQC studies point out that MpDHFR has a stronger affinity to 
NADP
+
 than the E. coli counterpart, due to the lack of the occluded conformation. It is unclear how 
MpDHFR could faithfully follow the physical steps in a consecutive manner. Possibly, MpDHFR has 
evolved to possess a stronger affinity for THF, thereby ensuring that NADP
+
 first exits from the 
active site after the step of hydride transfer. This is evident by the slightly higher (~1.6x) koff value 
measured for THF in the MpDHFR.NADPH.THF complex. Alternatively, MpDHFR might bind 
more weakly to NADP
+
 than the E. coli variant. However, additional work is needed to quantify the 
extent of NADP
+
 binding. Moreover, the pH rate profile of the MpDHFR reaction shows a bell-
shaped curve, instead of the sigmoidal curve that was observed with the EcDFHR reaction and koff 
for THF from the MpDHFR.NADP
+
.THF complex at pH values below 6 is faster than kcat. This can 
be due to the existence of two parallel kinetic pathways. Whereas one pathway employs the ‘regular’ 
EcDHFR catalytic pathway, the parallel pathway might have an alternative rate-determining step, 
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which could be the release of NADP
+
 or the generation of apoenzyme. As a matter of fact, similar 
hypotheses have been suggested for DHFRs from Human (HsDHFR)
129-130
 and Mycobacterium 
tuberculosis (MtDHFR).
70
 In particular, the occluded conformers of these enzymes have never been 
observed, and the amino acid sequence seem to lack the key serine residue for stabilizing this 
conformer.
70,129-130
  
 
Perhaps more interestingly, the descending limb at low pH was removed when the occluded 
conformation is enabled in the MpDHFR catalysis via a Pro150Ser site-directed mutation. This 
indicates that the occluded conformation rescues the enzyme from poor steady-state activity at low 
pH. A probable explanation is that product binding is weakened at low pH due to a change in- 
protonation state(s) in product(s) and/or the enzyme; this might disturb the order of physical steps, 
consequently slowing the reaction rate. In contrast, when the occluded conformation is enabled in the 
MpDHFR-P150S reaction, the order of product release is strictly controlled and consequently the 
rate of reaction is retained. It is somewhat unfortunate that high concentration of MpDHFR leads to 
protein aggregation in acidic condition, precluding us from obtaining additional NMR data and 
insights into the habits of product binding. Currently, our group continues the investigation using 
other experimental methods, including solvent isotope effect measurement and/or binding isotope 
effect measurements of isotopically labeled products. 
 
4.8 Conclusions 
In this chapter, the role of the occluded conformation was investigated by a combination of 
techniques, including site-directed mutagenesis, steady and pre-steady-state kinetics, binding 
measurement and NMR studies. It was clearly revealed that the occluded conformation does not 
affect the step of hydride transfer. Yet, it is of great importance for EcDHFR catalysis, because it 
controls the enzyme’s affinity for NADP+ and guides the enzyme through the physical steps in a 
strictly ordered manner. Inability to form the occluded conformation had a strong impact on 
EcDHFR, resulting in a change in the steady state rate limiting step and a great decrease in the value 
of kcat. MpDHFR seems to follow a similar catalytic cycle, but it functions efficiently without the 
involvement of an occluded conformation. This enzyme might have evolved to hold a stronger 
affinity to THF or a weaker affinity to NADP
+
, either of which ensures the sequential order of 
product release at pH 7. However, this character of MpDHFR is hampered in acidic condition, 
decreasing the steady-state reaction rate constant and contributing to the bell-shaped curve in the pH 
rate profile, diverting the reaction into two parallel kinetic pathways as has been described previously 
for MtDHFR.
70
 This impairment, interestingly, could be rescued by enabling the occluded 
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conformation in the MpDHFR catalytic cycle. Since many DHFRs lack a hydrogen bond donor in 
the position corresponding to Ser148, and since the occluded conformation has been observed only in 
EcDHFR, the occluded conformation is unlikely to be universal and the E. coli enzyme may not 
always be the best choice for the study of general aspects of catalysis by dihydrofolate reductase.  
  101 
 
 
 
 
 
 
 
 
 
 
5 
 
Loop dynamics during catalysis by 
dihydrofolate reductase 
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5.1 Preface 
Studying protein variants is a very important tool to understand the relation between enzyme 
structure, dynamic and catalysis. Although many protein variants have properties similar to their 
corresponding wild-type structures, the replacement of a single amino acid often produces dramatic 
changes in enzymes structures, stabilities, and function.
131-133
 Many proteins exist simultaneously in 
multiple conformations and previous studies have provided evidence of the importance of enzyme 
motion during catalysis by DHFR.
7,77,127,134-135
 Various X-ray crystallographic structures for DHFR 
from Escherichia coli (EcDHFR) indicate that the enzyme assumes different conformations along the 
reaction pathway as discussed in detail in Chapters 1 and 4.
7,59,74,136-137
 
 
Often the effect of a single mutation is distributed over many protein properties. Enzyme mutation 
can have various effects on the protein structure; such as affecting ligand binding, resulting in an 
altered affinity for a substrate, product, and inhibitor. In addition, it can increase or decrease 
enzymatic activity;
138-140
 and can cause changes in protein stability,
141
 or disturb the protein 
conformations
142
 and the rates of conformational change.
143
 In this chapter, different MpDHFR and 
EcDHFR variants were designed, produced using site-directed mutagenesis and studied alongside the 
wild type enzymes to elucidate the role of individual amino acids or areas of the proteins in terms of 
structure and function.  
 
5.2 Choosing MpDHFR and EcDHFR variants 
Dihydrofolate reductase contains three mobile loops: the M20 loop (residues 9-24), FG loop 
(residues 116 to 132 in EcDHFR), and GH loop (residues 142 to 149 in EcDHFR). The movements 
of these three loops were thought to be essential for catalysis.
7,59,127
  
 
In particular, depending on the nature of the bound ligand, two different conformations have been 
observed for the M20 loop (residues 9-24) of EcDHFR: closed and occluded.
7
 The M20 loop adopts 
the closed conformation when the substrate (DHF) and the coenzyme (NADPH) are bound to 
EcDHFR. This conformation is stabilized by hydrogen bonding interactions between the M20 loop 
and the FG loop.
7,59
 The M20 loop switches to the occluded conformation in the product binary and 
ternary complexes and two new hydrogen bonds are formed between the M20 loop and the GH 
loop.
7,59
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Mutations in the GH loop in position 150 (MpDHFR number) were discussed in chapter 4 in detail. 
In this chapter, the effect of site directed mutagenesis in the M20 loop and FG loop on DHFR 
catalysis will be studied. 
 
5.3 Mutation in the M20 loop 
Alignment of the amino acid sequences for the two DHFR homologues, EcDHFR and MpDHFR 
shows three major differences in the M20 loop (Figure 5.1).  
 
 
Figure 5.1: Alignment of the amino acid sequences of EcDHFR and MpDHFR showing the main 
different residues in the M20 loop in red. 
 
These residues are methionine 16 (replaced by leucine in MpDHFR), alanine 19 (replaced by lysine 
in MpDHFR) and asparagine 23 (replaced by histidine in MpDHFR). The backbone of asparagine 23 
in EcDHFR was found to form two hydrogen bonds with serine 148 in the GH loop in the product 
complex to stabilize the occluded conformation. Since MpDHFR is most probably not capable of 
forming the occluded conformation due to the absence of serine 148 (replaced with proline in 
MpDHFR, see chapter 4 for further details), the replacement of asparagine 23 in EcDHFR with 
histidine in MpDHFR should not have any effect on the hydride transfer step. Furthermore, the 
MpDHFR-H23N variant (EcDHFR numbers) has a similar pH dependence in the steady state to the 
wild type MpDHFR with similar kcat values, suggesting that the mutation did not affect the steady 
state rate limiting step. In addition, this variant has a similar CD spectrum to wild type MpDHFR, 
indicating no change in the secondary structure for this variant compared to wild type MpDHFR (see 
chapter 4). 
 
The mutations in the M20 loop were created mainly in two positions (positions 16 and 19) in both 
EcDHFR and MpDHFR (Figure 5.2), to investigate the role of these active site residues in catalysis 
by dihydrofolate reductase. The differences in these positions are the most dramatic changes to the 
M20 loop between the two enzymes. 
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Figure 5.2: (A) Alignment of the active site loops of EcDHFR (green, PDB 1DRE)
1
 and MpDHFR 
(yellow, PDB 3IA4)
4
 in complex with methotrexate (MTX) and NADP
+
 (green) showing  the position 
of M16 and A19 in EcDHFR and the corresponding residues in MpDHFR (L17 and K20). (B) 
Alignment of EcDHFR (cyan, PDB 1RX2)
1
 in the closed conformation, in complex with NADP
+
 and 
folate and EcDHFR (blue, PDB 1RX6)
1
 in the occluded conformation showing the difference of the 
position of M16 and A19 in the closed and the occluded conformation. 
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5.3.1 EcDHFR variants at positions 16 and 19 
The temperature dependence of hydride/deuteride transfer and the kinetic isotope effect (KIE) were 
measured, under single turnover conditions, for the variants EcDHFR-M16L, EcDHFR-A19K 
(Figure 5.3 and Table 5.1), EcDHFR-M16L/A19K, EcDHFR-M16L/S148P (Figure 5.4 and Table 
5.2), EcDHFR-A19K/S148P and EcDHFR-M16L/A19K/S148P (Figure 5.5 and Table 5.4). The data 
obtained were compared to the temperature dependence of the rate constants and kinetic isotope 
effect for wild type EcDHFR (Figure 5.6). 
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Figure 5.3: Temperature dependence (right) and Arrhenius plots (left) of the pre-steady-state rate 
constants for hydride (kH, circles) and deuteride (kD, triangles) transfer during catalysis by wild type 
EcDHFR (blue), EcDHFR-M16L (cyan) and EcDHFR-A19K (orange) at pH 7. 
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Figure 5.4: Temperature dependence (right) and Arrhenius plots (left) of the pre-steady-state rate 
constants for hydride (kH, circles) and deuteride (kD, triangles) transfer during catalysis by wild type 
EcDHFR (blue), EcDHFR-M16L/S148P (light blue) and EcDHFR-A19K/S148P (pink) at pH 7. 
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Figure 5.5: Temperature dependence (right) and Arrhenius plots (left) of the pre-steady-state rate 
constants for hydride (kH, circles) and deuteride (kD, triangles) transfer during catalysis by wild type 
EcDHFR (blue), EcDHFR-M16L/A19K (red) and EcDHFR-M16L/A19K/S148P (green) at pH 7. 
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Figure 5.6: The temperature dependence of KIEs plotted on a logarithmic scale against the inverse 
temperature during catalysis by wild type EcDHFR (blue), EcDHFR-M16L (cyan), EcDHFR-A19K 
(orange) and EcDHFR-M16L/A19K (red) left, and by wild type EcDHFR (blue), EcDHFR-
M16L/S148P (light blue), EcDHFR-A19K/S148P (pink) and EcDHFR-M16L/A19K/S148P (green), 
right, under single turnover conditions at pH 7. 
 
The six variants EcDHFR-M16L, -A19K, -M16L/S148P, -A19K/S148P, -M16L/A19K and -
M16L/A19K/S148P have similar hydride transfer rate constants to the wild type EcDHFR (Figures 
5.3 to 5.5) and similar temperature dependence of the KIE (Figure 5.6), indicating that the mutation 
did not affect the chemical step. However, while the mutation did not affect hydride transfer, a 
dramatic decrease in the steady state rate constant (kcat) was obtained for all the variants (Table 5.6). 
The steady state rate constant of EcDHFR represents the rate of the product (THF) release from the 
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ternary complex E.NADPH.THF
7
 (kcat = 6.9 ± 0.1 s
-1
 at pH 7 and 20 ˚C). The EcDHFR-M16L variant 
has shown very similar KM values to wild type EcDHFR for both NADPH and DHF (Table 5.15), 
however the smallest kcat of the six variants was obtained for this variant and the EcDHFR-
M16L/S148P variant as well, followed by EcDHFR-M16L/A19K/S148P (kcat = 0.66 ± 0.12 s
-1
) and 
EcDHFR-M16L/A19K (kcat = 1.67 ± 0.12 s
-1
). The EcDHFR-A19K and EcDHFR-A19K/S148P 
variants show the highest kcat in all the EcDHFR variants studied here with a value comparable to 
that obtained for the EcDHFR-S148P variant as was shown in Chapter 4 (kcat = 2.15 ± 0.25, 2.2 ± 
0.40 and 2.8 ± 0.4 s
-1 
for EcDHFR-A19K, EcDHFR-A19K/S148P and EcDHFR-S148P 
respectively). 
 
Table 5.1: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR-M16L and A19K at pH 7.  
T (
o
C) 
EcDHFR-M16L
a 
EcDHFR-A19K
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 108.91 ± 1.24 31.49 ± 0.06 70.87 ± 0.32 17.15 ± 2.05 
10 124.65 ± 5.66 37.57 ± 0.09 87.60 ± 0.71 26.35 ± 5.95 
15 150.36 ± 1.74 45.20 ± 0.61 102.38 ± 3.85 46.33 ± 1.87 
20 185.57 ± 3.18 59.93 ± 0.73 133.28 ± 5.96 52.68 ± 4.56 
25 226.00 ± 2.97 79.91 ± 5.00 183.54 ±15.26 79.18 ± 19.34 
30 258.36 ± 7.52 98.72 ± 4.48 197.05 ± 19.73 80.75 ± 0.78 
35 296.01 ± 11.85 121.14 ± 4.34 nd nd 
nd: not determined, 
a
 rate constants measured by Jiannan Guo 
 
Table 5.2: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR-M16L/S148P and A19K/S148P at pH 7.  
T (
o
C) 
EcDHFR- M16L/S148P
a 
EcDHFR-A19K/S148P
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 89.2  ± 4.2 28.2 ± 0.7 85.2 ± 0.8 16.9 ± 1.9 
10 104.6 ± 2.1 33.0 ± 0.8 74.7± 23.4 20.4 ± 4.2 
15  123.3± 3.3 40.8 ± 0.4   88.4± 24.2 30.3 ± 0.2 
20  146.9± 3.3 54.2 ± 0.8 118.6  ± 50.2 37.7 ± 0.2 
25 175.0 ± 5.8 66.6 ± 0.3  141.6 ± 58.7 49.9 ± 5.8 
30 196.3 ± 7.0 76.0 ± 1.8  225.3 ± 5.0 94.5 ± 11.5 
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35 230.9 ± 4.9 90.3 ± 0.5 nd nd 
a
 data measured by Jiannan Guo, nd: not determined 
 
Table 5.3: Temperature dependence of the pre-steady-state kinetic isotope effect during catalysis 
by EcDHFR-M16L, A19K, M16L/S148P and A19K/ S148P at pH 7. 
T (
o
C) 
EcDHFR-M16L
a 
EcDHFR-A19K
 
EcDHFR-
M16L/S148P
a 
EcDHFR-
A19K/S148P 
5 3.46 ± 0.04 4.13 ± 0.06 3.16 ± 0.17 3.45 ± 0.06 
10 3.32 ± 0.15 3.33 ± 0.11 3.17 ± 0.10 3.65  ± 0.21 
15 3.33 ± 0.06 2.21 ± 0.03 3.02 ± 0.08 2.92 ± 0.16 
20 3.10 ± 0.07 2.53 ± 0.05 2.71 ± 0.07 3.15 ± 0.24 
25 2.83 ± 0.18 2.32 ± 0.13 2.63 ± 0.09 2.84 ± 0.25 
30 2.62 ± 0.14 2.44 ± 0.06 2.58 ± 0.11 2.38 ± 0.06 
35 2.44 ± 0.13 nd 2.56 ± 0.06 nd 
nd: not determined, 
 a
 rate constants measured by Jiannan Guo, nd: not determined 
 
 
 
 
 
 
 
 
Table 5.4: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR-A19K/M16L and A19K/M16L/S148P at pH 
7.  
T (
o
C) 
EcDHFR- M16L/A19K
 
EcDHFR- M16L/A19K/S148P
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 89.35 ± 3.75 22.80 ± 1.70 76.00 ± 2.26 18.30 ± 0.42 
10 114.85 ± 1.63 40.50 ± 3.54 104.60 ± 19.23 26.35 ± 0.49 
15 142.50 ± 0.71 51.00 ± 5.66  136.25 ± 21.14 35.25 ± 0.35 
20 214.00 ± 4.24 73.50 ± 4.95 145.50 ± 0.71 48.50 ± 3.54 
25 252.00 ± 28.28 87.00 ± 1.41 181.00 ± 8.49 56.50 ± 0.71 
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30 288.50 ± 31.82 119.50 ± 2.12 213.00 ± 11.31 73.00 ± 1.41 
 
Table 5.5: Temperature dependence of the pre-steady-state kinetic isotope effect during 
catalysis by EcDHFR-M16L/A19K and M16L/A19K/ S148P at pH 7. 
T (
o
C) EcDHFR-M16L/A19K
 
EcDHFR-M16L/A19K/S148P
 
5 3.92 ± 0.04 4.15 ± 0.02 
10 2.84 ± 0.04 3.97 ± 0.11 
15 2.79 ± 0.06 3.87 ± 0.09 
20 2.91 ± 0.04 3.00 ± 0.04 
25 2.90 ± 0.07 3.20 ± 0.03 
30 2.41 ± 0.06 2.92 ± 0.03 
 
Table 5.6: Steady-state turnover number (kcat) measured at 
pH 7 and 20 
o
C during catalysis by different EcDHFR 
variants. 
Enzyme kcat (s
-1
) 
WT-EcDHFR 6.9 ± 0.10 
EcDHFR-M16L 0.47 ± 0.01 
EcDHFR-A19K 2.15 ± 0.25 
EcDHFR-M16L/S148P
a 
0.42 ± 0.01 
EcDHFR-A19K/S148P
 
2.2 ± 0.40 
EcDHFR-M16L/A19K
 
1.67 ± 0.12 
EcDHFR-A19K/M16L/S148P
 
0.66 ± 0.12 
a
 measured by Jiannan Guo 
 
5.3.2 MpDHFR variants at position 16 and 19 (EcDHFR numbering) 
The temperature dependence of hydride/deuteride transfer and the kinetic isotope effect (KIE) were 
measured, under single turnover conditions, for the variants MpDHFR-M16L, MpDHFR-A19K 
(Tables 5.7 and 5.9), MpDHFR-M16L/P150S, MpDHFR-A19K/P150S (Tables 5.8 and 5.9), 
MpDHFR-M16L/A19K and MpDHFR-M16L/A19K/P150S (Tables 5.10 and 5.11). The data 
obtained were compared to the temperature dependence of the rate constants and kinetic isotope 
effect for wild type MpDHFR (Figures 5.7 to 5.10). 
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Figure 5.7: Temperature dependence (left) and Arrhenius plots (right) of the pre-steady-state rate 
constants for hydride (kH, circles) and deuteride (kD, triangles) transfer during catalysis by wild type 
MpDHFR (blue), MpDHFR-L16M (cyan) and MpDHFR-K19A (orange) at pH 7. 
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Figure 5.8: Temperature dependence (left) and Arrhenius plots (right) of the pre-steady-state rate 
constants for hydride (kH, circles) and deuteride (kD, triangles) transfer during catalysis by wild type 
MpDHFR (blue), MpDHFR-L16M/P150S (light blue) and MpDHFR-K19A/P150S (pink) at pH 7. 
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Figure 5.9: Temperature dependence (left) and Arrhenius plots (right) of the pre-steady-state rate 
constants for hydride (kH, circles) and deuteride (kD, triangles) transfer during catalysis by wild type 
MpDHFR (blue), MpDHFR-L16M/K19A (red) and MpDHFR-L16M/K19A/P150S (green) at pH 7. 
 
The rate constants and the KIE for all the single MpDHFR variants were similar to wild type 
MpDHFR at most temperatures (Figure 5.7). However, the rate of deuteride transfer for the single 
mutants were similar to the rate of hydride transfer at 5 ˚C, unlike their wild type counterpart (Figure 
5.7), resulting in a KIE of 1.27 ± 0.12 and 1.34 ± 0.15 for MpDHFR-L16M and MpDHFR-K19A 
respectively, indicating that hydride transfer becomes less rate limiting at such conditions for these 
two variants (Figure 5.10, right). A similar effect was obtained for the double variant MpDHFR-
L16M/K19A but with higher KIEs compared to the wild type counterpart and the single variants at 
temperatures ≥ 10 ˚C (Figure 5.10, left). 
 
For the double variant MpDHFR-L16M/K19A and the triple variant MpDHFR-L16M/K19A/P150S, 
not much difference was observed for the rate constants of hydride transfer; however the rate 
constants for deuteride transfer were less temperature dependent than those obtained for the wild 
type MpDHFR (Figure 5.9). For the triple variant in addition to the two variants MpDHFR-
L16M/P150S and MpDHFR-K19A/P150S, the temperature dependences of the KIEs showed two 
phases with a breakpoint at 10 or 15 ˚C (Figure 5.10, right). Similar behavior was reported 
previously for EcDHFR at pH 9.5. Interestingly, the values of the KIEs obtained for the triple variant 
and all the double variants above the breakpoint were higher than those observed for their wild type 
counterpart at the same temperatures, and comparable to that observed for EcDHFR (Figure 5.9). 
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Figure 5.10: Temperature dependence of the kinetic isotope effect (KIE) plotted on a logarithmic 
scale against the inverse temperature for wild type MpDHFR (blue), MpDHFR-L16M (cyan), 
MpDHFR-K19A (orange) and MpDHFR-L16M/K19A (red) (left), and wild type MpDHFR (blue), 
MpDHFR-L16M/P150S (light blue), MpDHFR-K19A/P150S (pink) and MpDHFR- 
L16M/K19A/P150S (green) (right), measured under single turnover conditions at pH 7. 
 
The steady state rate constants (kcat) were measured as well for all the MpDHFR variants in 
phosphate buffer at pH 7 and 20 
o
C (Table 5.12). In contrast to the corresponding EcDHFR variants, 
the values of kcat observed for the MpDHFR variants were in the same order of magnitude compared 
to the wild type MpDHFR. Furthermore, the values of kcat were elevated in the single variants with 
kcat values of 21.56 ± 1.56 for MpDHFR-L16M and 18.08 ± 0.73 for MpDHFR-K19A compared to 
14.78 ± 0.79 for wild type MpDHFR under the same conditions.79 However, kcat values for all of the 
double and the triple variants were decreased slightly compared to wild type MpDHFR (Table 5.12). 
 
Table 5.7: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by MpDHFR-L16M and K19A at pH 7.  
T (
o
C) 
MpDHFR-L16M
 
MpDHFR-K19A
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 271.77 ± 4.81 214.00 ± 19.61 255.20 ± 5.21 191.00 ± 21.71 
10 344.80 ± 4.24 187.25 ± 37.66 372.10 ± 33.69 192.50 ± 19.77 
15 457 ± 23.76 226.10 ± 30.69 416.25 ± 8.77 177.00 ± 12.83 
20 525.73 ± 3.54 307.83 ± 72.83 533.50 ± 7.78 227.00 ± 25.15 
25 600.32 ±0.14 325.60 ± 13.44 533.00 ± 30.54 268.00 ± 19.24 
30 543.23 ± 13.86 292.55 ± 41.01 520.50 ± 58.45 277.25 ± 15.90 
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Table 5.8: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by MpDHFR-L16M/P150S and MpDHFR-K19A/P150S at 
pH 7. 
T (
o
C) 
MpDHFR-L16M/P150S
 
MpDHFR-K19A/P150S
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 250.65 ± 8.27 162.10 ± 23.05 259.15 ± 14.35 nd 
10 257.75 ± 3.89 133.95 ± 24.11 314.00 ± 8.49 132.50 ± 17.68 
15 324.85 ± 3.04 132.60 ± 26.94 453.50 ± 26.16 145.00 ± 7.07 
20 357.50 ± 7.07 142.90 ± 10.54 536.50 ± 42.43 185.00 ± 6.36 
25 428.70 ± 19.80 148.88 ± 13.88 619.00 ± 40.00 205.00 ± 15.56 
30 507.33 ± 91.05 196.87 ± 7.94 nd  nd 
nd: not determined 
 
 
 
 
 
 
 
Table 5.9: Temperature dependence of the pre-steady-state kinetic isotope effects during catalysis 
by MpDHFR-L16M, K19A, L16M/P150S and MpDHFR-K19A/P150S at pH 7. 
T (
o
C) MpDHFR-L16M
 
MpDHFR-K19A
 
MpDHFR-
L16M/P150S
 
MpDHFR-
K19A/P150S
 
5 1.27 ± 0.12 1.34 ± 0.15 1.55 ± 0.23 nd 
10 1.84 ± 0.37 1.93 ± 0.26 1.92 ± 0.35 2.37 ± 0.32 
15 2.02 ± 0.29 2.35 ± 0.18 2.45 ± 0.50 3.13 ± 0.24 
20 1.71 ± 0.40 2.35 ± 0.26 2.50 ± 0.19 2.90 ± 0.20 
25 1.84 ± 0.08 1.99 ± 0.18 2.88 ± 0.30 3.02 ± 0.30 
30 1.86 ± 0.26 1.88 ± 0.24 2.58 ± 0.47 nd 
nd: not determined 
 
Table 5.10: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
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deuteride (kD) transfer during catalysis by MpDHFR-L16M/K19A and L16M/K19A/P150S at pH 
7.  
T (
o
C) 
MpDHFR-L16M/K19A
 
MpDHFR-L16M/K19A/P150S
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 278.00 ± 37.07 235.50 ± 11.21 233.50 ± 3.82 129.00 ± 11.31 
10 433.52 ± 28.61 137.25 ± 32.17 330.50 ± 3.54 137.50 ± 13.44 
15 479.83 ± 43.60 144.28 ± 144.28 504.50 ± 19.09 145.00 ± 4.24 
20 576.05 ± 42.46 188.00 ± 15.56 537.50 ± 48.79 156.50 ± 9.19 
25 531.33 ± 25.42 174.15 ± 5.87 632.00 ± 48.08 201.50 ± 40.31 
30 nd nd 556.50 ± 4.95 181.85 ± 1.63 
nd: not determined 
 
 
 
 
 
 
 
 
 
Table 5.11: Temperature dependence of the pre-steady-state kinetic isotope effect during 
catalysis by MpDHFR-L16M/K19A and L16M/K19A/P150S at pH 7. 
T (
o
C) MpDHFR-L16M/K19A
 
MpDHFR-L16M/K19A/P150S
 
5 1.18 ± 0.17 1.81 ± 0.16 
10 3.16 ± 0.77 2.40 ± 0.24 
15 3.33 ± 0.32 3.48 ± 0.17 
20 3.06 ±0.34 3.43 ± 0.37 
25 3.05 ± 0.18 3.14 ± 0.67 
30 nd 3.06 ± 0.04 
nd: not determined 
 
Table 5.12: Steady-state turnover number (kcat) measured at 
pH 7 and 20 
o
C during catalysis by different MpDHFR 
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variants. 
Enzyme kcat (s
-1
) 
WT-MpDHFR 14.78 ± 0.79 
MpDHFR-M16L 21.56 ± 1.56 
MpDHFR-A19K 18.08 ± 0.73 
MpDHFR-M16L/P150S
a 
10.04 ± 0.77 
MpDHFR-A19K/P150S
 
9.75 ± 1.02 
MpDHFR-M16L/A19K
 
9.75 ± 1.02 
MpDHFR-A19K/M16L/P150S
 
12.74 ± 2.04 
 
5.4 Mutation in the FG loop – variants at positions 124 and 123 (MpDHFR numbering) 
X-ray crystallographic data reported by Sawaya and Kraut proposed that the M20 loop of DHFR 
modulates ligand specificity by adopting either of two conformations (closed and occluded),
59
 as 
described previously. Hydrogen bonds between the M20 loop and neighboring loops are the key 
stabilizing contacts for these conformations. The closed M20 conformation occurring in substrate 
complexes (E.NADPH and E.NADPH.DHF) relies on interactions with the FG loop, whereas the 
occluded conformation occurring in product complexes involves interactions with the GH loop (see 
chapter 3 for further details). Hydrogen bonds act as support for stabilisation of the M20 loop, 
maintaining its various conformations throughout the catalytic cycle
59
 (see Chapter 1) and different 
variants indicated the importance of hydrogen bonding between the FG and M20 loops to catalysis.
71
 
MpDHFR and EcDHFR have a conserved aspartate residue at position 124 (D122 in EcDHFR 
numbering) and glycine residue at position 123 (G121 in EcDHFR numbering) (Figure 5.11). 
Aspartic acid 122 of EcDHFR has been extensively studied by Benkovic and coworkers,
126
 with 
substitution to asparagine, serine or alanine. Such variants of EcDHFR disrupt the hydrogen bonding 
potential between the highly mobile M20 loop and the FG loop. In this part of the thesis, we targeted 
the hydrogen bond between the side chain of Asp124 in the FG loop in MpDHFR and the amide 
backbone of Glu18 in the Met20 loop for mutagenesis to weaken the strength of this bond.  
 
Glycine 121 (EcDHFR numbers) has also seen much investigation by many research groups both in 
terms of effect on enzyme stability through equilibrium unfolding and CD spectroscopy experiments 
and catalytic efficiency through kinetic experiments.
71,122,144-146
 For further investigation of the effect 
of mutation in the FG loop on catalysis by MpDHFR, hydride transfer by the variant MpDHFR-
G123V, where the mutation in the FG loop is 19 Å away from the active site, was studied as well. 
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Replacing G123 with a bulky hydrophobic valine residue most probably will affect the loop 
flexibility. Our study will spot the influence of this mutation on hydride transfer by MpDHFR and 
make it comparable with previous data reported for the same variant in EcDHFR. 
 
Figure 5.11: Cartoon representation showing the positioning of residue G123 (violet sphere) and 
D124 (orange sphere) in EcDHFR (PDP 1DRE, green) and MpDHFR (PDP 3IA4, yellow) (A) and 
hydrogen bonding between D124 (EcDHFR numbers) in the FG loop and residues E/D18 and G16 
in the M20 loop (MpDHFR numbering), (B). NADP
+
, MTX and residues G16, E/D18, G123 and 
D124 are shown in stick representation. 
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5.4.1 Temperature dependence of kH and KIE for the FG loop variants 
The temperature dependence of the hydride/deuteride transfer rate constant by the two variants, 
MpDHFR-G123V and -D124N were measured with both NADPH and NADPD (Table 5.13), and the 
temperature dependence of the kinetic isotope effect for each variant was obtained by dividing the 
rate of hydride transfer by the rate of deuteride transfer (Table 5.14). 
 
For the MpDHFR-D124N variant, the mutation did not affect either the rate of hydride/deuteride 
transfer or the kinetic isotope effect (Figures 5.12 and 5.13). The enzyme showed very similar 
behavior to the wild type MpDHFR under pre-steady state conditions. The only difference obtained 
was in the steady state rate that showed a ~35 fold decrease in the MpDHFR-D124N variant (kcat = 
0.41 ± 0.08) compared to wild type MpDHFR. 
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Figure 5.12: The temperature dependence of the pre-steady-state rate constant (left) and 
corresponding Arrhenius plot (right) with NADPH (circles) and NADPD (triangles) for wild type 
MpDHFR (blue), MpDHFR-D124N (orange), and MpDHFR-G123V (green) catalysis, measured 
under single turnover conditions at pH 7. 
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Figure 5.13: Temperature dependence of the kinetic isotope effect (KIE) plotted on a logarithmic 
scale against the inverse temperature for wild type MpDHFR (blue), MpDHFR-D124N (orange), 
and MpDHFR-G123V (green) catalysis, measured under single turnover conditions at pH 7. 
 
However, the temperature dependence of the KIE for the MpDHFR-G123V variant was similar to its 
wild type counterpart within experimental errors (Figure 5.13). This enzyme has shown a remarkable 
decrease in hydride transfer rates at temperatures ≥ 20 ˚C. The decrease in hydride transfer rate 
constants at higher temperatures might suggest a decrease in the thermostability of this variant. This 
variant has shown very similar KM values for both NADPH and DHF to the wild type MpDHFR
90
 
and a kcat value of 0.47 ± 0.04 s
-1
 similar to the MpDHFR-D124N, suggesting that these two 
mutations are having similar effect on the steady state kinetics. 
 
The results for both variants are very different compared to the data reported previously for the same 
variants with EcDHFR. Replacing D124 in EcDHFR (D122 in EcDHFR numbering) with asparagine 
causes a 25 fold decrease in the rate of hydride transfer and the enzyme shows a kinetic isotope 
effect of 1.6 ± 0.2 under steady state conditions, suggesting contribution from the chemical step. In 
addition, the affinity for the reduced cofactor decreases 3-4 fold, whereas binding of the oxidized 
cofactor was not affected. In case of the MpDHFR-D124N, the only difference was obtained is the 
decrease in the value of kcat compared to the wild type enzyme. A similar effect was reported 
previously for the EcDHFR variant suggesting change in the catalytic cycle for these two variants. 
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Table 5.13: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by MpDHFR-D124N and -G123V at pH 7.  
T (
o
C) 
MpDHFR-D124N
 
MpDHFR-G123V
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 282.50 ± 0.71 122.00 ± 5.66 307.50 ± 24.75 127.00 ± 11.46  
10 334.00 ± 19.80 158.00 ± 4.24 273.50 ± 7.78 121.50 ± 7.78 
15 393.50 ± 4.95 168.00 ± 1.41 355.00 ± 35.36 176.00 ± 12.73 
20 503.00 ± 18.38 229.00 ± 11.31 360.50 ± 16.26 199.00 ± 20.01 
25 540.00 ± 9.90 274.50 ± 2.12 373.95 ± 28.35 211.00 ± 12.73 
30 689.50 ± 41.72 389.00 ± 1.41 nd nd 
 
Table 5.14: Temperature dependence of the pre-steady-state kinetic isotope effects during 
catalysis by MpDHFR-D124N and -G123V at pH 7. 
T (
o
C) MpDHFR-D124N
 
MpDHFR-G123V
 
5 2.32 ± 0.11 2.42 ± 0.29 
10 2.11 ± 0.14 2.25 ± 0.16 
15 2.34 ± 0.04 2.02 ± 0.25 
20 2.20 ± 0.13 1.81 ± 0.20 
25 1.97 ± 0.04 1.77 ± 0.17 
30 1.77 ± 0.11 nd 
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Table 5.15: KM for NADPH and DHF for different EcDHFR and MpDHFR variants at 
pH 7 and 20 C. 
Enzyme KM
DHF
 (µM) KM
NADPH
 (µM) 
EcDHFR
a
 0.7 ± 0.2 4.8 ± 1.0 
EcDHFR-S148P 0.7 ± 0.1 4.7 ± 0.7 
EcDHFR-A19K 0.9 ± 0.2 nd 
EcDHFR-A19K/S148P 0.7 ± 0.1 nd 
EcDHFR-M16L
b 
0.7 ± 0.1 6.2 ± 0.3 
MpDHFR
c
 2.4 ± 0.2 5.7 ± 0.2 
MpDHFR-P150S 2.2 ± 0.2 10.7 ± 0.6 
MpDHFR-K19A nd 8.2 ± 0.1 
MpDHFR-L16M/K19A nd 10.5 ± 0.1 
MpDHFR-L16M/K19A/P150S nd 20.9  ± 0.1 
MpDHFR-G123V
d 
1.1 ± 0.1 8.7 ± 0.1 
nd: not determined, 
a
: taken from reference 
79
, 
b
: measured by Jiannan Guo, 
c
: taken 
from reference 
7
 at pH 7.5, 
d
: measured by Dr Rhiannon Evans. 
 
5.5 Discussion 
Enzymes are known to switch between conformations; even so, understanding the contribution of 
enzyme motions to catalysis is difficult. The static window into the DHFR catalytic cycle provided 
by X-ray crystallographic data indicates two conformations for the M20 loop (closed and occluded) 
exist in liganded complexes.
7,59
 The contributions of these studies emphasize the importance of the 
motion of the mobile loops (M20 loop, FG loop and GH loop) during catalysis by EcDHFR. The 
work presented in this thesis has focused on catalysis by DHFR from the cold adapted enzyme 
Moritela profunda (MpDHFR) and spotting the differences between this enzyme and the mesosphilic 
homologue from Escherichia coli which has been studied extensively. In this chapter we 
demonstrated the effect of mutation in the M20 loop and FG loop on catalysis by both enzymes. 
Compared to the widely studied EcDHFR, the psychrophilic MpDHFR shows extensive conservation 
of catalytically important residues.
62
 Our study targeted residues in the highly mobile M20 loop, in 
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particular positions L16 and K19 (EcDHFR numbers) in MpDHFR and compared to the opposite 
residues in the mesophilic homologue, EcDHFR (M16 and A19).  
 
All the EcDHFR variants studied here have shown rate constants and temperature dependence of the 
KIE comparable to their wild type counterpart in the pre-steady state, indicating that the mutations 
did not affect the chemical step. However, a decrease was observed in the turnover numbers for all 
the EcDHFR variants. Taking the position of M16 and A19 in consideration is highly suggestive that 
the mutation in these two positions has affected the motion of the M20 loop (Figure 5.2). The effect 
of the mutations is comparable to that seen in chapter four when the interactions between the M20 
and GH loops were perturbed in the EcDHFR-S148P variant. On the other hand, the opposite 
mutations in the MpDHFR variants did not cause a big difference in the steady state rate constant. 
These observations support the suggestion that MpDHFR does not depend on large scale motions of 
the loop regions during catalysis.
96
 
 
Although the temperature dependence of the rate constants and the KIEs for the single variants 
MpDHFR-L16M and K19A were very similar to the wild type MpDHFR, except at 5 ˚C, the double 
and the triple variants (MpDHFR-L16M/K19A and -L16M/K19A/P150S) showed a breakpoint at 15 
˚C with similar temperature dependence of the KIE at temperatures higher than 15 ˚C. However, the 
KIE values were higher compared to those obtained for wild type MpDHFR at the same 
temperatures. The higher KIE values for the double and the triple MpDHFR variants were most 
probably due to the change in the electrostatic forces at the active site compared to the wild type. 
Psychrophilic enzymes have been suggested to improve the electrostatic fields at the active site of as 
a part of adaptation to catalysis at low temperatures.
147
 Electrostatic interactions were found to be 
stabilised at lower temperatures and modification of the electrostatic potential of key residues central 
to ligand binding and catalysis was suggested be a strategy for cold adaptation.
148
 While the basic 
side chain of Lys19 was initially thought to interact with the oppositely charged folate during the 
reaction causing the high kcat values for MpDHFR,
60
 the crystal structure of MpDHFR subsequently 
showed that the side chain of K19 is projecting out in solution (Figure 5.2A),
62
 thus interaction 
between the side chain of K19 and folate is most probably unlikely to occur. Thus, replacing M16 
and A19 in EcDHFR with leucine and lysine, respectively, in MpDHFR might instead be a kind of 
structure adaptation for the psychrophilic DHFR. 
 
In this chapter we also studied the effect of weakening the bond strength between the M20 loop and 
the FG loop by replacing Asp124 in MpDHFR with an asparagine residue. The side chain of this 
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residue was thought to form a hydrogen bond with the amide backbone of Glu17 in the M20 loop, as 
proposed from the X-ray data reported by Sawaya and Kraut in 1997.
59
 This loop interaction between 
the FG loop and the M20 loop was thought to be essential for stabilizing the closed conformation in 
EcDHFR.
59,126,134
 Disturbing the hydrogen bonding between the M20 loop and the FG loop in 
EcDHFR has significantly affected the chemical step, causing around 25 to 55 fold reduction in the 
rate constants of hydride transfer and causing the chemical step to contribute to the steady state 
turnover as shown from the increase in the kinetic isotope effect under saturating conditions.
126
 
 
The G121V variant has been extensively studied in EcDHFR as well in different research groups 
using molecular dynamics, CD, NMR and fluorescence in addition to kinetic studies.
71,122,134
 
Substitution of Gly121 by valine (or other bulky side chains) has a dramatic effect on the kinetics of 
EcDHFR, decreasing the hydride transfer rate constant by up to 1000 fold and resulting in an 
additional kinetic step in the reaction mechanism.
71
 However, various molecular dynamics, CD, and 
fluorescence studies of apo-EcDHFR have suggested that the G121V mutation causes structural 
perturbation by destabilising the contacts between the Met20 and the FG loops.
122
 It has been 
suggested that the G121V mutation as well as the D122 variants in EcDHFR, at a position distant 
from the active site, interferes with coupled loop movements and appears to impair catalysis by 
destabilizing the closed Michaelis complex.
126,134
 
 
Interestingly, in contrast to EcDHFR, neither substitution of D122 (124 in MpDHFR) with 
asparagine nor the substitution of G121 (123 in MpDHFR) with valine in MpDHFR seems to 
significantly affect the chemical step of this enzyme as shown from the data presented in this part of 
the thesis. However, these two substitutions affected the steady state rate dramatically in MpDHFR, 
causing around a 35 fold decrease in kcat value at pH 7 and 20 ˚C. 
 
In EcDHFR, substitutions of Asp122 were found to perturb all ligand complexes, changing the 
catalytic pathway preferred by wild-type DHFR under saturating conditions of substrate and 
cofactor.
126
 Most probably this is the case for the FG loop variants in MpDHFR, changing the steady 
state rate limiting step and causing a big decrease in kcat. Weaker hydrogen bonding between the M20 
and FG loops was thought to facilitate the binding and release of THF.
126
 The steady state rate 
constants for the MpDHFR FG loop variants are similar to the dissociation rate constant of THF 
from the E.THF binary complex. This might suggest that disturbing the interactions between the 
M20 loop and the FG loop in MpDHFR diverts the catalytic cycle to the release of THF from the 
E.THF binary complex instead of the product ternary complex E.NADPH.THF. This might be the 
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case as well for the EcDHFR-M16L variant, which has a similar steady state rate constant. In all of 
the three variants, most probably due to the weak interactions between the M20 and the FG loops, the 
steady state rate constant was decreased dramatically without any significant change in the chemical 
step.  However these observations cannot be confirmed in the absence of kinetic binding 
measurements of the dissociation rate constants for these variants.  
 
Previous quantum mechanical and molecular mechanical simulation studies suggested that the 
G121V mutation in EcDHFR leads to an altered transition state structure, with a concomitant 
increase in the activation free energy barrier,
144,149
 and also perturbs the critical hydrogen-bonding 
interactions between the M20 and FG loops.
150
 Venkitakrishnan et al. have shown that the G121V 
variant adopts the occluded conformation in the E:folate:NADPH and E:folate:NADP
+
 complexes in 
contrast to what was observed for the wild-type DHFR, which occupies the closed conformation in 
the same complexes. 
134
 This striking difference between the G121V variant and wild type EcDHFR 
was thought to be the reason for the decrease in the hydride transfer rate constant for the G121V 
variant by destabilizing of the closed state shifting the equilibrium towards the occluded 
conformation. As shown previously (Chapter 4), MpDHFR lacks the key residue that stabilizes the 
occluded conformation. Therefore, destabilization of the closed conformation in MpDHFR most 
probably will lead to formation of a destabilized closed conformation rather than favouring the 
occluded conformation, which in the absence of its stabilizing bonds will presumably never form. 
 
Interestingly, a recent NMR study has shown that the EcDHFR-G121V.NADPH.MTX complex, 
which most resembles the transition state, forms a closed complex. That study showed that in the 
G121V transition state analog complex, the FG and M20 loops suffer excursions away from this 
accurate alignment causing changes in active site geometry .151  These results suggest that EcDHFR-
G121V can form the closed conformation but conformational fluctuation is different to the wild type 
enzyme. This was suggested as well when replacing M42 (≈20 Å away from the active site) with 
tryptophan in EcDHFR.
152
 Such variant was found to affect the hydrogen transfer rate constant 
dramatically.
150,153
 Thus, it might be interesting to study the effect of similar mutation (M42W) on 
the hydride transfer rate of MpDHFR as previous studies in our group have shown that this kind of 
mutation in MpDHFR decreases the steady state rate constant significantly.
90
 
 
We have suggested previously that the electrostatic preorganization within the active site during 
DHFR reaction is determined by the conformational state of the enzyme at the point of reaction.
47
 
MpDHFR cannot form the occluded conformation and mutations in the FG loop in positions 121 and 
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122 did not affect the chemical step, but only the physical steps as shown from the change in the 
steady state rate constant. In light of these findings the decrease in the rate of the chemical step for 
the FG variants in EcDHFR most probably is not due to impairing loop dynamics. Thus, the dynamic 
properties of DHFR and its mutants clearly affect the conformational motions that are important for 
the turnover of substrate to product, but no correlation between these conformational motions and the 
chemical motions that chemical step. The G121V mutation in EcDHFR most likely affected the 
active site preorganization which in turn manifests in alterations to the chemical step. This effect was 
not seen in the same variant in MpDHFR suggesting that MpDHFR does not use loop dynamics to 
modulate the active site conformation. This is unlikely to be a kind of adaptation of the psychrophilic 
enzyme as we have shown previously in Chapter 4 that many other DHFRs from various organisms, 
including DHFR from the mesophilic bacterium Lactobacillus casei (LcDHFR) and DHFR from the 
thermophilic species Geobacillus stearothermophilus (BsDHFR), lack the key residues that stabilize 
the occluded conformation. 
 
5.6 Conclusions 
Recently, studying the EcDHFR-N23PP/S148A variant has shown that conformational fluctuations 
are not directly involved in the chemical step of the reaction for EcDHFR.
47
 In Chapter 4 we 
demonstrated that the occluded conformation does not affect the chemical step of the DHFR reaction 
and only modifies the affinity of the enzyme to ligands. In addition, many DHFRs are actually 
lacking the key residues which stabilize the occluded conformation, including MpDHFR, suggesting 
that the occluded conformation might be a specific case for EcDHFR rather than a general 
phenomenon for all DHFRs.  In this part of the thesis we provide evidence that the dynamic nature of 
the mesophilic enzyme from Escherichia coli is not observed for the psychrophilic homologue from 
Moritella profunda. 
 
The first line of evidence was derived from mutation in the M20 loop, which most probably 
disturbed the dynamic of that highly mobile loop in EcDHFR, causing a sharp decrease in the 
turnover numbers for all the EcDHFR variants studied here. This reflects the physical steps of the 
catalytic cycle, without perturbing the nature of the chemistry of the hydride transfer reaction. On the 
contrary, none of the MpDHFR variants has shown a large difference in the turnover number, 
suggesting that such M20 loop dynamics observed in EcDHFR do not control the catalytic cycle in 
MpDHFR. 
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The second line of evidence was derived from the mutation in the FG loop. In contrast to the reported 
data from similar mutations for EcDHFR, mutation in positions 121 and 122 in MpDHFR did not 
affect the chemical step of the reaction as shown from the similar temperature dependences of the 
KIE compared to the wild type MpDHFR. Instead the two variants have shown a sharp decrease in 
the steady state rate. 
 
The data presented here in addition to the data presented in chapter four provide evidence that 
MpDHFR is using a different mechanism in modulating the enzyme’s ability to form different ligand 
complexes compared to the mesophilic enzyme EcDHFR. However, the two enzymes use the same 
catalytic cycle and the nature of the chemistry in both enzymes is similar. 
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6 
 
Effect of salt and denaturants on catalysis by 
dihydrofolate reductase 
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6.1 Preface 
Since buffer conditions (salt and pH) can have dramatic effects on the stability of proteins, the 
description of a protein’s stability is incomplete without a consideration of the role of solvent in 
protein folding and function. In the presence of cosolvents/cosolutes, a protein can fluctuate among 
vast numbers of folded and unfolded conformations, and this can occur via many different pathways, 
and leading to enzymes stabilizition or destabilization.
154 
Explaining how different salts stabilize or 
denature a protein is still a subject of debate.
155
 However, some general features are clear. Cosolutes 
that stabilize proteins cause preferential hydration, where the cosolute is expelled from the protein 
surface. Such salt cosolutes have the effect of salting-out hydrophobic moieties (i.e., they cause weak 
interactions between protein and water and promote protein-protein hydrophobic interactions) and 
their efficiency is consistent with the idea that these salts affect the water structure.
156
 Alternatively, 
cosolutes such as I2, (SCN)2, or guanidinium HCl, that destabilize proteins, salt-in the peptide group 
(i.e., promote solvent/solute interactions), and may act by breaking protein hydrogen bonds and 
interact preferentially with the protein surface which in turn leads to denaturation of the 
macromolecule.
157-158 
 
Previous studies showed the effect of salt and different denaturants on the stability, structure and 
dynamic of proteins.
157,159-162
 To understand the contribution of different electrostatic effects and 
denaturants on the stabilization, related to the associated structural changes and enzyme activity, in 
this chapter we are going to monitor enzyme activity as a function of salt concentration, or 
denaturant concentration, and examine their effect on the dihydrofolate reductase (DHFR) chemical 
step 
 
6.2 Effect of denaturants on catalysis by dihydrofolate reductase 
The mechanism of protein denaturation by urea and guanidinium hydrochloride in aqueous solutions 
is still an unsolved and important problem in protein chemistry, in spite of the presence of many 
experimental and theoretical studies on denaturation of proteins by these molecules.
163-167
 It is still 
unclear whether these molecules act directly by binding to peptide groups, thereby weakening 
internal hydrogen bonds, or indirectly by causing a change in the structure of water’s hydrogen bond 
network around hydrophobic groups in proteins, thereby increasing their solubility and weakening 
the hydrophobic effect. It is also possible that both mechanisms are operating.
163-167
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To investigate the effect of denaturants on catalysis by DHFR, different concentrations of urea and 
guanidinium hydrochloride were added to potassium phosphate buffers, pH 7 and used for kinetic 
experiments. 
 
6.2.1 Effect of urea on catalysis by MpDHFR 
The effect of urea on catalysis by dihydrofolate reductase, hydride transfer (kH) rate constants and 
steady state rate constants (kcat) were measured for MpDHFR in potassium phosphate buffers, pH 7, 
containing 0-7 M urea (Figure 6.1). 
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Figure 6.1: Left, effect of urea denaturation on the steady state rate constant (kcat) for MpDHFR. 
Right, effect of different concentrations of urea on the rate constant of hydride transfer (kH) during 
catalysis by MpDHFR (red) and EcDHFR (blue) at pH 7 and 20 C. 
 
Previous work reported by Xu et al., has shown that the concentration of urea required for half 
denaturation of the MpDHFR enzyme is 1.6 M.
60
 This value shows that the conformational stability 
for MpDHFR in urea is lower than the mesophilic (EcDHFR) and the thermophilic (TmDHFR) 
homologues which need 3.1
168
 and 5.5
169
 M urea, respectively, to reach the mid denaturation point. 
 
Measurements of the turnover number for MpDHFR at various concentrations of urea show that, 
within experimental errors, the steady state rate constant is not affected when using 2 M urea in the 
experimental buffer (Figure 6.1, left). However, at about 3.2 M of urea, a 50% decrease in the steady 
state rate constant was observed and more than 90% of the activity was reduced at 5-7 M urea (Table 
6.1). During measuring the steady state kinetics in this thesis, DHFR was incubated in the urea 
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containing buffer for 1 min. before the measurements were made. This explains why MpDHFR lost 
50% of its activity in the steady state at 3.2 M urea, while it was found that 1.6 M urea has a 50% 
denaturation (i.e., when the enzyme was allowed to fully equilibrate), as reported previously.
60
 
 
The rate constants of hydride transfer were also measured at different concentrations of urea (Table 
6.2). The data presented here shows that different concentrations of urea are affecting the pre-steady 
state rates for both enzymes, MpDHFR and EcDHFR, in a similar manner (Figure 6.1, right). Both of 
the mesophilic and the psychrophilic enzyme lose half of their activity when using around 4 M of 
urea in the reaction buffer. This perhaps might give indication that the chemical step is less affected 
by the structure denaturation than the other physical steps involved in the DHFR catalytic cycle. 
 
In contrast to what was observed for MpDHFR and EcDHFR, urea was found to activate the dimeric 
and thermophilic DHFR from Thermotoga maritima.
94
 In addition, enzyme activity for DHFR from 
Chinese hamster increased to about twice that of the native enzyme at 1.5 M urea, and then fell with 
increased urea concentration until complete inactivation occurred at 4 M.
170
 Apart from TmDHFR, 
which has similar properties to both eukaryotic and prokaryotic DHFRs,
94,171
 this property has only 
been observed only for vertebrate DHFRs, most probably due to loosening up of the protein structure 
near the active site.
161,172
 
 
Table 6.1: Steady-state rate constants (kcat) during 
catalysis by MpDHFR in different concentrations of urea 
at pH 7 and 20 C. 
Urea (M) kcat /s
-1
 
0 11.89 ± 1.29 
1 11.31 ± 2.31 
2 11.22 ± 1.60 
3 6.66 ± 0.63 
4 3.65 ± 0.75 
5 1.18 ± 0.35 
6 0.94 ± 0.20 
7 0.92 ± 0.19 
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Table 6.2: Pre-steady state hydride transfer rate constant (kH) during 
catalysis by MpDHFR and EcDHFR in different concentrations of urea 
at pH 7 and 20 C. 
Urea (M) 
MpDHFR EcDHFR
 
 
kH /s
-1 
kH /s
-1 
0 341.15 ± 25.37 194.99 ± 0.84 
1 196.40 ± 16.65 177.13 ± 9.93 
2 241.66 ± 30.18 143.57 ± 11.13 
3 182.36 ± 50.52 119.53 ± 7.19 
4 185.17 ± 35.05 96.61 ± 1.97 
5 222.08 ± 42.91 81.38 ± 11.07 
6 nd 79.16 ± 14.84 
7 nd 90.58 ± 1.54 
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6.2.2 Effect of guanidinium hydrochloride (Gdn-HCl) on catalysis by MpDHFR 
For further investigation of the effect of enzyme denaturants on DHFR catalysis, the effect of 
guanidinium hydrochloride (Gdn-HCl) on hydride transfer rate constants (kH) and steady state rate 
constants (kcat) was measured for EcDHFR, MpDHFR and TmDHFR in potassium phosphate 
buffers, pH 7, containing 0-1 M Gdn-HCl (Figure 6.2). 
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Figure 6.2: Effect of different concentrations of Gdn-HCl on catalysis by MpDHFR (red), EcDHFR 
(blue) and TmDHFR (kH in cyan and kcat in orange), at pH 7 and 20 C. 
 
The activity of the three enzymes was decreased by increasing the concentration of Gdn-HCl (Figure 
6.2). TmDHFR, despite being activated in the presence of urea,
94
 is the most sensitive of the three 
enzymes to Gdn-HCl and lost 50% of its activity at 100 mM Gdn-HCl, which is about the same value 
that Glansdorff et al. have reported previously.
94
 MpDHFR seems to be the most stable of the three 
enzymes to Gdn-HCl (Table 6.3). This enzyme lost 50% of its activity in the pre-steady state at about 
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400 mM Gdn-HCl, while EcDHFR lost half of its activity at 250 mM Gdn-HCl. On the other hand, 
activation of EcDHFR was seen at very low concentrations of Gdn-HCl in the steady state where the 
rate-limiting step is the product release step (Table 6.4).
7
 
 
Table 6.3: Pre-steady-state hydride rate constants (kH) during catalysis by MpDHFR, 
EcDHFR and TmDHFR in different concentrations of Gdn-HCl at pH 7 and 20 C. 
Gdn-HCl (M) 
kH (s
-1
) 
MpDHFR EcDHFR
 
 TmDHFR
 
 
0 341.15 ± 25.37 192.22 ± 20.30 0.13 ±0.010 
0.01 395.57 ± 59.23 179.93 ± 18.98 0.12 ±0.008 
0.02 388.12 ± 71.48 169.50 ± 11.41 0.12 ±0.017 
0.05 356.90 ± 51.98 153.92 ± 3.65 0.10 ±0.012 
0.1 327.19 ± 24.33 135.10 ± 2.08 0.07 ±0.004 
0.25 259.34 ± 20.53 106.63 ± 2.74 0.04 ±0.004 
0.5 119.44 ± 19.90 77.22 ± 4.13 0.02 ±0.004 
0.75 52.82 ± 4.49 51.18 ± 2.91 0.01 ±0.003 
1 37.35 ± 6.39 30.91 ± 4.68 nd 
nd: not determined 
 
Table 6.4: Steady-state rate constants (kcat) during catalysis by MpDHFR, EcDHFR and 
TmDHFR in different concentrations of Gdn-HCl at pH 7 and 20 C. 
Gdn-HCl (M) 
kcat /s
-1 
MpDHFR EcDHFR
 
 TmDHFR
 
 
0 13.94 ± 0.20 8.12 ± 0.83 0.09 ± 0.023 
0.01 12.36 ± 1.33 10.21 ± 0.46 0.12 ± 0.028 
0.02 12.28 ± 0.72 10.88 ± 0.84 0.09 ± 0.003 
0.05 9.48 ± 4.08 11.02 ± 0.27 0.08 ± 0.014 
0.1 5.87 ± 1.86 8.45 ± 1.05 0.06 ± 0.005 
0.25 5.72 ± 0.15 7.80 ± 0.20 0.04 ± 0.006 
0.5 4.72 ± 0.25 6.64 ± 0.60 0.03 ± 0.004 
0.75 3.42 ± 0.42 4.91 ± 0.29 0.01 ± 0.004 
1 2.11 ± 0.48 3.91 ± 0.07 nd 
nd: not determined 
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6.3 Salt effect on catalysis by MpDHFR 
Previous work was done in our group to explore the effect of various salts on the steady state rate 
constant of MpDHFR.
90
 For further investigation, the pre-steady state rate constant of hydride 
transfer and the kinetic isotope effect for MpDHFR were measured at pH 7 and 20 C with NADPH 
and NADPD using 100 mM potassium phosphate buffer containing various concentrations of NaCl, 
KF and KCl.  
 
The rate constant for hydride transfer is not affected by different salt concentration (Figure 6.3). 
However, with NADPD the rate constant decreased with increasing salt concentration. The deuteride 
transfer rate constant is salt independent above 0.5 M of NaCl and KCl, but not with KF. MpDHFR 
has shown a salt dependent KIE at concentrations lower than 0.5 M of NaCl and KCl. However, 
there was no further salt dependence of the KIE at concentrations higher than 0.5 M. In contrast to 
MpDHFR, recent work in our group done by Dr Joel Loveridge has shown that the rate constants 
during the EcDHFR reaction and the kinetic isotope effect are salt independent. 
 
 
Figure 6.3: A. Rate constants for hydride (diamonds) and deuteride (circles) transfer catalysed by 
MpDHFR in the presence of varying concentrations of salts at 20 C. B. Pre-steady state KIE for 
MpDHFR with different salts at 20 C. 
 
Previously, the effect of various salts (NaCl, KCl, and KF) and their concentration on the steady state 
rate constant of TmDHFR
173
 and MpDHFR
90
 has been investigated. For TmDHFR, a significant 
decrease in the specific activity of the enzyme was noted when the ionic strength of KF was raised 
above 0.1 M. The specific activity of TmDHFR was increased somewhat with NaCl across the 
A B 
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concentration range studied with ~8% increase in activity compared to ~0 M NaCl. KCl slightly 
increased the steady state rate of TmDHFR up to ~250 mM, but at concentrations above 0.5 M the 
rate decreased to ~80% of the initial activity at low ionic strength. Increasing the ionic strength of the 
solution in which the enzyme was incubated was found also to increase the thermal melting 
temperature of TmDHFR.
173
  
 
The steady-state reaction catalysed by MpDHFR in the presence of various salts (NaCl, KCl, and 
KF) shows a similar effect to that seen with TmDHFR, except the specific activity was decreased 
below that at ~0 M with NaCl and KCl at concentrations above 0.5 M. In addition, the effect of KF 
on the specific activity was different to that seen in TmDHFR as the rate of MpDHFR was not 
reduced to below that at ~0 M until concentrations above 0.75 M, with about 10% average increase. 
An activating effect on the steady state reaction for MpDHFR was seen at concentrations lower than 
0.5 M of NaCl and KCl, with an average increase in the rate constant of ~20% for NaCl and ~12% 
for KCl.
90
 Similar to the salt effect seen in TmDHFR, and the effect of bound ligands on the thermal 
stability of MpDHFR, the presence of salt also increased the thermal melting point of the 
psychrophilic enzyme. This was seen with each salt used, suggesting the anion is no more 
responsible for the stabilising effect than the cation.  
 
DHFR from the halophilic bacterium Haloferax volcanii (HvDHFR) is activated as well at high salt 
concentrations. This finding was attributed to the effect of salt on substrate affinity.
157
 However, 
while salts were found to stabilize both enzymes, EcDHFR and HvDHFR, by a common 
mechanism,
157
 the mesophilic DHFR showed loss of steady state activity with increasing salt 
concentrations. This reduction in the turnover number for EcDHFR is not accompanied by any 
significant change in structure or substrate binding affinities. It was suggested that the loss of 
catalytic ability for EcDHFR in the presence of salt may arise from an reduced flexibility of the 
enzyme as it becomes more stable in the presence of salt.
157
 EcDHFR is known to have mobile and 
flexible loops which undergo conformational changes during the catalytic cycle (see Chapter 
1).
71,75,174
 However, this hypothesis cannot be confirmed in the absence of NMR data for EcDHFR at 
different salt concentrations to assess the effect of salt on enzyme flexibility. 
 
Generally speaking, in the steady state the behaviour of the mesophilic enzyme is similar to the 
psychrophilic DHFR at salt concentration ≥ 0.5M. Both enzymes suffer from a decrease in turnover 
numbers and show structure stability. Under pre-steady state conditions both enzymes show salt 
independent kinetic isotope effect under the same conditions (EcDHFR at all salt concentrations and 
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MpDHFR at salt concentration ≥ 0.5M). These observations show the similarity between the two 
enzymes and suggest adaptation from MpDHFR to the environment of its original organism, 
Moritella profunda, which needs NaCl for growth and is classified as a moderately halophilic 
bacterium.
175
 The loss of activity with increasing concentrations of chloride salts for EcDHFR may 
be due to impaired loop dynamics causing changes to the rate-determining step at high salt 
concentrations.
157
 But taking into consideration our previous findings that MpDHFR does not depend 
on loop dynamics during progress through the catalytic cycle (see Chapters 4 and 5) and the 
increased thermal stability for both enzymes at high salt concentrations, it may instead be that 
reduction in the weak interactions such as electrostatic interactions cause the decrease in the steady 
state rate constant at high salt concentrations rather than affecting the enzyme flexibility. 
 
Table 6.5: Pre-steady-state rate constant with NADPH (kH) during catalysis by MpDHFR in 
different concentrations of NaCl, KCl and KF at pH 7 
[Salt] (M) NaCl KCl
 
 KF
 
 
0 327.61 ± 30.06 327.61 ± 21.26 327.61 ± 30.10 
0.1 301.94 ± 30.53 331.62 ± 4.69 328.92 ± 20.22 
0.2 279.53 ± 7.78 337.69 ± 5.47 318.68 ± 20.37 
0.5 335.95 ± 30.79 35.63 ± 47.90 312.10 ± 7.22 
0.1 312.21 ± 26.83 302.93 ± 16.44 323.80 ± 16.22 
1.5 306.66 ± 30.86 335.18 ± 27.72 313.91 ± 15.86 
2 266.21 ± 14.58 368.39 ± 6.31 419.25 ± 22.53 
 
Table 6.6: Pre-steady-state rate constant with NADPD (kD) during catalysis by MpDHFR in 
different concentrations of NaCl, KCl and KF at pH 7 
[Salt] (M) NaCl KCl
 
 KF
 
 
0 257.98 ± 24.75 257.98 ± 24.75 257.98 ± 24.75 
0.1 196.36 ± 12.86 171.76 ± 15.15 161.14 ± 26.39 
0.2 173.01 ± 14.11 158.14 ± 14.14 188.87 ± 72.82 
0.5 135.40 ± 13.29 131.07 ± 7.60 172.72 ± 58.26 
0.1 119.40 ± 4.35 132.67 ± 6.74 142.32 ± 43.55 
1.5 125.57 ± 3.33 129.02 ±1 2.65 142.87 ± 0.01 
2 118.61 ± 9.51 160.48 ± 39.77 153.91 ± 13.00 
 
Chapter 6: Results and discussion 
 136 
Table 6.7: Pre-steady-state kinetic isotope effect during catalysis by MpDHFR in different 
concentrations of NaCl, KCl and KF at pH 7 
[Salt] (M) NaCl KCl
 
 KF
 
 
0 1.27 ± 0.13 1.27 ± 0.12 1.27 ± 0.13 
0.1 1.54 ± 0.12 1.39 ± 0.09 2.04 ± 0.17 
0.2 1.62 ± 0.09 2.14 ± 0.09 1.69 ± 0.39 
0.5 2.48 ± 0.13 2.64 ± 0.15 1.81 ± 0.34 
0.1 2.61 ± 0.09 2.28 ± 0.07 2.28 ± 0.31 
1.5 2.44 ± 0.10 2.60 ± 0.13 2.20 ± 0.05 
2 2.24 ± 0.10 2.30 ± 0.25 2.73 ± 0.10 
 
Table 6.8: Effect of salts on the steady state rate constants for the MpDHFR reaction at pH 7 
[Salt] (M) NaCl KCl
 
 KF
 
 
0 11.41± 0.82 11.41± 0.82 11.41± 0.82 
0.1 14.78 ± 0.79 14.89 ± 0.79 13.45 ± 0.66 
0.2 15.41 ± 0.76 12.98 ± 0.47 13.28 ± 0.78 
0.5 12.22 ± 0.68 11.17 ± 0.58 12.72 ± 0.48 
0.75 10.65 ± 0.57 9.03 ± 0.42 11.24 ± 0.53 
1.0 7.95 ± 0.26 6.59 ± 0.34 9.80 ± 0.35 
Data measured by Dr Rhiannon Evans
90
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6.4 Temperature dependence of the pre-steady state hydride transfer rate constant and KIEs 
for MpDHFR and EcDHFR at 0.5 M NaCl. 
To investigate the effect of salt on the temperature dependence of the KIE for DHFR the pre-steady 
state rate constant for hydride/deuteride transfer (kH/kD) during MpDHFR and EcDHFR catalysis was 
measured at pH 7.0 as a function of temperature between 5 and 30 °C using 100 mM potassium 
phosphate buffer, 10 mM βME and 0.5 M NaCl.  
2
3
4
5
6
3.2 3.3 3.4 3.5 3.6
10
-3
/T / K
-1
ln
 (
k
)
A)
-0.2
0.2
0.6
1
1.4
1.8
3.2 3.3 3.4 3.5 3.6
10
-3
/T / K
-1
ln
 (
K
IE
)
4
5
6
3.2 3.3 3.4 3.5 3.6
10
-3
/T / K
-1
ln
 (
k
)
B)
-0.4
0
0.4
0.8
1.2
1.6
3.2 3.3 3.4 3.5 3.6
10
-3
/T / K
-1
ln
 (
K
IE
)
.
.
.
Figure 6.4: Arrhenius plots for hydride (circle)/deuterium (triangle) transfer and the corresponding 
KIEs for the reaction catalysed by EcDHFR (A) using 0.1 M (black) and 0.5 M (cyan) NaCl, and 
MpDHFR (B) using 0.1 M (blue), 0.5 M (green) and 0.5 M NaCl with 33% glycerol (red). 
 
For EcDHFR, using 0.5 M NaCl affected the rate constants of hydride transfer but not deuteride 
transfer rate constants, which caused the decrease in the KIE values. The KIE was decreased by 
increasing temperature either at low or high salt concentration (Figure 6.4A). On the other hand, the 
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KIE for MpDHFR in 0.5 M NaCl and 0.5 M NaCl with 33% glycerol increases with temperature 
(Figure 6.4B), suggesting the chemical step is masked by kinetic complexity at low temperatures 
(i.e., the chemical step becomes less rate limiting). To explore if the effect of salt on the kinetic 
isotope effect during catalysis by MpDHFR is due to effects on enzyme flexibility and not 
electrostatic interactions, the temperature dependence of the KIE was measured in 0.5 M salt and 
33% glycerol. The data obtained was very similar to that in absence of glycerol, indicating that the 
change in the temperature dependence of the KIE is due to changing active site electrostatic forces 
rather than enzyme dynamics. 
 
Table 6.9: Temperature dependence of the pre-steady-state rate constants for hydride (kH) 
and deuteride (kD) transfer during catalysis by EcDHFR and MpDHFR at 0.5 M NaCl and 
pH 7.  
T (
o
C) 
EcDHFR
 
MpDHFR 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 63.83 ± 1.08 24.51 ± 1.24 233.98 ± 7.35 137.46 ± 2.94 
10 83.01 ± 3.53 36.59 ± 0.16 277.80 ± 4.35 122.21 ± 8.19 
15 107.20 ± 3.53 46.20 ± 1.81 278.42 ± 22.56 122.21 ± 4.39 
20 119.85 ± 9.95 60.98 ± 2.06 404.36 ± 3.13 162.72 ± 3.24 
25 168.10 ± 5.01 91.11 ± 6.79 437.73 ± 6.82 17.77 ± 7.63 
30 196.32 ± 0.61 104.71 ± 2.01 488.80 ± 119.64 182.45 ± 10.49 
 
Table 6.10: Temperature dependence of the pre-steady-state rate kinetic isotope 
effect during catalysis by EcDHFR and MpDHFR at 0.5 M NaCl and pH 7.  
T (
o
C) EcDHFR
 
MpDHFR 
5 2.60 ± 0.05 1.70 ± 0.04 
10 2.27 ± 0.04 2.27 ± 0.07 
15 2.32 ± 0.05 2.28 ± 0.09 
20 1.97 ± 0.09 2.49 ± 0.02 
25 1.84 ± 0.08 2.48 ± 0.05 
30 1.87 ± 0.02 2.68 ± 0.25 
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Table 6.11: Temperature dependence of the pre-steady-state rate constants for 
hydride (kH) and deuteride (kD) transfer and kinetic isotope effect (KIE) during 
catalysis by EcDHFR and MpDHFR at 0.5 M NaCl, pH 7 and 33% glycerol.  
T (
o
C) kH (s
-1
) kD (s
-1
) KIE 
5 119.45 ± 9.69 107.63 ± 16.50 1.11 ± 0.17 
10 144.37 ± 37.95 106.08 ± 11.34 1.36 ± 0.28 
15 152.31 ± 20.49 106.08 ± 1.12 1.44 ± 0.13 
20 219.60 ± 12.70 149.88 ± 13.93 1.47 ± 0.11 
25 233.41 ± 15.20 148.01 ± 3.95 1.58 ± 0.07 
30 221.38 ±  14.04 130.38 ± 4.30 1.70 ± 0.07 
 
The salt effect on the pre-steady state rate constants and temperature dependence of the KIEs was 
examined as well for the EcDHFR-S148P and EcDHFR-A19K/S148P variants (Figure 6.5) to test 
the hypothesis that impairing loop dynamics in MpDHFR is probably the reason for the striking 
differences in the salt effect on the temperature dependence of KIE in the mesophilic and the 
psychrophilic enzyme. 
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Figure 6.5: Arrhenius plots (right) and temperature dependence of KIE (left) of the pre-steady-state 
rate constants for hydride (kH, circles) and deuteride (kD, triangles) transfer at pH 7 during catalysis 
by wild type EcDHFR at 0.1 M salt (black) and 0.5 M salt (cyan) and for the two variants EcDHFR-
S148P (green) and EcDHFR-A19K/S148P (orange) at 0.5 M salt. 
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The two variants at 0.5 M NaCl show very similar rate constants and temperature dependence of the 
KIE to the wild type EcDHFR (Tables 6.12 and 6.13). These data indicate that impairing loop 
dynamics in MpDHFR is not the reason for the salt effect observed here for this enzyme. 
 
Table 6.12: Temperature dependence of the pre-steady-state rate constants for hydride (kH) and 
deuteride (kD) transfer during catalysis by EcDHFR and MpDHFR at 0.5 M NaCl and pH 7.  
T (
o
C) 
EcDHFR-S148P
 
EcDHFR-A19K/S148P
 
kH (s
-1
) kD (s
-1
) kH (s
-1
) kD (s
-1
) 
5 56.56 ± 0.37 15.22 ± 0.01 49.15 ± 5.51 12.02 ± 0.80 
10 72.70 ± 1.15 20.34 ± 0.21 68.55 ± 6.83 15.72 ± 0.45 
15 83.78 ± 1.15 29.89 ± 3.80 77.00 ± 6.83 25.30 ± 4.38 
20 107.55 ± 6.15 37.82 ± 0.82 92.69 ± 2.70 34.75 ± 6.01 
25 142.00 ± 1.41 49.10 ± 0.42 113.58 ± 3.29 47.64 ± 1.05 
30 185.50 ± 0.71 61.00 ± 0.71 142.00 ± 1.41 55.42 ± 2.39 
 
Table 6.13: Temperature dependence of the pre-steady-state rate kinetic isotope 
effect during catalysis by EcDHFR and MpDHFR at 0.5 M NaCl and pH 7.  
T (
o
C) EcDHFR-S148P
 
EcDHFR-A19K/S148P
 
5 3.72 ± 0.01 4.09 ± 0.13 
10 3.57 ± 0.02 4.36 ± 0.10 
15 2.80 ± 0.13 3.04 ± 0.19 
20 2.84 ± 0.06 2.67 ± 0.18 
25 2.89 ± 0.01 2.38 ± 0.04 
30 3.04 ± 0.01 2.56 ± 0.04 
 
6.5 Conclusions 
Studying the origins of the stability of proteins is essential to understand their structure and function. 
Protein stability is the result of a delicate balance of strong attractive and repulsive forces, yielding 
the free energy of stabilization as a small difference between large numbers equivalent to a few weak 
intermolecular interactions.
176
 In this part of the thesis we examined the effect of different 
denaturants and salt concentrations on catalysis by DHFR.  
 
Chapter 6: Results and discussion 
 141 
A previous study has shown that the conformational stability for MpDHFR in urea is lower than the 
mesophilic and the thermophilic homologues.
60
 Unlike the dimeric, thermophilic homologue from 
Thermotoga maritima,
94
 no activation was observed for either MpDHFR and EcDHFR in urea. 
However, while the steady state rate constant is not affected when using 2 M urea, by about 3.2 M 
urea a 50% decrease in the steady state rate constant for MpDHFR was observed and more than 90% 
of the activity was lost at 5-7 M urea. The data presented here have shown that different 
concentrations of urea affect the rate constants of hydride transfer for the psychrophilic and the 
mesophilic DHFRs in a similar manner. 
 
For all of the three enzymes, TmDHFR, EcDHFR and MpDHFR, the activity was decreased by 
increasing the concentration of Gdn-HCl, with TmDHFR seeming to be the most sensitive and 
MpDHFR the least sensitive between the three enzymes. On the other hand, an activation of 
EcDHFR was seen at very low concentrations of Gdn-HCl in the steady state where the rate-limiting 
step is the product release step.
7
 
 
Previous studies in our group have shown that the thermal melting point of apo-MpDHFR is ~38 °C, 
which is lower than that of EcDHFR (TM ~51 °C) and TmDHFR (TM ~80 °C).
173
 The thermal 
melting point of MpDHFR can be increased by bound ligands such as MTX,
79
 and with increasing 
salt concentrations.
90
 Under steady state conditions at neutral pH, the MpDHFR catalysed reaction 
was slightly enhanced by addition of salts to the reaction buffer at concentrations <0.5 M. Such 
enzyme activation was not observed for the mesophilic EcDHFR,
157
 but a similar effect was seen for 
TmDHFR.
94,173
 However, no salt discrimination was seen for MpDHFR, unlike TmDHFR. A 
previous study suggested that the moderate halophilicty for MpDHFR is perhaps a feature of the 
enzyme due to the habitat of the native bacterium,
90
 which requires NaCl for growth.
175
  
 
In summary, structure stability and enzyme inactivation in the steady state was seen for the 
mesophilic DHFR at all salt concentrations
157
 and for the psychrophilic DHFR at salt concentration ≥ 
0.5 M.
90
 Under pre-steady state conditions both enzymes show salt independent kinetic isotope effect 
under the same conditions (EcDHFR at all salt concentrations and MpDHFR at salt concentration ≥ 
0.5 M). The different behaviour observed for MpDHFR at salt concentrations lower than 0.5 M 
suggesting adaptation to the environment of its original bacterium. The loss of activity for EcDHFR 
and MpDHFR at high salt concentrations is most probably due to affecting enzyme electrostatic 
interactions rather than decreasing protein flexibility.  
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7.1 Overall summary 
Studying the role of protein dynamics in enzyme catalysis is one of the hot spots in recent 
enzymology. The fact that the conformational movements of proteins can be important to ligand 
binding and release is broadly accepted. However, the debate arises when discussing the contribution 
of protein motion to the reaction chemical step. While some researchers support enzymatic 
promoting motion models suggesting that catalysis can be enhanced by the coupling of vibrational 
motion to the reaction coordinate pushing the reactants into a position that efficiently compresses the 
reaction barrier and enhances tunnelling in hydrogen-transfer reactions,
40,46-47,177
 others believe that 
such dynamics are not important for catalysis, but instead that the energy landscape and 
preorganisation within the active site is the dominant feature.
38,48-50,178
 
 
Studying the temperature dependence of the KIE is often used to understand the relation between 
protein dynamics and the rate of enzymatic reaction. For better understanding of how protein 
motions couple to the reaction coordinate and the effect of environmental conditions on these 
motions in DHFR, in this thesis the hydride transfer reaction and kinetic isotope effect have been 
investigated for the psychrophilic MpDHFR and various variants and compared to the mesophilic 
EcDHFR and the dimeric and thermophilic TmDHFR.  
 
MpDHFR is a cold adapted enzyme that was isolated from the organism Moritella profunda, isolated 
from deep sea sediments at 2 
o
C.
175
 MpDHFR has shown the highest rate constants compared to the 
mesophilic and the thermophilic DHFR homologues (EcDHFR and TmDHFR respectively). 
However, comparing the three DHFRs at their typical operating temperatures at pH 7 shows that 
MpDHFR is actually a slightly poorer catalyst than EcDHFR under single turnover conditions and is 
equivalent to TmDHFR in the steady state. Studying the temperature dependences of the KIE on 
hydride transfer reaction catalysed by MpDHFR, the mesophilic and extremely studied homologue, 
EcDHFR
103
 and the thermophilic homologue, TmDHFR
101
 have shown that the origin of chemistry 
in the three enzymes is similar. The data was interrupted according the environmentally coupled 
tunnelling model. 
 
In the steady state, TmDHFR has shown a different kinetic behaviour for the hydride transfer step 
than that observed for MpDHFR and EcDHFR. This can be due to dimeric properties for this 
enzyme. In the steady state, however, product release is the rate limiting step for MpDHFR and 
EcDHFR
7
 at pH 7 and the chemical step is partially limited at elevated pH. The chemical step is 
partially rate limiting the steady state rate constants for the dimeric enzyme, TmDHFR, at pH7. Thus, 
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it is difficult to compare the behaviour of the steady state temperature dependence of the KIEs of the 
monomeric enzymes with that of the dimeric enzyme.  
 
We have shown that impairing the occluded conformation does not affect the chemical step during 
catalysis by DHFR. Steady state kinetics and binding measurements in addition to evaluating a novel 
NMR method to study binding of NADPH to DHFR have suggested that the occluded conformation 
is important for EcDHFR to control the binding to NADP
+
 and guides the enzyme to follow the steps 
of the catalytic cycle in a strictly ordered manner. Removal of the occluded conformation in 
EcDHFR causes a great decrease in the value of kcat resulting from the change in the steady state rate 
limiting step for product release from the ternary complex E.NADP
+
.THF instead of E.NADPH.THF. 
In spite of lacking the occluded conformation, MpDHFR seems to follow a similar catalytic cycle to 
EcDHFR at pH 7, however, it still unclear how this occurs. At low pH, the decrease in the steady-
state reaction rate for MpDHFR might be due to the reaction being diverted into two parallel kinetic 
pathways as has been described previously for MtDHFR.
70
  
 
A recent study by Wright and co-workers
179
 is in a good agreement with our data. The study has 
shown that the occluded conformation is important for EcDHFR as NADP
+
 and THF concentrations 
in the Escherichia coli cells is inhibitory. The study has shown also that human DHFR do not form 
the occluded conformation and instead binds to the cofactor more tightly and release it more slowly 
which is explaining the NMR date we reported for MpDHFR in Chapter 4. This behaviour for human 
DHFR was suggested to be due to the low cellular concentrations of NADP
+
 and THF in vertebrate 
cells.
179
 However, in this thesis we have reported the same behaviour for the bacterial DHFR from 
Moritella profunda and have shown that many others DHFRs lack a hydrogen bond donor in the 
position corresponding to Ser148. Therefore, the occluded conformation is unlikely to be a general 
characteristic for DHFR catalysis. 
 
For further understanding of the role of loop dynamics during catalysis by DHFR, various MpDHFR 
and EcDHFR variants in the M20 loop and the FG loop were created and studied. Mutations in the 
M20 loop of EcDHFR most probaply has affected the dynamic of the loop causing the remarkable 
decrease in the steady state rate constants without affecting the hydride transfer step. On the other 
side, none of the MpDHFR variants has shown a large difference in the turnover number, suggesting 
that such M20 loop dynamics observed in EcDHFR do not control the catalytic cycle in MpDHFR. 
In contrast to the reported data from similar mutations for EcDHFR, mutation in the FG loop at 
positions 121 and 122 in MpDHFR did not affect the chemical step of the reaction. Instead the two 
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variants have shown a sharp decrease in the steady state rate constants, which suggests a change in 
the physical step without perturbing the chemistry of the reaction. Studying the MpDHFR-M42W 
variant in the future could be of great interest as the equivalent variant in EcDHFR has shown a 
sharp decrease in the hydride transfer rate constant and is thought to be involved in long range 
coupled motion in EcDHFR.
150,152
 
 
H/D exchange experiments have suggested that the M20 loop, FG loop and GH loop may be more 
flexible in EcDHFR compared to MpDHFR.
96
 Therefore, in light of the above findings, it is 
reasonable to conclude that the dynamic nature reported for the mesophilic enzyme from Escherichia 
coli is not clear for the psychrophilic homologue from Moritella profunda suggesting that MpDHFR 
is using a different mechanism to modulate the enzyme’s ability to adopt different ligand complexes 
compared to the mesophilic enzyme EcDHFR. On basis of these findings it is important to refer that 
the currant enzymatic models that reveals enzyme dynamics to catalysis efficiency has become 
invalid. As a consequence, modifying these models has become an essential matter. 
 
The effect of different denaturant and salt concentrations on catalysis by DHFR was also examined. 
The results have shown that addition of urea to the reaction buffer is affecting the chemical step of 
the reaction catalysed by the monomeric DHFRs (MpDHFR and EcHFR) in a similar manner and 
different to that catalysed by the dimeric enzyme, TmDHFR. Increasing the concentration of Gdn-
HCl decreased the activity for all the DHFR homologues studied here. However, TmDHFR has 
shown the greatest sensitivity to Gdn-HCl followed by EcDHFR then MpDHFR. Circular dichroism 
spectroscopic and NMR can be used for further understanding of the effect of denaturants on 
structure and catalysis of DHFR 
 
Studying salt effect on MpDHFR and EcDHFR has shown that the kinetic isotope effect does not 
dependent on salt concentration. The data suggests adaptation of MpDHFR to the environmental of 
its original bacterium Moritella profunda, which is a moderately halophilic organism that needs 
NaCl for growing and can cultured from marine broth.175 The loss of activity for EcDHFR and 
MpDHFR at high salt concentrations is most probably due to affecting enzyme electrostatic 
interactions rather than decreasing protein flexibility. However, this cannot be confirmed in absence 
of structure information at various salt concentrations. 
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7.2 Future directions 
The best evidence for the existence of an occluded conformation in MpDHFR would be from a 
structural technique such as crystallography or multidimensional NMR spectroscopy. The crystal 
structures of the apo-MpDHFR and the ternary complex MpDHFR.NADPH.MTX have been 
reported earlier.
62
 Also, previous work in our group have determined the 
1
H, 
13
C and 
15
N chemical 
shift assignments of MpDHFR in complex with NADP
+
 and folate.
95
 In the long term the crystal 
structure and the three dimensional solution structure of MpDHFR.folate complex or 
MpDHFR.MTX (as a model for the DHFR.THF complex) can be solved. These complexes show the 
occluded conformation in EcDHFR,
59
 but will expected to be in the closed conformation in 
MpDHFR, similar to LcDHFR
119
 which also lacks the Serine residue at position 148. 
 
15
N labelling of the cofactor NADP
+
 has provided valuable information of how the cofactor binds to 
various DHFRs through 
1
H-
15
N HSQC NMR spectroscopy. Such methodology can be applied to 
study the different EcDHFR and MpDHFR M20 loop variants, studied in chapter 5, to investigate 
how the M20 loop residues can affect the binding of NADP
+
. This method can also be used in studies 
of many other nicotinamide dependent enzymes to improve our understanding of enzyme catalysis in 
general and may lead to advances in enzymology and other aspects of chemical catalysis in the 
broadest sense. Furthermore, it would be exciting to synthesise labelled DHF and THF and design a 
different NMR experiments to evaluate more information on how DHFR binds to different ligands. 
 
Study of the various M20 loop and FG loop variants has shown that loop dynamic that has well 
established for the mesophilic enzyme from Escherichia coli does not control catalysis by the 
psychrophilic homologue from Moritella profunda, however, the two enzymes use the same catalytic 
cycle and the nature of the chemistry in both enzymes is similar. Various NMR experiments can be 
used to study dynamics in MpDHFR and compare it to the extensively studied enzyme (EcDHFR). It 
seems interesting also to study the MpDHFR-M42W variant and compare it to the equivalent variant 
in EcDHFR. 
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Scheme 1: Formation of 
15
N-nicotinamide. 
 
 
 
 
Scheme 2: Formation of 
15
N-NADP
+ 
 
 
 
 
Figure I.1: 
1
H-NMR spectra in d6-DMSO of nicotinamide (left, red) and 
15
N-nicotinamide (right, 
black). The peaks of the amide protons are indicated. 
 
 
 
 
Figure I.2: 
13
C-NMR spectra in d6-DMSO of nicotinamide (left, red) and 
15
N-nicotinamide (right, 
black), showing the splitting of the amide carbonyl peak by 
15
N. 
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Figure I.3: 
15
N-NMR spectrum in d6-DMSO of 
15
N-nicotinamide. 
 
 
 
 
 
 
 
 
 
 
Figure I.4: FPLC trace for the preparation of tetrahydrofolate (THF) from dihydrofolate (DHF) 
using dihydrofolate reductase (DHFR). 
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Figure I.5: 
1
H-NMR spectrum in D2O of tetrahydrofolate (THF). 
 
 
 
 
Figure I.6: Expansion of 
1
H-NMR spectrum of tetrahydrofolate (THF) in D2O showing the chemical 
structure and corresponding peak integration. 
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Figure I.7: FPLC trace (absorption at 280 nm, purple line) showing the elution of DHFR from Q-
sepharose anion exchange resin using a 0-1 M NaCl gradient (green line). 
 
 
 
 
Figure I.8: 10% SDS-PAGE gel showing purification of MpDHFR. lane 1 to 12: fractions collected 
during Q-sepharose purification, lane 13: pure DHFR after elution from a Superdex75 size exclusion 
column. M: protein molecular markers shown in kDa. 
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Figure I.9: FPLC trace (absorption at 280 nm) for the purification of DHFR using a Superdex75 size 
exclusion column. 
 
 
 
 
Figure I.10: 10% SDS-PAGE gel showing purification of MpDHFR. M: protein molecular markers 
shown in kDa, lane 1: supernatant solution, lanes 2 to 5: protein after Q-sepharose purification, lanes 
6 to 8: pure DHFR after elution from the Superdex75 size exclusion column.  
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Figure I.11: FPLC trace for the preparation of reduced nicotinamide dinucleotide phosphate 
(NADPH/D) from the oxidized nicotinamide dinucleotide phosphate (NADP
+
). 
 
 
 
